[
    "This sample is a phase 1 trial for patients with small cell lung carcinoma, testing the drugs regorafenib (bay73-4506) in sequential or continuous administration with cisplatin and pemetrexed, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for cancer patients with rare tumors, testing the effectiveness of imatinib mesylate and cyclophosphamide at different dosing levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin 300mg and placebo in combination with metformin or other glucose lowering agents, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for women with metastatic or locally advanced breast cancer and HER2 overexpression, testing the effectiveness of trastuzumab, paclitaxel, and myocet as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase I trial for patients with schizophrenia and cognitive deficits, testing the effectiveness of papaverine or placebo as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug azd4547 on Japanese patients with advanced solid malignancies, including cancer, and the eligibility criteria include being over 25 years old and in relatively good overall health other than cancer.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors that have failed standard therapy or for which there is no standard therapy, and is indicated for treatment with anthracyclines. The study will test the efficacy of doxorubicin, pazopanib, and epirubicin in treating these tumors.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable solid tumors, including colorectal cancer, non-small-cell lung cancer, melanoma, and papillary thyroid cancer. The study aims to evaluate the safety and efficacy of XL281 and famotidine as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the drugs docetaxel and epirubicin hydrochloride, with eligibility criteria including confirmed adenocarcinoma of the prostate, progressive systemic disease, and specific patient characteristics such as age, performance status, and hematopoietic and hepatic function.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients with tumors overexpressing HER2neu, testing the efficacy of the drugs myocet, taxotere, and herceptin, with various eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drugs pemetrexed and topotecan on patients with various types of cancer, including ovarian, endometrial, cervical, and lung cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with adenocarcinoma of the pancreas, recurrent pancreatic cancer, or stage IV pancreatic cancer, testing the drugs vismodegib and gemcitabine hydrochloride, with specific eligibility criteria including age, performance status, blood counts, liver function, and contraceptive use.",
    "This sample is a phase 1 trial for healthy male volunteers, testing the effects of bisoprolol and rosuvastatin on subjects with specific inclusion and exclusion criteria, including age, BMI, blood pressure, and history of certain diseases or substance abuse.",
    "This sample is a phase 1 clinical trial for patients with mantle cell lymphoma, testing the drugs PD 0332991 and bortezomib, with specific eligibility criteria including prior chemotherapy and rituximab treatment, as well as normal organ and marrow function.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drugs dasatinib, bortezomib, and dexamethasone, with specific eligibility criteria for participation.",
    "This sample is a phase 1/phase 2 trial for the treatment of diabetic macular edema using ranibizumab, with specific inclusion and exclusion criteria, and the use of OCT testing and retinal photography for assessment.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug canagliflozin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 1 diabetes using etanercept and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma who have relapsed or are refractory to prior treatments, and it aims to evaluate the efficacy and safety of hll1-dox, a doxorubicin conjugate of milatuzumab, as a potential treatment option.",
    "This sample is a phase 1/phase 2 trial for patients with progressive or recurrent glioblastoma, testing the drug tandutinib, with eligibility criteria including histologically confirmed glioblastoma, measurable disease, and specific medical conditions and exclusions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the combination of abt-751 and carboplatin as a potential treatment option. The eligibility criteria include age, confirmed diagnosis, measurable lesions, advanced stage of disease, and adequate hematologic, renal, and hepatic function. The exclusion criteria include other malignancies, untreated CNS metastasis, concurrent anti-cancer therapy or radiotherapy, and allergies to carboplatin or sulfa.",
    "This sample is a phase 1/phase 2 trial for metastatic colorectal cancer, testing the drugs azd2171, folfox, and placebo cediranib, with inclusion criteria including WHO performance status 0-1 and a life expectancy of 12 weeks or longer.",
    "This sample is a phase 1 clinical trial for type 2 diabetes mellitus, testing the drugs mk-0893 at different doses and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients diagnosed with chronic lymphocytic leukemia or small lymphocytic leukemia, testing the effectiveness of lenalidomide, fludarabine, and rituximab as a systemic therapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for HIV prevention, testing the efficacy of rectal and vaginal formulations of tenofovir 1% gel and a universal hec placebo gel formulation, with eligibility criteria including being HIV-1 uninfected, having immunity to Hepatitis B, and abstaining from certain sexual practices.",
    "This sample is a phase 1 trial for patients with stage IIIB, IIIC, or IV breast cancer with HER2/neu overexpression, testing the combination of lonafarnib and paclitaxel as a potential therapy, with specific eligibility criteria for disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This sample is a phase 1 clinical trial for patients with various types of cancer, including lung, breast, pancreatic, head and neck, and gastric cancer. The trial is testing the drug 2-deoxy-d-glucose (2dg) in patients who have previously received chemotherapy and have no curative standard treatment available. The eligibility criteria include age, performance status, disease status, and ability to understand and consent to the study. There are also exclusion criteria, such as CNS metastases, infections, cardiovascular disease, and other medical conditions that could interfere with the study.",
    "This sample is a phase 1 clinical trial for cancer patients, testing the effectiveness of multiple drugs including trametinib, docetaxel, erlotinib, pemetrexed, carboplatin, nab-paclitaxel, and cisplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung carcinoma, testing the efficacy of pemetrexed, carboplatin, and sorafenib compared to pemetrexed, carboplatin, and placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of central retinal vein occlusion using ranibizumab (lucentis), with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the efficacy of exenatide once weekly compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic colorectal carcinoma, testing the drugs su011248, irinotecan, and cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the drug pazopanib in patients with macular degeneration, specifically those with subfoveal choroidal neovascularization, and it includes detailed eligibility criteria for participants.",
    "This sample is a phase 1 trial testing the drug glpg0492 and placebo on healthy male subjects, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer, testing the effectiveness of pemetrexed, cisplatin, and carboplatin as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with recurring or metastatic Pancreatic Adenocarcinoma, testing the effectiveness of gemcitabine and etanercept as potential treatments.",
    "This sample is a phase 1/phase 2 trial for patients with diabetes mellitus, testing the drugs viaject\u00ae25, viaject\u00ae7, and insulin lispro, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for patients with malignant melanoma, testing the drug cc-5013, with specific eligibility criteria including age, performance status, laboratory test ranges, and exclusion criteria such as prior chemotherapy treatment and serious medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced or metastatic pancreatic adenocarcinoma, testing the efficacy of capecitabine and PHY906 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of hepatitis C, using the drugs bavituximab and pegylated interferon, with specific eligibility criteria including age, HCV genotype, HCV RNA level, and normal hematology and chemistry variables.",
    "This sample is a phase 1/phase 2 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs glycopyrrolate, tiotropium, and placebo. The inclusion criteria include age, informed consent, COPD diagnosis, smoking history, lung function measurements, and airway reversibility. The exclusion criteria include allergies, blood eosinophil count, abnormal physical examination and ECG parameters, significant diseases unrelated to COPD, recent respiratory tract infection, oxygen therapy, other lung diseases, intolerance or hypersensitivity to treatment, history of alcohol or substance abuse, recent corticosteroid or tiotropium use, and pregnancy or lactation.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent epithelial ovarian cancer, primary peritoneal carcinomatosis, or fallopian tube cancer, testing the drug decitabine. The eligibility criteria include having platinum-resistant or platinum refractory disease, measurable or detectable disease, being at least 18 years old, and having acceptable organ function.",
    "This sample is a phase 1 trial for participants with type 2 diabetes mellitus, testing the effectiveness of ertugliflozin and placebo as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy individuals, testing the drug imatinib mesylate, and the eligibility criteria include being free from clinically significant illness or disease, having a BMI less than 31 kg/m2, and using effective birth control for female participants.",
    "This sample is a phase 1/phase 2 trial investigating the use of IVIG and rituximab in kidney transplant patients with anti-HLA antibodies, with the goal of inhibiting cytotoxic antibody activity and monitoring anti-HLA antibody levels.",
    "This sample is a phase 1/phase 2 trial for patients with confirmed HER2+ ve metastatic breast cancer who have previously been treated with trastuzumab and progressed. The study will test the effectiveness of panobinostat and trastuzumab in these patients, and includes eligibility criteria such as age > 18, adequate laboratory values, and an ECOG performance status of <2. There are also exclusion criteria, such as active CNS disease or brain metastases, impaired heart or gastrointestinal function, and concomitant use of certain drugs or anti-cancer therapies. Female patients who are pregnant or breastfeeding or not willing to use an effective method of birth control are also excluded.",
    "This sample is a phase 1 clinical trial for ulcerative colitis, testing the drugs placebo and rhumab beta7, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drug placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with melanoma, testing the drugs bortezomib and interferon alfa-2b, with specific eligibility criteria including measurable disease, ECOG performance status \u2264 2, and normal organ and marrow function. Exclusion criteria include certain blood counts, creatinine clearance, brain metastases, peripheral neuropathy, hypersensitivity to the drugs, proteinuria, pregnancy or breastfeeding, recent use of other investigational drugs, and serious medical or psychiatric illness.",
    "This sample is a phase 1/phase 2 trial for patients with non-resectable or metastatic pancreatic cancer, testing the effectiveness of everolimus, cetuximab, irinotecan, capecitabine, and oxaliplatin as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 clinical trial for patients with prostate cancer, testing the drugs taxotere and doxil, with eligibility criteria including specific disease progression markers, previous cytotoxic therapy, age, performance status, and adequate organ function.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndromes (MDS) and leukemia, testing the effectiveness of arsenic trioxide and azacitidine as treatments. The eligibility criteria include confirmed MDS diagnosis, adequate iron stores, and certain blood test results.",
    "This sample is a phase 1 trial for a respiratory syncytial virus drug called medi-557, with eligibility criteria including age, informed consent, birth control, weight, and ability to complete a follow-up period, while exclusion criteria include inability to complete the follow-up period, concurrent enrollment in another study, abnormal ECG, history of immunodeficiency, and positive lab tests for Hep A, B, C, or HIV.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia (AML) who did not respond to first-line induction therapy. The study aims to evaluate the efficacy of gemtuzumab ozogamicin, mitoxantrone, and etoposide as potential treatments for CD33 positive AML. The inclusion criteria include age between 18 and 70, ECOG Performance Status of 0-2, and specific laboratory values. Exclusion criteria include prior use of the mentioned drugs, certain medical conditions, and pregnancy or breastfeeding.",
    "This sample is a phase 1 trial testing the effectiveness of sertraline (Zoloft) and simvastatin (Zocor) in treating mild depression in patients aged 18-60 with elevated inflammatory markers.",
    "This sample is a phase 1/phase 2 trial for liver cancer patients who meet specific eligibility criteria, including having hepatocellular carcinoma, being a candidate for transarterial chemoembolization, and meeting certain patient characteristics. The trial involves the use of doxorubicin-eluting beads and everolimus as potential treatments.",
    "This sample is a phase 1 trial for patients with relapsed/refractory B-cell CLL or SLL, testing lenalidomide, rituximab, and cyclophosphamide as a treatment option, with specific eligibility criteria including age, previous therapy, performance status, and laboratory test results.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent non-small cell lung cancer, recurrent prostate cancer, stage III prostate cancer, stage IIIB non-small cell lung cancer, stage IV non-small cell lung cancer, stage IV prostate cancer, or unspecified adult solid tumor. The trial will test the drug docetaxel and has specific eligibility criteria for participants.",
    "This phase 1 clinical trial aims to evaluate the efficacy of velcade and vorinostat in patients with non-small cell lung cancer (NSCLC) who are eligible for surgical resection, and the study includes specific inclusion and exclusion criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for patients with refractory metastatic melanoma, testing the efficacy of dmf5 melanoma reactive til, cyclophosphamide, fludarabine, and aldesleukin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with schizophrenia, testing the efficacy of aripiprazole im depot and aripiprazole tablets as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic breast cancer, testing the drug amrubicin, and includes eligibility criteria such as age, HER2-negative diagnosis, prior chemotherapy regimens, organ function requirements, and exclusion criteria such as concurrent therapy, previous high-dose chemotherapy, uncontrolled brain metastases, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial testing the drug cetuximab for patients with histologically proven squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myeloid leukemia (CML) who have resistance or suboptimal response to imatinib, dasatinib, or nilotinib and no known T315I/A Abl-kinase mutation. The study will test the efficacy of dasatinib and bms-833923 in treating CML patients with advanced-phase CML or chronic-phase CML.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia (AML) using autologous tumor cell vaccine and therapeutic autologous dendritic cells as treatment, with specific eligibility criteria including diagnosis of AML, adequate dendritic cells and AML blasts, and no clinical evidence of CNS leukemia.",
    "This sample is a phase 1 clinical trial for patients with advanced and/or metastatic cancer that is refractory to standard therapy, testing the drug ly2584702. The eligibility criteria include having adequate organ function, a performance status of less than or equal to 2, and an estimated life expectancy of 12 weeks or greater.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable solid tumors, testing the drug 1-methyl-d-tryptophan. The eligibility criteria include specific disease requirements, performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions.",
    "This sample is a phase 1 trial investigating the use of riociguat in patients with pulmonary hypertension due to chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with lung cancer and metastatic cancer, testing the drug rad001, and includes eligibility criteria such as stable extracranial disease, specific performance status, and various laboratory values.",
    "This sample is a phase 1 trial that aims to investigate the effects of Nexium and placebo on athletes with exercise-triggered asthma and gastroesophageal reflux, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial testing the drug mp-424 (telaprevir) on patients with genotype 1b chronic hepatitis C, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for esophageal cancer, testing the drugs cisplatin and fluorouracil, with eligibility criteria including histologically confirmed carcinoma, resectable disease, and specific patient characteristics.",
    "This sample is a phase 1 clinical trial for patients with metastatic or inoperable malignancy, testing the drug PT-523 for injection, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent glioblastoma multiforme, glioma, astrocytoma, or brain tumor, testing the efficacy of the drug combination itv depocyt + temozolomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of irritable bowel syndrome (IBS-C) using the drugs lubiprostone and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 trial for patients with breast cancer, testing the drugs sunitinib and taxotere, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia, lymphoma, neuroblastoma, immunodeficiencies, and anemia, testing the efficacy of drugs such as alemtuzumab, melphalan, busulfan, phenytoin, fludarabine, cyclophosphamide, horse antithymocyte globulin, rabbit antithymocyte globulin, and thiotepa, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with malignant melanoma, testing the drug pivanex, and includes eligibility criteria such as previous treatment with chemotherapy or IL-2, measurable disease, adequate renal and liver function, and a predicted life expectancy of at least 6 months.",
    "This sample is a phase 1 clinical trial for pancreatic adenocarcinoma, testing the drugs imexon and gemcitabine, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1 trial for patients with advanced solid tumors and cancer, testing the drugs azd7762 and irinotecan, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with pulmonary disease, chronic obstructive. The trial uses the drug uk-369,003 and has specific inclusion and exclusion criteria, such as GOLD criteria 2 to 4 and a 10 pack year history of smoking.",
    "This sample is a phase 1 trial for patients with metastatic or unresectable melanoma, testing the drugs bortezomib and sorafenib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for the drug ravpal-peg in patients with phenylketonuria (PKU), with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung carcinoma, testing the drugs bi 2536 and pemetrexed, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for patients with advanced, non-resectable and/or metastatic solid tumors who have failed conventional treatment. The trial aims to evaluate the efficacy of the drug \"bi 2536 bs\" administered intravenously. The inclusion criteria include patients with evaluable tumor deposits, age 18 or older, life expectancy of at least 6 months, and Eastern Cooperative Oncology Group (ECOG) performance score \u2264 2. Exclusion criteria include serious illness, pregnancy or breastfeeding, active infectious disease, known brain metastases, and other specific medical conditions.",
    "This sample is a phase 1/phase 2 trial for various diseases including leukemia, myeloma, lymphoma, and Hodgkin disease, with the drug AMD3100 being tested. The eligibility criteria include age restrictions, HLA-matched sibling donors, adequate organ function, negative HIV and HTLV antibodies, and compliance with the study regimen.",
    "This sample is a phase 1 trial testing the drugs ilaprazole and esomeprazole on healthy subjects to evaluate their pharmacokinetics and pharmacodynamics, with inclusion criteria including being between 18 and 55 years old, negative pregnancy test results, and negative breath test for H pylori.",
    "This sample is a phase 1/phase 2 trial for patients with glioblastoma multiforme (GBM) recurrence, testing the effectiveness of bcnu wafer, irinotecan, and bevacizumab drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for previously untreated patients with histologically confirmed DLBCL, testing the efficacy of bortezomib, cyclophosphamide, doxorubicin, vincristine, prednisolone, and lenograstim in patients aged 70 or less with advanced stage disease, normal liver function, and measurable disease. The study has specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer, testing the efficacy of cabazitaxel plus bavituximab as a second-line chemotherapy regimen, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with advanced, non-resectable and/or metastatic solid tumors who have failed conventional treatment, testing the drug bi 6727. The inclusion criteria include confirmed diagnosis of advanced tumors, age 18 or older, written informed consent, ECOG performance score \u2265 2, and measurable tumor deposits. The exclusion criteria include serious illness, pregnancy or breastfeeding, active infectious disease, active brain or leptomeningeal disease, second malignancy requiring active therapy, and various blood count and liver function abnormalities.",
    "This sample is a phase 1 clinical trial for refractory brain tumors, using the drug busulfan, with specific eligibility criteria including age, prior therapy, concomitant medication, and organ function requirements.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, specifically pancreatic cancer, testing the combination of romidepsin and gemcitabine as a treatment option. The eligibility criteria include histologically confirmed tumors, measurable or evaluable disease, written informed consent, and an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. Exclusion criteria include prior treatment with romidepsin or gemcitabine, prior chemotherapy or investigational agent treatment within specific timeframes, prior radiotherapy within a specific timeframe, prior surgery within a specific timeframe (excluding biopsies and port placements), concomitant use of other anti-cancer therapy or investigational agents, and various medical conditions or infections.",
    "This sample is a phase 1 trial for subjects with type 2 diabetes, testing the drugs placebo and srt2104, with eligibility criteria including HbA1c < 9.0%, fasting plasma glucose \u2264 13.875 mmol/L, and a minimum 5-year non-smoking history for diabetic subjects.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory acute myelogenous leukemia, testing the drug azd4877, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, kidney disease, and kidney failure, using drugs such as alemtuzumab, mycophenolate mofetil, sirolimus, and tacrolimus, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial testing the drugs 1-methyl-d-tryptophan and docetaxel in patients with metastatic solid malignancy, with specific eligibility criteria including measurable disease, ECOG performance status \u2264 2, and various laboratory values within normal ranges.",
    "This sample is a phase I clinical trial for patients with metastatic pancreatic cancer who have previously been treated with gemcitabine hydrochloride-based chemotherapy. The study is testing the effectiveness of pioglitazone hydrochloride as a potential treatment option.",
    "This sample is a phase 1 clinical trial for healthy volunteers with a BMI of 30.0 to 39.9 kg/m2, testing the drug canagliflozin (jnj-28431754) against a placebo, with inclusion and exclusion criteria related to diabetes, smoking, and previous medication use.",
    "This sample is a phase 1/phase 2 trial for Alzheimer's disease, testing the drugs ly2886721 and placebo, with inclusion criteria including meeting criteria for mild cognitive impairment (MCI) or mild Alzheimer's disease (AD), specific cognitive test scores, absence of other potential causes of cognitive decline, and positive scan for the presence of amyloid beta.",
    "This sample is a phase 1 trial for subjects with type 2 diabetes mellitus, testing the efficacy of the drugs asp1941, metformin, and placebo in combination with metformin monotherapy or dual therapy with metformin and a Sulfonylureum Derivative (SUD) for stable disease management. The inclusion criteria include specific fasting serum glucose levels and BMI range, while the exclusion criteria include type 1 diabetes, diabetes-related complications, renal disease, recent severe hypoglycemia, and abnormal pulse and blood pressure levels.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer (NSCLC) who are medically inoperable or have unresectable stage II, IIIA, or IIIB disease. The study will test the effectiveness of docetaxel and oxaliplatin drugs in treating NSCLC patients who meet the inclusion criteria, such as having measurable disease by CT scan and meeting certain blood count and organ function requirements.",
    "This sample is a phase 1 clinical trial for the drug sb705498 and placebo in healthy Caucasian volunteers with dermatitis, atopic, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with peripheral arterial disease, testing the effects of atorvastatin, ascorbic acid, and placebo on patients undergoing non-emergent vascular surgery, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for metastatic melanoma, testing the drug rituximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with locally recurrent or metastatic HER2+ breast neoplasms resistant to trastuzumab, testing the combination of grn163l and trastuzumab as a potential treatment option.",
    "This sample is a phase 1 trial for patients with relapsed/refractory leukemias, including acute non-lymphocytic leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), or chronic myelogenous leukemia (CML) in blast crisis, and it will test the drug triciribine. The eligibility criteria include having a ECOG performance status of 0-3, using acceptable contraceptive methods, and having certain clinical laboratory values within normal limits.",
    "This sample is a phase 1 trial for patients with advanced or metastatic breast cancer, testing the effectiveness of lapatinib ditosylate and tamoxifen citrate as treatment options, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1/phase 2 clinical trial for patients diagnosed with multiple myeloma, testing the effectiveness of the drugs bortezomib, lenalidomide, and dexamethasone, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for patients with previously treated multiple myeloma, testing the drugs lenalidomide and dexamethasone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug abt-348 in patients with various types of leukemia and myelodysplasia, who have not responded to standard therapies, and have specific eligibility criteria.",
    "This sample is a phase 1 trial for HIV-infected patients, testing the effectiveness of lopinavir/ritonavir in combination with nucleoside reverse transcriptase inhibitors (NRTIs) for infants with a viral load greater than 10,000 copies/ml, weighing more than 5.5 lbs, and meeting other eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with squamous cell carcinoma, testing the drugs azacitidine and cisplatin, with specific eligibility criteria including prior treatment completion, normal organ function, and no concurrent therapy.",
    "This sample is a phase 1 trial testing the drug combination of bez235 and mek162 in patients with advanced non-resectable solid tumors, excluding those with primary CNS tumor or CNS tumor involvement, diabetes mellitus, and unacceptable ocular/retinal conditions.",
    "This sample is a phase 1 trial testing the drug bms-907351 (xl184) on patients with advanced or metastatic solid tumors, who have exhausted standard treatment options, and have a life expectancy of at least 3 months. The study excludes patients with uncontrolled intercurrent illness.",
    "This sample is a phase 1 trial for patients with HER-2 overexpressing metastatic breast cancer, testing the drug everolimus (rad001) in combination with trastuzumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug laromustine for patients with fludarabine refractory or relapsed chronic lymphocytic leukemia (CLL), Richter syndrome, or other refractory lymphoproliferative diseases. Eligible patients must have an ECOG performance status of 0-2, creatinine \u2264 2.0 mg/dL, AST and ALT \u2264 3 times ULN, and meet other criteria.",
    "This sample is a phase 1 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs salbutamol and ipratropium. The eligibility criteria include a diagnosis of COPD, stable symptoms and medication, and specific lung function measurements.",
    "This sample is a phase 1 trial for cancer patients who are refractory to established therapy, testing the drug triciribine phosphate monohydrate, which targets p-Akt positive tumors, and requires biopsies before and after treatment initiation.",
    "This sample is a phase 1/phase 2 trial for the treatment of diffuse systemic sclerosis, using the drugs abatacept and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for prostate cancer, testing the drug mdv3100, with inclusion criteria including men over 18 with confirmed adenocarcinoma of the prostate and ongoing androgen deprivation therapy, and exclusion criteria including severe concurrent disease and prior treatment with docetaxel-based chemotherapy.",
    "This sample is a phase 1 trial testing the drug denosumab on subjects with severe CKD and CKD requiring hemodialysis, who have renal impairment, and have met certain inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for breast neoplasms, testing the drugs exemestane and sunitinib malate in postmenopausal patients with unresectable, locally recurrent, or metastatic disease, who are estrogen and/or progesterone receptor positive, and meet other eligibility criteria.",
    "This sample is a phase 1 clinical trial for ulcerative colitis, testing the drugs avx 470 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for patients with fallopian tube cancer, ovarian cancer, or peritoneal cavity cancer, testing the drug topotecan hydrochloride. The eligibility criteria include having received prior chemotherapy, measurable or evaluable disease, specific blood counts and liver function, and a life expectancy of at least 12 weeks. Exclusion criteria include certain types of previous neoplasms, severe infections or hepatitis, and severe gastrointestinal bleeding.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the combination of zio-201-t and doxorubicin, with specific eligibility criteria including age, performance status, disease documentation, and adequate organ function.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed multiple myeloma, testing the drug cep-18770, and includes eligibility criteria such as previous treatment history, disease measurements, organ function, and contraception requirements.",
    "This sample is a phase 1 clinical trial for the drug sibutramine, targeting obesity (ICD-10 codes: E66.8, E66.9, E66.1, O99.214, O99.215, O99.210, O99.211), with inclusion criteria including a BMI between 30.0 and 40.0 kg/m2 and previous sustained weight loss, and exclusion criteria including cardiovascular disease, hepatic disease, and recent weight loss or gain.",
    "This sample is a phase 1/phase 2 clinical trial for castrate-resistant prostate cancer, testing the drugs bez235, prednisone, and abiraterone acetate, with eligibility criteria including confirmed adenocarcinoma of the prostate, radiographic evidence of disease, castrate levels of testosterone, and adequate bone marrow and organ function.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the combination of hydroxychloroquine and gemcitabine as a treatment option. The eligibility criteria include biopsy-proven adenocarcinoma of the pancreas, specific staging requirements, normal organ function, and the ability to understand and sign a consent form. Exclusion criteria include prior chemotherapy or radiotherapy, evidence of metastasis, and allergies to the study drugs. Additionally, there are specific criteria related to pregnancy, HIV, porphyria, psoriasis, enzyme-inducing anti-epileptic medication, macular degeneration, and diabetic retinopathy.",
    "This sample is a phase 1 clinical trial for participants with type 2 diabetes mellitus, testing the drugs placebo and LY2409021, with eligibility criteria including specific blood glucose levels and BMI ranges, and exclusion criteria such as previous participation in a drug study and certain medical conditions.",
    "This sample is a phase 1 trial for patients with metastatic pancreatic adenocarcinoma, testing the combination of nab-paclitaxel, gemcitabine, and capecitabine as a systemic therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for advanced breast cancer patients with HER2 positive breast cancer, testing the drugs hki-272 and trastuzumab, and includes eligibility criteria such as specific disease stage, prior treatment history, and adequate organ function.",
    "This sample is a phase 1 clinical trial testing a placebo for the prevention of infections caused by papillomavirus in females aged 9 to 25, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with type 2 diabetes mellitus, testing the efficacy of pb1023 or placebo in single and multiple subcutaneous doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with ulcerative colitis, testing the effectiveness of the drugs placebo and he3286 in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drugs polatuzumab vedotin and rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of chronic hepatitis C, testing the drugs bi 207127 na and placebo, with specific eligibility criteria including age, gender, HCV infection confirmation, liver fibrosis status, HCV RNA load, and exclusion criteria such as previous HCV treatment, liver cirrhosis, and concurrent diseases.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable pancreatic adenocarcinoma, testing the combination of azd0530 and gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior concurrent therapy.",
    "This sample is a phase 1/phase 2 trial for individuals with type 2 diabetes mellitus, testing the efficacy of two different formulations of metformin (efb0027 and efb0026) in combination with DPP-4 inhibitors, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with neoplastic meningitis, testing the drug topotecan hydrochloride, and includes eligibility criteria such as specific disease diagnoses, negative bone marrow aspiration, and performance status requirements.",
    "This sample is a phase 1/phase 2 trial for the drug imatinib in healthy male non-smoking subjects with seasonal allergic rhinitis, who must meet specific inclusion criteria such as a positive skin prick test to Timothy grass pollen and symptomatic worsening after nasal allergen challenge. There are also exclusion criteria, including the use of certain medications and history of renal insufficiency or abnormal liver function.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of multiple myeloma using carfilzomib, lenalidomide plus dexamethasone, and the eligibility criteria include newly diagnosed, previously untreated multiple myeloma patients with measurable disease and specific laboratory values, among other requirements.",
    "This sample is a phase 1/phase 2 trial for patients with progressive hormone-refractory prostate cancer, testing the drugs docetaxel, prednisone, and su011248, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with head and neck cancer, testing the drugs fenretinide (4-hpr) and sch66336, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the efficacy of trv130 and morphine in treating acute pain, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of diabetic macular edema using the drugs efalizumab and ranibizumab, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with myelodysplastic syndromes (MDS) or leukemia, testing the effectiveness of azacitidine and lenalidomide as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with newly diagnosed acute myeloid leukemia (AML) who are eligible for intensive induction chemotherapy with the drugs clofarabine, cytarabine, and idarubicin. The eligibility criteria include specific genetic mutations and laboratory values, as well as requirements for informed consent and contraception for female patients.",
    "This sample is a phase 1/phase 2 trial for left ventricular diastolic dysfunction, testing the drugs bnp (nesiritide) and placebo, with inclusion criteria including subjects with ejection fraction greater than 50% and moderate or severe diastolic dysfunction, and exclusion criteria including recent myocardial infraction, unstable angina, and severe congenital heart diseases.",
    "This sample is a phase 1/phase 2 trial for HIV-infected individuals with specific genotypic or phenotypic resistance mutations, testing the effectiveness of lopinavir/ritonavir and saquinavir as protease inhibitors.",
    "This sample is a phase 1/phase 2 trial investigating the use of busulfan, cyclophosphamide, methotrexate, and tacrolimus in patients with graft versus host disease, leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases, who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced or metastatic melanoma that is refractory to standard therapy or for which no curative standard therapy exists. The study will test the drug tki258 and includes eligibility criteria such as confirmed diagnosis, measurable disease, age requirement, baseline laboratory requirements, and ECOG performance status.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug gs-9219 on patients with relapsed or refractory non-hodgkin's lymphoma, chronic lymphocytic leukemia, or multiple myeloma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing different combinations of dasatinib, lenalidomide, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic prostate cancer, testing the drugs abt-888 and temozolomide, with eligibility criteria including confirmed prostate cancer, prior treatment history, specific PSA levels, organ function requirements, and contraception use.",
    "This sample is a phase 1 trial for patients with advanced non-hematologic malignancies, including breast, lung, colon, pancreatic, prostate, head and neck, or sarcoma, who have failed or become intolerant to prior standard therapy. The trial will test the combination of cisplatin, pemetrexed disodium, and sorafenib as a potential treatment option.",
    "This sample is a phase 1 clinical trial for patients with squamous cell carcinoma, head and neck cancer, oral cancer, laryngeal cancer, and pharyngeal cancer. The trial aims to evaluate the effectiveness of bortezomib, cetuximab, and cisplatin in combination with radiation therapy for the treatment of these diseases. The eligibility criteria include specific disease characteristics, prior treatment history, organ and marrow function, age, and contraception requirements.",
    "This sample is a phase 1/phase 2 trial for patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia, testing the effectiveness of cyclophosphamide and fludarabine phosphate drugs in combination with related HLA-haploidentical natural killer cell adult donors.",
    "This sample is a phase 1 clinical trial for patients with glioblastoma, gliosarcoma, or anaplastic astrocytoma, testing the effectiveness of oral topotecan and temodar in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for sickle cell disease, testing the effectiveness of sodium nitrite injection, usp in relieving severe pain in patients aged 8-23 years old, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with refractory solid tumor malignancy, testing the efficacy of the drug HSP90 inhibitor AUY922. The eligibility criteria include specific disease requirements, performance status, and various laboratory values.",
    "This sample is a phase 1 clinical trial testing the drug compound 506u78 on patients with various hematologic malignancies who have failed standard therapy or for whom no standard therapy exists. The eligibility criteria include age 18 and over, specific performance status, life expectancy, and certain hematopoietic, hepatic, renal, neurologic, and other conditions. Prior concurrent therapies are also specified.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of benign prostatic hyperplasia (BPH) using the drugs prx302 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with progressive or recurrent malignant glioma, testing the drugs ixabepilone and anticonvulsant, with eligibility criteria including specific disease types, prior therapy recovery, performance status, blood counts, organ function, and exclusion criteria such as concurrent infections, pregnancy, and certain medications.",
    "This sample is a phase 1 trial for patients with peritoneal neoplasms, testing the efficacy of nanoparticulate paclitaxel as a systemic treatment option for extra-peritoneal disease, with specific eligibility criteria and exclusion criteria.",
    "In this sample, the phase of the trial is Phase 1 and the disease being studied is stomach neoplasms. The ICDCodes associated with the disease are D13.1, C16.9, C16.1, C16.2, D37.1, C16.8, and C16.5. The drugs being tested are cisplatin, s-1, and sunitinib. The eligibility criteria include histologically or cytologically confirmed diagnosis of gastric cancer, chemonaive patients, and adequate organ function. The exclusion criteria include patients who meet the contra-indications of S-1 and Cisplatin, as well as prior chemotherapy failure patients.",
    "This sample is a phase 1 trial for patients with cancer, testing the combination of e7389 and carboplatin as a potential treatment option. The eligibility criteria include age, performance status, life expectancy, renal and liver function, and previous therapy.",
    "This sample is a phase 1 clinical trial for ovarian, peritoneal, and fallopian tube cancer patients, testing the combination of dasatinib, paclitaxel, and carboplatin as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with recurrent ovarian carcinoma, testing the drug cisplatin as a treatment option, with specific eligibility criteria including prior chemotherapy, tumor characteristics, and surgical requirements.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of xl147 (sar245408) and erlotinib as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for advanced cancer patients not eligible for curative treatment, testing the drug sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs zgn-440 and zgn-440 sterile diluent on obese females with a BMI between 30 and 45 kg/m2, aiming to study their effects on weight loss.",
    "This sample is a phase 1 clinical trial testing the drug panobinostat for the treatment of recurrent glioma, high-grade meningioma, and brain metastasis, with specific eligibility criteria including age, performance status, laboratory criteria, and exclusion criteria such as prior use of certain inhibitors or impaired cardiac function.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung carcinoma, testing the drug celecoxib, and includes eligibility criteria such as confirmed and surgically resectable cancer and ineligibility for neoadjuvant therapy.",
    "This sample is a phase 1/phase 2 trial for patients with follicular lymphoma, testing the effectiveness of rituximab, bortezomib, and ibritumomab tiuxetan as treatment options, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with non-Hodgkin's lymphoma, testing the efficacy of ibritumomab tiuxetan, rituximab, melphalan, and vinorelbine tartrate/g-csf in combination with autologous stem cell transplantation.",
    "This sample is a phase 1 trial for patients with metastatic breast cancer, testing the drugs vinorelbine oral and capecitabine, with specific eligibility criteria including age, disease confirmation, measurable disease, performance status, contraceptive use, liver and renal function, and written consent.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the effectiveness of gpo-vir z30 tablet, lamivudine, nevirapine, and zidovudine in children weighing between 6 and 30 kilograms who are receiving HAART regimen of NVP and 2 NRTIs, and meet other eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the drugs enfuvirtide and amdoxovir, with specific eligibility criteria including previous treatment failures and viral load requirements.",
    "This sample is a phase 1/phase 2 trial for metastatic bladder cancer, testing the drugs pemetrexed, gemcitabine, and platinol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs ogx-427 and docetaxel in patients with metastatic neoplasms, with specific eligibility criteria including failed prior therapies and a possibility of responding to docetaxel.",
    "This sample is a phase 1 clinical trial for non-small cell lung cancer, testing the drugs ipilimumab, paclitaxel, and carboplatin, with eligibility criteria including no prior chemotherapy or targeted therapy for NSCLC, Eastern Cooperative Oncology Group performance score of 0-1, and adequate organ function.",
    "This sample is a phase 1 clinical trial for patients with squamous cell carcinoma of the cervix, testing the combination of cisplatin and erlotinib hydrochloride as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with glioblastoma multiforme, testing the drug temodar (temozolomide) as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drug pf-00299804 on patients with neoplasms, specifically malignant solid tumors, who have no currently approved treatment options. The inclusion criteria include adequate bone marrow, liver, cardiac, and kidney function, while the exclusion criteria include cardiac disease, recent anticancer therapy, and pregnancy or breastfeeding.",
    "This sample is a phase 1 trial for liposomal daunorubicin citrate in patients with histologically confirmed Kaposi's sarcoma (KS) and serologically confirmed HIV positivity, who have measurable cutaneous lesions and meet certain eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for graft failure, testing the drugs fludarabine, campath 1h, and fk506, with eligibility criteria including a diagnosis of engraftment failure, availability of a healthy donor, and age between birth and 65.",
    "This sample is a phase 1/phase 2 trial for patients with previously treated, relapsed or refractory acute lymphoblastic leukemia, testing the efficacy of vincristine sulfate liposomes injection and dexamethasone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the drug rituximab in patients with rheumatoid arthritis, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1/phase 2 trial for idiopathic Parkinson's disease patients experiencing motor fluctuations associated with LD/CD dosing, testing the efficacy of saline and carbidopa as drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug mifepristone in HIV-infected individuals with specific eligibility criteria, such as CD4 count and viral load requirements, and exclusion criteria, including prior ART treatment and certain medical conditions.",
    "This sample is a phase 1 trial for healthy subjects, testing the drugs maraviroc and fosamprenavir/ritonavir, individually and in combination, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with advanced cutaneous T-cell lymphoma, testing the effectiveness of vorinostat and bexarotene as potential treatments, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drug simvastatin, and includes specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for Parkinson's disease, testing the efficacy of levodopa and carbidopa solution for sc administration compared to a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for patients with leukemia and solid tumors, testing the drug sb939. The eligibility criteria include histological verification of malignancy, specific disease statuses, and prior systemic therapy requirements. Exclusion criteria include cardiac arrhythmia, inability to take oral medication, and certain infections.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer or other gastrointestinal malignancies, testing the combination of tivozanib (av-951) plus folfox6 chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for heart failure patients with specific criteria, including chronic kidney disease and cardiac ejection fraction <40%, testing the drugs clp and spironolactone.",
    "This sample is a phase 1 trial for patients with metastatic cancer, testing the combination of carboplatin and pazopanib, with specific eligibility criteria including age, tumor type, organ function, and exclusion criteria such as CNS metastases, gastrointestinal abnormalities, cardiovascular conditions, and recent surgeries.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug asp1941, with specific inclusion and exclusion criteria related to diabetes, renal function, and other comorbidities.",
    "This sample is a phase 1/phase 2 clinical trial for patients with small cell lung cancer (SCLC) who have relapsed after first-line chemotherapy. The study aims to evaluate the efficacy and safety of topotecan and vorinostat as treatment options. The inclusion criteria include a histologically or cytologically proven diagnosis of SCLC, measurable lesions according to RECIST criteria, and adequate cardiac, hepatic, renal, and bone marrow function. The exclusion criteria include prior treatment with an HDAC inhibitor, symptomatic and/or unstable pre-existing brain metastases, and severe or uncontrolled medical diseases. Pregnant or breastfeeding women are also excluded from the study.",
    "This sample is a phase 1/phase 2 trial for patients with heart failure, testing the drug cxl-1020 and its various doses, along with a placebo, to evaluate its efficacy and safety in improving left ventricular ejection fraction and reducing heart failure symptoms.",
    "This sample is a phase 1 trial that focuses on patients with various hematological malignancies, such as leukemia and lymphoma, and aims to evaluate the effectiveness of a combination of drugs including cyclophosphamide, cyclosporine, fludarabine phosphate, and mycophenolate mofetil in the treatment. The eligibility criteria include age range, HLA matching, disease criteria, and organ function requirements.",
    "This sample is a phase 1 trial for HIV-1 infection, testing the drugs doravirine and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for advanced breast cancer and advanced malignant solid tumors, testing the drugs HKI-272 and paclitaxel, with specific inclusion and exclusion criteria for each part of the trial.",
    "This sample is a phase 1 trial testing the drug dasatinib in patients with various diseases, including chronic myelogenous leukemia and childhood solid tumors, who have not responded to other treatments.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, testing the drugs alemtuzumab, sirolimus, tacrolimus, and methylprednisolone (or equivalent), among others, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with hematologic neoplasms, testing the drug snx-5422, with inclusion criteria including confirmed hematological malignancy and refractory to available therapy, and exclusion criteria including CNS malignancy and significant GI/liver disease.",
    "This sample is a phase 1 trial for the treatment of chronic genotype 1a or 1b Hepatitis C virus (HCV) infection, testing the efficacy of the drug tmc649128 compared to a placebo, with specific inclusion and exclusion criteria for volunteers.",
    "This sample is a phase 1 clinical trial for HCV infection, testing the drugs gs-5885 and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or recurrent breast cancer who overexpress the HER-2 gene, testing the combination of vorinostat and trastuzumab as a treatment option. The eligibility criteria include various medical and treatment history requirements, such as no active infections, no history of allergic reactions to similar compounds, and specific time intervals since prior therapies.",
    "This sample is a phase 1 clinical trial for the treatment of head and neck cancer using the drugs cudc-101 and cisplatin, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 1 trial testing the drug bazedoxifene in generally healthy postmenopausal women with a BMI between 18.0 to 35.0 kg/m2 and body weight >= 50 kg, and the exclusion criteria include pregnant or nursing females and females of childbearing potential.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors or lymphoma, testing the effectiveness of the drug src kinase inhibitor kx2-391. Eligibility criteria include confirmed diagnosis of metastatic or unresectable disease, specific performance status, and various laboratory values within normal ranges. Prior concurrent therapy restrictions apply, and patients must not have certain medical conditions or histories.",
    "This sample is a clinical trial for patients with metastatic prostate cancer, testing the drug 2-deoxyglucose in both Phase I and Phase II, with specific eligibility criteria including disease progression, age, performance status, previous therapy, and various medical parameters.",
    "This sample is a phase 1 trial for healthy volunteers, testing the drugs achn-975 and placebo, with key inclusion criteria including body weight between 40 and 100 kilograms, use of contraception, stable health, and negative tests for alcohol, tobacco, and drugs of abuse, and key exclusion criteria including a history of clinically significant disease and pregnancy.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the effectiveness of imatinib mesylate and docetaxel drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 clinical trial for patients with refractory or recurrent ovarian or fallopian tube cancer, testing the effectiveness of gemcitabine hydrochloride and topotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial for alcohol dependence, testing the efficacy of an opioid receptor kappa antagonist drug, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the drugs erlotinib and sunitinib, and includes eligibility criteria such as histological proof of NSCLC, measurable disease, and adequate organ function.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, testing the efficacy of erlotinib hydrochloride, pemetrexed disodium, and vinflunine as treatment options, with specific eligibility criteria and prior concurrent therapy requirements.",
    "This sample is a phase 1 trial testing the drug AZD8418 and a placebo on healthy male and non-childbearing female volunteers, with exclusion criteria including a history of clinically significant medical, neurologic, or psychiatric disease, and severe allergy/hypersensitivity.",
    "This sample is a phase 1/phase 2 trial testing the drug vildagliptin in healthy volunteers and patients with type 2 diabetes, who are on metformin and/or sufonylurea, to evaluate its effectiveness in treating diabetes mellitus, type 2.",
    "This sample is a phase 1 clinical trial for lung cancer patients, testing the drug docetaxel, with specific eligibility criteria including histologically proven NSCLC, no brain metastases, and certain patient characteristics such as Zubrod performance status and blood counts.",
    "This phase 1 trial aims to investigate the effects of placebo, pioglitazone, and hyperinsulinemic euglycemic clamp on subjects with a BMI between 28 and 38 kg/m^2, who are nonsmokers and willing to avoid major dietary changes. The study excludes subjects with a history of diabetes, hypersensitivity to pioglitazone, liver disease, congestive heart failure, atherosclerotic heart disease, stroke, major neurological disorder, and other clinically significant abnormalities or neoplastic disease within the past 5 years.",
    "This sample is a phase 1 trial testing gemcitabine, capecitabine, and zd6474 in patients with malignant solid tumors, biliary cancer, and pancreatic cancer, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial for the treatment of advanced or metastatic breast cancer, specifically targeting patients with ErbB2 overexpression and estrogen receptor positive tumors. The study will test the combination of kw-2450 with lapatinib and letrozole as a potential treatment option.",
    "This sample is a phase 1 trial for type 2 diabetes mellitus, testing the effectiveness of sitagliptin, saxagliptin, vildagliptin, and placebo, with eligibility criteria including BMI, HbA1c levels, previous treatment history, and lifestyle requirements.",
    "This sample is a phase 1/phase 2 trial testing the drug combretastatin a4 phosphate for the treatment of age-related macular degeneration (AMD) with choroidal neovascularization (CNV), and the eligibility criteria include age 50 or older, specific ophthalmic criteria, and various medical conditions that would exclude patients from participating in the trial.",
    "This sample is a phase 1 trial for ovarian, fallopian tube, and peritoneal cancer patients who have completed adjuvant treatment, and it involves the drug low dose cyclophosphamide (oral). The eligibility criteria include specific disease stages, previous treatments, and exclusion of certain concurrent therapies or medical conditions.",
    "This sample is a phase 1 clinical trial for patients with colorectal cancer, testing the drug capecitabine, and includes eligibility criteria such as specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 clinical trial for contraception, testing the effectiveness of levonorgestrel patch in women with specific eligibility criteria and excluding those with contraindications.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drugs asp1941 and placebo, with specific inclusion and exclusion criteria related to diabetes, renal function, and gastrointestinal health.",
    "This sample is a phase 1 clinical trial for patients with advanced neoplasms or malignant lymphoma, testing the drug E7820, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is investigating the use of lenalidomide in patients with anemia, leukemia, acute myeloid leukemia (AML), or myelodysplastic syndromes (MDS) who are red blood cell transfusion-dependent, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial testing the combination of gefitinib and sunitinib in patients with histologically confirmed renal cell carcinoma with metastases, and includes eligibility criteria such as failure of prior immunotherapy or no prior systemic therapy for metastatic RCC.",
    "This sample is a phase 1 trial for depression, testing the drug vortioxetine (lu aa21004) against a placebo, with specific inclusion and exclusion criteria for subjects.",
    "This sample is a phase 1 trial testing the drug AZD2820 and placebo on obese male subjects with a BMI between 27 and 40 kg/m2, aiming to assess its safety and tolerability.",
    "This sample is a phase 1 trial for patients with relapsed/refractory acute leukemia, testing the drugs ac220, cytarabine, etoposide, and methotrexate, with eligibility criteria including age, diagnosis, prior treatment, and renal and hepatic functions.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myelogenous leukemia and acute lymphoblastic leukemia, testing the drug nilotinib. The eligibility criteria include specific disease diagnoses, performance status, and exclusion of certain cardiovascular and gastrointestinal conditions.",
    "This sample is a phase 1 trial for patients with TdT positive acute lymphocytic leukemia or blastic chronic myelogenous leukemia who have failed at least one standard treatment. The drugs being tested are cordycepin and deoxycoformycin. The eligibility criteria include age 18 and over, Karnofsky performance status greater than 70%, and no serious concurrent illness.",
    "This sample is a phase 1 clinical trial for patients with recurrent ovarian cancer, peritoneal cancer, and stage IV ovarian cancer, testing the drug fludeoxyglucose f 18, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for type 1 diabetes, testing the drugs sitagliptin and insulin, with inclusion criteria including diabetes diagnosis, age at onset, disease duration, GADA positivity, and fasting C-peptide level, and exclusion criteria including insulin requirements, chronic infection, malignancy history, pregnancy, secondary diabetes, congestive heart failure, renal disease, and concurrent medical conditions.",
    "This sample is a phase I clinical trial for patients with peripheral T-cell lymphomas and cutaneous T-cell lymphoma with nodal/visceral disease, testing the effectiveness of lenalidomide as a treatment option, with specific eligibility criteria and laboratory test requirements.",
    "This sample is a phase 1 trial for patients with squamous cell carcinoma of the head and neck, testing the efficacy of a combination treatment including emd 1201081, 5-fu, cisplatin, and cetuximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase I trial for patients with nonischemic dilated cardiomyopathy and congestive heart failure, testing the drug sitagliptin to determine its effectiveness in improving heart function.",
    "This sample is a phase 1 clinical trial for patients with metastatic or recurrent head and neck cancer who have failed prior chemotherapeutic regimens, and it involves the drugs gemcitabine and paclitaxel. The eligibility criteria include age, disease status, prior treatments, and various health parameters.",
    "This sample is a phase 1/phase 2 trial for type II diabetes, testing the drugs placebo, sitagliptin, and lez763, with eligibility criteria including age, weight, BMI, and diabetes diagnosis.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug auy922, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the combination of belinostat and erlotinib in patients with non-small cell lung cancer, with specific eligibility criteria including signed consent, suitable histological or cytological confirmation, performance status \u2264 2, acceptable liver, kidney, and bone marrow function, and exclusion criteria such as recent experimental or anti-cancer therapy, active infection, significant cardiovascular disease, altered mental status, and intestinal obstruction.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer (CRPC) who have failed previous treatments, and it aims to evaluate the efficacy of temsirolimus and casodex (bicalutamide) in combination therapy. The eligibility criteria include having a histologically-confirmed adenocarcinoma of the prostate, rising PSA levels, and a castrate level of testosterone, among others.",
    "This sample is a clinical trial for patients with gastrointestinal cancer, testing the drugs everolimus and tivozanib in phase I/II, with specific eligibility criteria for enrollment.",
    "This sample is a phase 1 trial for patients with metastatic or locally advanced bladder cancer and transitional cell cancer of the renal pelvis and ureter. The study aims to evaluate the efficacy of cisplatin, gemcitabine hydrochloride, and lapatinib ditosylate in patients who overexpress HER1 and/or HER2 receptors.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of carfilzomib, cyclophosphamide, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for healthy female subjects, testing the effects of tipranavir, ritonavir, and norethindrone-ethinyl estradiol on organ function, with various inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug pirfenidone in patients with diabetes mellitus and diabetic nephropathy, with specific inclusion and exclusion criteria related to kidney function, blood pressure, and other medical conditions.",
    "This sample is a phase 1 clinical trial for patients with recurrent epithelial ovarian cancer or primary peritoneal cancer, testing the drug paclitaxel. The eligibility criteria include age greater than or equal to 18 years, platinum-resistant or platinum-refractory disease, and a treatment-free interval of at least three weeks. Exclusion criteria include previous administration of tgDCC-E1A, progression on any taxane-containing regimen, and certain abnormal laboratory values.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer (ICD-10 codes: C78.00, C78.01, C78.02, D14.30, D14.31, D14.32, C34.2) who have not responded to chemotherapy. The study will test the effectiveness of the drugs rad001 and erlotinib in treating the disease, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of hepatitis C, testing the drugs ribavirin and ribavirin + pegylated interferon-alpha, with specific eligibility criteria including age, genotype, liver biopsy results, and various blood counts, as well as exclusion criteria such as previous therapy, other viral infections, liver disease, and psychiatric illness.",
    "This sample is a phase 1 clinical trial for patients with neoplasms, testing the effectiveness of mitoxantrone hydrochloride liposome and mitoxantrone drugs in treating malignant solid tumors that have failed standard chemotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug trv120027 and placebo in patients with heart failure, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndrome (MDS) who have non-del(5q) low or Intermediate-1 risk MDS. The study aims to evaluate the efficacy of ezatiostat hydrochloride and lenalidomide (Revlimid\u00ae) in treating MDS patients with significant cytopenia.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma and non-Hodgkin's lymphoma, testing the drug pci-24781, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with HER2+ cancer or HER2+ metastatic breast cancer, testing the drug arry-380, an oral HER2 inhibitor, as a potential therapy option for patients who are no longer candidates for standard therapy or choose not to pursue it.",
    "This sample is a phase 1 trial that focuses on healthy subjects and non-dependent recreational opioid users, testing the effects of different drugs such as alo-02 and oxycodone on intranasal opioid administration. The study excludes individuals with substance and/or alcohol dependence or those seeking treatment for substance and/or alcohol-related disorders.",
    "This sample is a phase 1 clinical trial for HCV infection, testing the drugs ana773 and placebo, with specific inclusion and exclusion criteria for different parts of the trial.",
    "This sample is a phase 1 trial for healthy volunteers, testing the drugs aleglitazar, aspirin, and placebo, with inclusion criteria including age, BMI, contraception use, smoking and caffeine consumption restrictions, and exclusion criteria including abnormal lab results, recent medication use, and various medical conditions.",
    "This sample is a phase 1/phase 2 trial testing the drugs voraxaze (glucarpidase) and placebo on patients with solid tumors and hematologic malignancies who have delayed methotrexate clearance, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-alcoholic steatohepatitis and increased iron storage/disturbed distribution, testing the drug exjade (deferasirox) to treat the condition. The inclusion criteria include elevated liver enzymes, elevated serum ferritin, and liver histology consistent with a diagnosis of NASH, while the exclusion criteria include alcohol intake, liver cirrhosis, anemia, elevated liver enzymes, and various other conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with head and neck cancer, testing the drugs docetaxel and everolimus. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "The sample is a phase 1 trial for cystic fibrosis patients with Burkholderia dolosa lung infection, testing the effectiveness of amiloride solution for inhalation as a treatment.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or resistant diffuse large B cell lymphoma, testing the effectiveness of azacytidine and vorinostat drugs, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 1/phase 2 trial that aims to test the effectiveness of lapatinib, carboplatin, and paclitaxel in treating relapsed ovarian, primary peritoneal, fallopian tube carcinoma patients, as well as stage IV metastatic breast cancer patients who have failed previous chemotherapies. The eligibility criteria include measurable disease and the exclusion criteria include prior treatment with specific therapies and concomitant requirement for certain medications.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 2 diabetes mellitus, testing the drug gk1-399 (formerly ttp399) and placebo, with inclusion criteria including a diagnosis of T2DM and a stable dose of background medication for diabetes.",
    "This sample is a phase 1/phase 2 trial for atopic dermatitis, testing the efficacy of dpk-060 1% ointment compared to placebo, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 1 trial for patients with unresectable or locally advanced pancreatic cancer, testing the effectiveness of gemcitabine hydrochloride as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced castration-resistant prostate carcinoma, testing the drug AR antagonist (BMS-641988) to evaluate its effectiveness in treating the disease. The eligibility criteria include having progressive disease, adequate liver and kidney function, and meeting certain blood value requirements.",
    "This sample is a phase 1 trial for the treatment of chronic hepatitis C, testing the drugs ALS-002200 and placebo, with specific inclusion and exclusion criteria for subjects with genotype 1 infection.",
    "This sample is a phase 1/phase 2 clinical trial for patients with primary Hepatocellular Carcinoma (HCC) using talaporfin sodium as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with glioblastoma multiforme, testing the combination of mpc-6827 and carboplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma, testing the combination of temsirolimus and sorafenib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for obesity, testing the drugs zgn-433 and normal saline on obese but otherwise healthy females with a BMI between 30 and 50 kg/m2, who have not used weight loss agents in the past month and do not have a history of eating disorder, gastric bypass surgery, or current smoking.",
    "This sample is a phase 1 clinical trial for previously untreated metastatic pancreatic adenocarcinoma, testing the combination of temsirolimus and gemcitabine as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients diagnosed with myelofibrosis, polycythemia vera, or thrombocytosis, using the drug ruxolitinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for smoking cessation, testing the effectiveness of nicotine (2 mg) and nicotine (4 mg) in healthy smokers who usually smoke their first cigarette within 30 minutes of waking, with a BMI range of 19-27 kilograms/meters^2.",
    "This sample is a phase 1 trial for patients with metastatic breast cancer, testing the drugs docetaxel, rad001, and dexamethasone, with eligibility criteria including age, diagnosis, prior chemotherapies, consent, bone marrow and renal function, hepatic function, performance status, and exclusion criteria such as prior docetaxel treatment, thromboembolism, neuropathy, brain metastasis, infection, HIV seropositivity, bleeding diathesis, and other concurrent medical diseases.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of idiopathic Parkinson's disease using the drug combination of safinamide and levodopa, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of Hodgkin lymphoma using drugs such as brentuximab vedotin, doxorubicin, vinblastine, dacarbazine, and bleomycin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for hypertension, testing the drugs carvedilol cr capsules, placebo, and lisinopril, with eligibility criteria including age, BMI, and previous hypertension treatment.",
    "This sample is a phase 1 trial testing the drugs aliskiren, placebo, and vtp-27999 on healthy adults with renal function, with specific inclusion and exclusion criteria outlined.",
    "This sample is a clinical trial for patients with prostate neoplasms, testing the drugs abiraterone acetate and prednisone/prednisolone or dexamethasone in phases 1 and 2, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with severe combined immunodeficiency disease, severe primary immunodeficiency disorder, undefined T cell deficiency disorder, or Wiskott-Aldrich syndrome. The drug being tested is fludarabine, and the inclusion criteria include availability of a family member or unrelated donor for transplantation, normal creatinine levels, life expectancy greater than 6 weeks, and a Lansky/Karnofsky score of at least 70%.",
    "This sample is a phase 1 clinical trial for patients with b-cell chronic lymphocytic leukemia and small lymphocytic lymphoma, testing the drug pci-32765, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug \"bi 691751\" and a placebo on healthy subjects with the inclusion criteria of being male, aged 18-55, and having a BMI range of 18.5-29.9 kg/m2. The exclusion criteria include any relevant deviation from healthy conditions.",
    "This sample is a phase 1 clinical trial for the drug \"pf 03654746\" in patients with schizophrenia, who must meet specific inclusion criteria such as having a stable medication treatment regimen and a minimal level of symptoms. There are also exclusion criteria, including a history of substance abuse or dependence, certain medical conditions, and use of certain medications.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, specifically stage IIIA non-resectable or stage IIIB without pleural effusion, testing the drug S-3304, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of insomnia, testing the drugs zopiclone and zolpidem tartrate sublingual tablet, as well as placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for adult brain tumors, specifically targeting diseases such as anaplastic astrocytoma and glioblastoma, using drugs like ziv-aflibercept and temozolomide, with eligibility criteria including various medical conditions and prior treatments.",
    "This sample is a phase 1 clinical trial for cancer patients with non-hematologic, malignant solid tumors, testing the drugs bay80-6946, and bay80-6946, with eligibility criteria including Japanese patients over 20 years old, specific histological or cytological documentation, and Eastern Cooperative Oncology performance status of 0 or 1.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug bi 10773, with eligibility criteria including age, BMI, and specific exclusion criteria such as insulin or glitazone use, high blood glucose levels, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial for lupus nephritis, testing the drug nkt-01 in patients with active SLE nephritis who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This sample is a phase 1 trial for healthy volunteers, testing the drugs aleglitazar, placebo, and ibuprofen, with inclusion criteria including age, BMI, contraception use, smoking and caffeine intake restrictions, and exclusion criteria including abnormal lab results, recent medication use, and various medical conditions.",
    "This sample is a phase I clinical trial for patients with bladder carcinoma, testing the drug lapatinib, and includes eligibility criteria such as age, performance status, disease stage, and cardiac function.",
    "This sample is a phase 1 trial for the treatment of eosinophilic esophagitis using beclomethasone dipropionate and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent ovarian or primary peritoneal cancer, testing the drugs pemetrexed and carboplatin in combination with eligibility criteria including confirmed diagnosis, sensitivity to platinum therapy, and measurable disease or elevated CA-125 levels.",
    "This sample is a phase 1 trial for patients with locally advanced unresectable or borderline unresectable pancreatic cancer, testing the combination of gemcitabine and sorafenib as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with platinum-refractory ovarian cancer, testing the efficacy of vandetanib in combination with pegylated liposomal doxorubicin. The eligibility criteria include having received previous platinum- and taxane-based chemotherapy and having a progression-free interval of 6 to 12 months. Exclusion criteria include brain metastases, concomitant medications that may cause QTc prolongation, and more than two prior lines of chemotherapy.",
    "This sample is a phase 1 trial for patients with liver cirrhosis and hepatitis C, testing the drug bi 201335, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy male subjects, testing the drugs \"birt 2584 xx - multiple escalating dose\", \"placebo\", and \"birt 2584 xx - single dose\" with eligibility criteria including age, BMI, and exclusion criteria such as medical findings, disorders, surgeries, allergies, and substance use.",
    "This sample is a phase 1 clinical trial that includes patients with various types of leukemia, myelodysplastic syndromes, and myeloproliferative disorders. The trial aims to evaluate the efficacy and safety of vorinostat, cytarabine, and etoposide as treatment options. The eligibility criteria include specific disease diagnoses, performance status, organ function, and exclusion of certain medical conditions.",
    "This sample is a phase 1 trial for patients with advanced/metastatic solid tumors, specifically bladder cancer, who would typically receive treatment with gemcitabine plus carboplatin or gemcitabine plus cisplatin, and have not received more than three prior chemotherapeutic regimens. The eligibility criteria include age \u2265 18, Karnofsky Performance Status of \u2265 70%, and adequate organ function. The drugs being tested are cisplatin and carboplatin.",
    "This sample is a phase 1 trial testing the drug bi 409306 and placebo on healthy male Chinese and Japanese volunteers, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs retosiban, moxifloxacin, and placebo for the treatment of obstetric labor, premature, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with colon cancer, testing the use of metformin as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory low grade or intermediate-grade B-cell lymphoma, testing the drug clofarabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with neoplasms, testing the drugs azd0530, carboplatin, and paclitaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the efficacy of oral azacitidine in treating myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drug rg4733 on adult patients with advanced and/or metastatic solid tumor malignancy, with specific inclusion and exclusion criteria.",
    "This sample study is a phase 1/phase 2 trial testing the safety and efficacy of a placebo in healthy individuals aged 18-40 years for the prevention of influenza, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer who have failed prior platinum-based chemotherapy, and the drug being tested is docetaxel. The eligibility criteria include age, disease status, previous treatments, brain metastases, and various laboratory parameters.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced inoperable or metastatic adenocarcinoma of the pancreas or biliary tract. The trial aims to evaluate the efficacy and safety of oxaliplatin, capecitabine, and sorafenib as systemic treatment options.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, testing the effectiveness of carboplatin, erlotinib hydrochloride, and paclitaxel as combined modality therapy, with specific eligibility criteria for patients' disease characteristics and patient characteristics.",
    "This sample is a phase 1/phase 2 clinical trial for patients with acute myeloid leukemia, myelodysplastic syndrome, or multiple myeloma, testing the drug chr-2797 (tosedostat), an aminopeptidase inhibitor, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug XL184 on patients with advanced malignancies, including lymphoma, cancer, and thyroid carcinoma, who are not eligible for standard curative measures. The study has specific inclusion and exclusion criteria, and the drug's administration is restricted based on certain conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with various types of indolent B-cell non-Hodgkin lymphoma, testing the effectiveness of bendamustine hydrochloride and obatoclax mesylate drugs, with specific eligibility criteria including prior therapy, performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with prostate cancer, testing the drug odm-201, and includes eligibility criteria such as confirmed adenocarcinoma of the prostate, ongoing androgen deprivation therapy, progressive metastatic disease, and adequate bone marrow, hepatic, and renal function.",
    "This sample is a phase 1/phase 2 trial for patients with locoregionally confined stage III or IV squamous cell carcinoma of the head and neck region, testing the effectiveness of cisplatin, fluorouracil, and iressa as treatment options.",
    "This sample is a phase 1 trial for patients with locally advanced unresectable or metastatic gastric, gastro-oesophageal, or colorectal adenocarcinoma, testing the combination of Xeloda, Oxaliplatin, and TKI258, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for individuals with inherited erythromelalgia, testing the effectiveness of the drug xpf-001 compared to a placebo in reducing pain levels, with various inclusion and exclusion criteria for participation.",
    "This sample is a phase 1 trial for patients with cancer of the esophagus, gastroesophageal junction, or stomach, testing the effectiveness of vandetanib, 5 fluorouracil (fu), carboplatin, and paclitaxel as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs pf-03654746 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drugs ly2584702, erlotinib, and everolimus on patients with metastases, non-small cell lung carcinoma, renal cell carcinoma, and neuroendocrine tumors, who have failed previous treatments, and meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for the drug alisertib, which is being tested for the treatment of advanced solid tumors and lymphomas. The eligibility criteria include age, performance status, expected survival, and contraceptive use. Exclusion criteria include pregnancy, recent treatments, medical conditions, and other malignancies.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have achieved at least a partial response after standard dose chemotherapy, and it aims to evaluate the effectiveness of carboplatin, cyclophosphamide, etoposide, paclitaxel, and topotecan hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic malignant melanoma, testing the drugs karenitecin and valproic acid, with inclusion criteria including age greater than or equal to 18, ECOG performance status 0-2, and no major impairment of hematological function, and exclusion criteria including evidence of significant active infection, adequate renal and normal hepatic function, and exclusion of pregnant and nursing women.",
    "This sample is a phase 1 clinical trial for patients with refractory cutaneous T-cell lymphoma, testing the drug forodesine hydrochloride, with eligibility criteria including histologically confirmed lymphoma, measurable disease, and specific patient characteristics and prior therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer and brain metastases, testing the drug icotinib for those with a positive EGFR mutation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have previously received platinum-based chemotherapy, and it involves the drugs lenvatinib, carboplatin, and gemcitabine. The eligibility criteria include specific age, cancer type, relapse criteria, performance status, and various laboratory values.",
    "This sample is a phase I clinical trial for patients with stage IV tamoxifen-refractory breast cancer, testing the drug panobinostat (lbh589) to determine its effectiveness in treating the disease. The eligibility criteria include specific age, gender, disease stage, and laboratory criteria, while the exclusion criteria include prior use of certain inhibitors, impaired cardiac function, uncontrolled hypertension, and other medical conditions.",
    "This sample is a phase 1 trial for patients with tumors, specifically those with histological or cytological confirmation of a solid, malignant tumor, and at least one measurable or non-measurable site of disease. The study will test the drugs azd1152 part a and azd1152 part b as potential treatments. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 1 trial testing the drug \"bi 6727\" on patients with advanced, non-resectable, and/or metastatic solid tumors, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for HIV infections, testing the drugs raltegravir and emtricitabine/tenofovir disoproxil fumarate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial testing the drugs rifabutin and rifabutin + atazanavir + ritonavir in healthy subjects with the disease antivirals/hiv, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for hepatocellular carcinoma, testing the drugs mapatumumab, placebo, and sorafenib, with eligibility criteria including Child-Pugh Class A, Barcelona Clinic Liver Cancer advanced or intermediate stage, and measurable disease on imaging.",
    "This sample is a phase 1 trial for pancreatic neoplasms, testing the drugs nelfinavir and gemcitabine, with the eligibility criteria being closed to accrual.",
    "This sample is a phase 1/phase 2 trial investigating the use of bevacizumab, ag-013726, and ag-013736 (axitinib) in patients with locally advanced or metastatic colorectal cancer (CRC) who have not received any previous systemic therapy. The inclusion criteria include having measurable disease by RECIST and controlled hypertension, while the exclusion criteria include prior treatment with anti-angiogenesis agents and prior irradiation of bone marrow.",
    "This sample is a phase 1/phase 2 clinical trial for patients with ovarian cancer, testing the drugs sorafenib and topotecan, with specific eligibility criteria including prior treatment failure and no active cancer within the last 5 years.",
    "This sample is a phase 1/phase 2 trial testing the use of smoked cannabis in patients with multiple sclerosis who have moderate or severe spasticity, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory Acute Myeloid Leukemia (AML) or untreated AML patients aged 60 years to 74 years. The drug being tested is clofarabine, and the eligibility criteria include specific age range, performance status, and satisfactory organ function.",
    "This sample is a phase 1 trial for the treatment of chronic hepatitis C. The study includes patients infected with HCV genotype 1 and evaluates the efficacy of various drugs, including peginterferon alfa-2b and ritonavir, in combination with SCH 900518. The eligibility criteria include specific medical history, physical examination, and laboratory evaluations.",
    "This sample is a phase 1/phase 2 clinical trial for patients with urinary bladder neoplasms, testing the drug lenalidomide, with specific eligibility criteria including age, performance status, disease type, and organ function requirements.",
    "This sample is a phase 1 clinical trial testing the drug topotecan on patients with histologically confirmed rectal cancer who are candidates for preoperative radiotherapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic renal cell carcinoma, testing the drug everolimus (rad001) as a treatment option. The eligibility criteria include patients of Chinese origin who are \u2265 18 years old, have confirmed metastatic renal cell carcinoma, and have intolerance or progression on VEGF-targeted therapies.",
    "This sample is a phase 1 clinical trial for patients with relapsed or relapsed/refractory multiple myeloma, testing the drugs rad001 and lenalidomide, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of overactive bladder, testing the drugs vibegron and tolterodine er, with eligibility criteria including non-pregnancy, BMI \u226440 kg/m^2, and a clinical history of overactive bladder symptoms for at least 3 months.",
    "This sample is a phase 1 clinical trial for patients with ovarian, fallopian tube, or peritoneal cancer, testing the drug alemtuzumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with melanoma, testing the drugs lenalidomide and dacarbazine, with eligibility criteria including age, performance status, laboratory tests, and exclusion criteria such as prior chemotherapy, serious medical conditions, and concurrent use of other anti-cancer agents.",
    "This sample is a phase 1 trial for chronic hepatitis B, testing the drugs gs-7340 and tenofovir disoproxil fumarate, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for essential hypertension, testing the drug qgc001 and placebo in healthy Caucasian male subjects aged 18 to 45, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with advanced non-small cell lung cancer, testing the combination of carboplatin, hydroxychloroquine, and paclitaxel as a treatment option, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1 trial for patients with advanced colorectal cancer, testing the combination of OSI-906 and irinotecan, with specific eligibility criteria including KRAS mutation status and prior treatment history.",
    "This sample is a phase 1/phase 2 trial testing the drugs mrx-801 and placebo on patients with acute ischemic stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of type 1 diabetes mellitus using the drug lisofylline, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of recurrent childhood acute lymphoblastic leukemia, using a combination of drugs including l-asparaginase, doxorubicin hydrochloride, and vincristine sulfate, among others. The eligibility criteria include specific diagnosis requirements, performance status, blood count limits, and various other medical conditions.",
    "This sample is a phase 1/phase 2 trial for asthma patients, testing the effectiveness of active and placebo drugs, with specific inclusion and exclusion criteria.",
    "This phase 1 trial aims to evaluate the efficacy of azacitidine, lenalidomide, and grifola frondosa in treating advanced cancers that are refractory to standard treatment or have no standard therapy available, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 1 clinical trial for asthma patients, testing the drugs gw870086x and placebo. The eligibility criteria include age, documented history of bronchial asthma, sensitivity to adenosine mono phosphate (AMP), and response to inhaled AMP.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug mln8237 (alisertib) on patients with various advanced nonhematological malignancies, non-small cell lung cancer, small cell lung cancer, metastatic breast cancer, head and neck squamous cell carcinoma, and gastroesophageal adenocarcinoma, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for the drug LX4211 and Januvia in adults with type 2 diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma, testing the drug vandetanib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug pf-00299804 in patients with advanced non-small cell carcinoma and neoplasm metastasis, with specific eligibility criteria including ECOG performance status, platelet and ANC counts, and prior treatment history.",
    "This sample is a phase 1 trial for participants with type 2 diabetes mellitus, testing the effectiveness of sitagliptin phosphate and placebo as comparators, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for the treatment of intermittent claudication, a symptom of peripheral artery disease (PAD), using trans sodium crocetinate (TSC) and 0.9% normal saline as drugs. The eligibility criteria include age, diagnosis of PAD, stable claudication severity, and stable exercise habits.",
    "This phase 1 trial aims to evaluate the efficacy of rm-131 and placebo in patients with diabetes mellitus type 1 and 2, diabetes mellitus complications, gastroparesis, and gastrointestinal motility disorder, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of dexamethasone, sorafenib tosylate, and lenalidomide as a potential treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial testing the drugs obatoclax mesylate and topotecan hydrochloride on patients with recurrent small cell lung cancer and unspecified adult solid tumors, with specific eligibility criteria including prior chemotherapy and stable brain metastases.",
    "This sample is a phase 1 clinical trial for a drug called ZYGK1, being tested on volunteers with type 2 diabetes, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug vosaroxin for patients with relapsed or refractory leukemia, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the combination of mpc-6827 and temozolomide as a treatment option. The eligibility criteria include having histologically proven melanoma, measurable metastases, and a performance score meeting certain criteria. The exclusion criteria include hypersensitivity to Cremophor EL, ocular melanoma, cardiovascular and cerebrovascular diseases, and elevated Troponin-I levels.",
    "This sample is a phase 1/phase 2 trial for chronic myeloid leukemia (CML) patients who have resistance or intolerance to imatinib mesylate, and it will test the effectiveness of dasatinib in treating the disease.",
    "This sample is a phase 1/phase 2 trial investigating the use of adefovir dipivoxil and hepatitis B vaccination in recipients of liver transplantation with hepatitis B core antibody positive grafts, who have not reached the 18 month post transplantation period, to prevent hepatitis B surface antigen positivity.",
    "This sample is a phase 1/phase 2 trial testing the drug Torisel in subjects with advanced adenocarcinoma and neoplasms, with specific inclusion and exclusion criteria.",
    "This sample is a clinical trial study that focuses on phase 1/phase 2 trials for patients with advanced non-hematologic malignancy, including brain and central nervous system tumors, melanoma, and solid tumors. The study evaluates the effectiveness of drugs such as ps-341 (velcade) and temozolomide in treating these diseases, and includes eligibility criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia, specifically acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or acute leukemia of ambiguous lineage. The study aims to evaluate the efficacy of drugs such as clofarabine, cytarabine, and methotrexate in patients who have relapsed or are refractory to prior induction therapy. Eligibility criteria include specific disease characteristics, performance status, kidney and liver function, and prior therapy history.",
    "This sample is a phase 1/phase 2 clinical trial for lung cancer patients, testing the drugs bevacizumab and bortezomib, with eligibility criteria including specific disease stage, previous treatments, and various health parameters.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the effectiveness of raltegravir poloxamer film coated tablet, raltegravir chewable tablet, and raltegravir oral granules for suspension in participants with HIV-1 infection who are on unchanged therapeutic regimen or treatment experienced. The study includes eligibility criteria such as documentation of HIV-1 infection, HIV RNA of 1,000 copies/mL or greater, and willingness to take assigned raltegravir preparation. Exclusion criteria include known Grade 3 or higher laboratory tests, clinical evidence of pancreatitis, and prior treatment with another experimental HIV integrase inhibitor.",
    "This phase 1 trial is investigating the use of multiple drugs, including erwinase, vincristine, and dexamethasone, in combination with other therapies for the treatment of relapsed acute lymphoblastic leukemia in pediatric patients with a history of allergic reactions to E. coli asparaginase.",
    "This sample is a phase 1/phase 2 trial for patients with malignant pleural mesothelioma, testing the effectiveness of chemotherapy as a treatment option. The eligibility criteria include age > 18 years, no previous chemotherapy, and adequate organ function.",
    "This sample is a phase 1 trial testing the drug bkm120 on patients with advanced solid tumors, specifically breast cancer, colon cancer, ovarian cancer, and endometrium cancer, who meet certain eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with cutaneous lupus and lupus, testing the drugs amg 557 and amg 557 placebo, with eligibility criteria including a diagnosis of subacute cutaneous lupus erythematosus (SCLE) and positive SS-A and/or SS-B antibodies.",
    "This sample is a phase 1 trial testing the drugs brentuximab vedotin, cyclophosphamide, prednisone, doxorubicin, and vincristine for the treatment of treatment-naive CD30-positive mature T-cell and NK-cell neoplasms, including systemic anaplastic large cell lymphoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for non-small cell lung cancer (NSCLC) patients, testing the combination of bortezomib, carboplatin, and docetaxel as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the drug ecopipam in patients with Tourette's Syndrome, with specific inclusion and exclusion criteria, including a minimum score on the Yale Global Tic Severity Score, age requirement, and contraception use for women.",
    "This sample is a phase 1/phase 2 trial for patients with advanced non-small cell lung cancer, testing the drugs docetaxel and npi-2358 + docetaxel, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs cisplatin and everolimus on patients with advanced solid tumors, with specific eligibility criteria including measurable disease and certain patient characteristics.",
    "In this sample, the phase of the trial is Phase 1 and the disease being studied is non-small-cell lung carcinoma. The ICD-10 codes associated with the disease are D02.20, D02.21, and D02.22. The drugs being tested are azd2171, paclitaxel, and carboplatin. The inclusion criteria include having confirmed NSCLC, being previously untreated with advanced/metastatic NSCLC, and having a WHO performance status of 0-1. The exclusion criteria include untreated unstable brain or meningeal metastases, inappropriate laboratory test values, and poorly controlled hypertension.",
    "This sample is a phase 1 clinical trial that includes patients with various hematological malignancies and solid tumors, testing the combination of vorinostat and decitabine as a potential treatment option.",
    "This sample is a phase 1 trial for patients with metastatic colorectal adenocarcinoma, testing the drugs folfox-4, amg 706, and folfiri, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable solid tumors, testing the drug xl765 (sar245409) to determine its effectiveness in treating the disease. The eligibility criteria include having no other treatment options available, being at least 18 years old, and having adequate organ and bone marrow function. The exclusion criteria include recent anticancer treatment, uncontrolled intercurrent illness, and known allergies to the drug.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have progressed after receiving prior chemotherapy. The study aims to evaluate the efficacy of everolimus and gefitinib as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial for patients with tumors and lymphoma, testing the drug cnf2024, with specific eligibility criteria including failed standard therapies, age over 18, and various health parameters within normal ranges.",
    "This sample is a phase 1 clinical trial for patients with unresectable and/or metastatic gastric cancer, testing the efficacy of capecitabine, cisplatin, and imatinib mesylate as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1 trial testing the effectiveness of atorvastatin and placebo in treating atherosclerotic vascular disease, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for subjects with hypercholesterolemia, testing the drug spc5001, and the eligibility criteria include age, BMI, and specific laboratory values.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the drugs gk activator and ethanol, with inclusion criteria including age, type 2 diabetes, and hepatic function, and exclusion criteria including type 1 diabetes, diabetic complications, recent insulin or PPAR gamma agonist use, and cardiovascular disease.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma, testing the efficacy of pegylated liposomal doxorubicin hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, performance status, hematopoietic, hepatic, renal, and cardiovascular requirements, as well as restrictions on prior concurrent therapies and other medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with ovarian cancer, peritoneal cancer, fallopian tube cancer, or bowel obstruction, testing the effectiveness of cisplatin and paclitaxel drugs in treating malignant bowel obstruction, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the efficacy of tipranavir capsules and ritonavir capsules in HIV-infected patients who are TPV na\u00efve and have not received a PI based regimen within 6 months of enrollment.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the drugs ly2228820, midazolam, and tamoxifen, with specific eligibility criteria including histological evidence of cancer, adequate organ function, and previous discontinuation of cancer therapies.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the drugs ly2090314, pemetrexed, and carboplatin, with eligibility criteria including performance status, life expectancy, contraceptive precautions, histological evidence of advanced cancer, and adequate organ function.",
    "This sample is a phase 1 clinical trial testing the drug ARQ 197 on patients with cancer who have not responded to available therapies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug td-1211 and placebo on healthy subjects and subjects with opioid-induced constipation, with specific inclusion and exclusion criteria.",
    "This sample is a phase I clinical trial for patients with recurrent malignant glioma or metastatic brain cancer, testing the drugs vardenafil and carboplatin, with specific eligibility criteria including normal hematologic, renal, and liver function, and exclusion criteria such as serious concurrent infection or medical illness, pregnancy or breastfeeding, and allergy to certain medications.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer, testing the drugs cs-1008 and folfiri, with specific eligibility criteria including age, performance status, organ function, and previous treatments, among others.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) or B-cell prolymphocytic leukemia (PLL), testing the drugs alvocidib hydrochloride and cyclophosphamide, with specific eligibility criteria including certain genetic markers and disease symptoms.",
    "This sample is a phase 1 trial for patients with chronic hepatitis C, testing the efficacy of peginterferon alfa-2a (Pegasys) in non-responders to previous therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the drug \"neu-p11\" and its placebo in treating primary insomnia, with eligibility criteria including sleep latency and total sleep time, age range, negative pregnancy test, good health, and exclusion criteria including certain sleep disorders, chronic infections, hypertension, and drug addiction.",
    "This sample is a phase 1 clinical trial for healthy individuals, testing the efficacy of different fentanyl transdermal systems combined with clinical procedures, and includes eligibility criteria such as age, weight, and medical history.",
    "This sample is a phase 1 trial for patients with melanoma, testing the drugs sorafenib tosylate and temsirolimus, with eligibility criteria including confirmed melanoma, accessible tumor for biopsy, normal bilirubin and creatinine levels, and no history of allergic reactions to similar compounds.",
    "This sample is a phase 1 clinical trial for epilepsy, testing the drugs brivaracetam, levetiracetam, and lorazepam, with inclusion criteria including healthy volunteers aged 18 to 50 with a BMI between 18.0 and 30.0 kg/m\u00b2, and exclusion criteria including known allergy to pyrrolidinone derivatives and abnormalities on EEG recordings.",
    "This sample is a phase 1 trial for patients with leukemia, specifically chronic phase chronic myelogenous leukemia (CML) or accelerated/blastic phase CML or acute lymphoblastic leukemia. The drug being tested is dasatinib, and the eligibility criteria include being resistant or intolerant to prior imatinib mesylate and having received and benefitted from at least 3 months of prior therapy with dasatinib.",
    "This sample is a phase 1 trial testing the safety, tolerability, and blood concentration of the drug azd3839 in healthy volunteers, with inclusion and exclusion criteria specified.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer, testing the drug abt-751. The eligibility criteria include prior hormonal therapy, prior treatment with docetaxel, and specific hematologic, renal, and hepatic function requirements.",
    "This sample is a phase 1 clinical trial testing the drug hydroxyurea on patients with advanced solid tumors, and it includes eligibility criteria such as confirmed malignant tumors, Karnofsky Performance status, predicted life expectancy, and adequate renal and hepatic function.",
    "This sample is a phase 1/phase 2 trial testing the drugs opa-6566, placebo, and latanoprost for the treatment of primary open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of lovaza\u00ae and a placebo in patients with acute myocardial infraction, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with type 1 diabetes, testing the effectiveness of insulin lispro in individuals aged 18 to 70 with a BMI between 18 and 35 kg/m2, and excluding those with type 2 diabetes, high serum C-peptide levels, or HbA1c levels above 10.0%.",
    "This sample is a phase 1/phase 2 clinical trial for the drug tak-700 in male patients with metastatic prostate adenocarcinoma, testing its efficacy and safety based on specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for non-small cell lung cancer patients, testing the drugs linifanib, carboplatin, and paclitaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs glucarpidase, high-dose methotrexate, and leucovorin for the treatment of osteosarcoma, leukemia, and lymphoma, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 clinical trial testing the drug srt2379 and placebo in healthy male subjects between 18 and 35 years old, with inclusion and exclusion criteria specified, to evaluate its safety and tolerability in treating sepsis.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel, cisplatin, and sti571 drugs, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of lo-ovral oral contraceptive pills and placebo in treating women with aplastic anemia, menorrhagia, and amenorrhea, who are aged 12-55 years, have a uterus and at least one functioning ovary, and do not desire pregnancy. The study also includes eligibility criteria and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial testing the drugs zalutumumab and cisplatin on patients with locoregionally advanced squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, excluding those who have had prior treatment with radiotherapy or chemotherapy in the head and neck area, or prior treatment with similar drugs.",
    "This sample is a phase 1 trial for breast cancer patients with metastatic disease, testing the drugs letrozole and dhea in postmenopausal patients with specific hormone receptor status and other eligibility criteria.",
    "This sample is a phase 1 trial for patients with advanced non-hematologic solid tumor malignancies, including breast, lung, colon, pancreatic, head and neck, kidney, sarcoma, and hepatocellular cancer, testing the drugs pazopanib and ixabepilone, with specific eligibility criteria and organ function requirements.",
    "This sample is a phase 1 trial for type 2 diabetes, testing the effectiveness of different doses of insulin glargine compared to a placebo, with specific eligibility criteria including HgbA1c levels, age, and BMI.",
    "This sample is a phase 1 clinical trial for the drug namilumab (mt203) versus placebo in patients with active rheumatoid arthritis, with specific inclusion and exclusion criteria, including stable doses of methotrexate and negative tuberculosis test.",
    "This sample study is a phase 1/phase 2 trial investigating the use of aliskiren, a drug used to treat hypertension, in patients with type 2 diabetes and incipient or overt nephropathy. The study aims to assess the safety and efficacy of aliskiren in reducing blood pressure and improving kidney function in these patients.",
    "This sample is a phase 1/phase 2 clinical trial for bladder cancer patients after transurethral resection of bladder tumor (TURBT), testing the effectiveness of mitomycin c and chemophase drugs, with specific eligibility criteria and exclusion criteria.",
    "The sample provided is a phase 1 trial involving healthy male subjects, testing the drug bi 1026706 and its placebo, with the inclusion criteria being healthy male subjects and the exclusion criteria being any relevant deviation from healthy conditions.",
    "This sample is a phase 1 trial testing the drugs dalotuzumab, mk-0752, ridaforolimus, and mk-2206 on participants with neoplasms malignant, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy male participants, testing the drugs \"bi 1744 cl\" and \"placebo\" with eligibility criteria including age, BMI, and absence of relevant medical conditions.",
    "This sample is a phase 1 clinical trial for healthy subjects, testing the effects of clopidogrel and placebo on individuals with specific CYP2C19 genotypes, with inclusion and exclusion criteria related to weight, BMI, smoking, and drug intake.",
    "This sample is a phase 1/phase 2 trial that focuses on patients with various types of cancer, including ovarian cancer, fallopian tube cancer, and bladder cancer. The trial aims to evaluate the effectiveness of belinostat, paclitaxel, and carboplatin as potential treatments. The eligibility criteria include signed consent, confirmed solid carcinomas with no known curative therapy, acceptable liver, renal, and bone marrow function, and acceptable coagulation status.",
    "This sample is a phase 1/phase 2 trial for pediatric patients with relapsed or refractory acute lymphoblastic leukemia (ALL), testing the efficacy of drugs such as abt-751, dexamethasone, peg-asparaginase, doxorubicin, cytarabine, methotrexate, cyclophosphamide, and 6-thioguanine, with specific eligibility criteria including age, diagnosis, prior therapy, and reproductive function.",
    "This sample is a phase 1 trial testing the drug bi 1021958 in healthy individuals and those with asthma, using placebo and different dosing regimens, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with type 2 diabetes mellitus, testing the drug GSK716155 for injection and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia, testing the drugs gx15-070ms, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial that includes patients with various diseases such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes, and it involves the use of drugs like cyclophosphamide and fludarabine phosphate. The eligibility criteria include specific disease criteria, organ function requirements, and age restrictions.",
    "This sample is a phase 1 clinical trial testing the drug NK012 on patients with various types of cancer who have failed conventional therapy, and it includes detailed inclusion and exclusion criteria for participant eligibility.",
    "This sample is a phase 1 trial that includes patients with various advanced hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. The trial aims to evaluate the effectiveness of drugs like busulfan, fludarabine phosphate, mycophenolate mofetil, and tacrolimus in treating these diseases. The eligibility criteria include specific disease characteristics and patient characteristics such as age, organ function, and availability of an umbilical cord blood donor.",
    "This sample is a phase 1 trial testing the drug combination of dasatinib and ketoconazole for patients with advanced or metastatic tumors, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia or myelodysplastic syndromes, testing the use of fludarabine and treosulfan drugs in combination with bone marrow or peripheral blood stem cell transplantation. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for patients with colon and rectal cancer, testing the drug lenalidomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for schizophrenia, Alzheimer's disease, and cognition disorders, testing the drugs jnj-39393406 and placebo, with eligibility criteria including a known history of schizophrenia, stable treatment for at least 3 months, and medically stable physical and laboratory tests.",
    "This sample is a phase 1 clinical trial for patients with solid tumors or malignant lymphoma, testing the drug enzastaurin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with end stage renal disease, testing the drug aliskiren, and includes eligibility criteria such as weight, vital signs, and medical history.",
    "This sample is a phase 1/phase 2 trial testing the drugs rapamycin and tacrolimus for graft versus host disease in patients who have received an allogeneic MSD or MUD PBSCT, and are currently on Tacrolimus for GVHD prophylaxis. The eligibility criteria include being 18 years or older, 24 weeks post SCT, and deemed eligible for tapering off of Tacrolimus by the primary BMT physician.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of bortezomib and sorafenib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the drug gsk573719 in patients with chronic obstructive pulmonary disease (COPD), with specific eligibility criteria including age, weight, spirometry results, and response to ipratropium bromide.",
    "This phase 1 trial is investigating the use of dacarbazine and bortezomib in patients with melanoma, soft tissue sarcoma, parathyroid carcinoma, small cell carcinoma of the lung, and carcinoid tumors, who have measurable or evaluable disease not appropriate for resection and/or radiation with curative intent, and meet other inclusion criteria.",
    "This sample is a phase 1 trial for kidney transplantation, testing the drugs bleselumab and placebo, with inclusion criteria including having a decreased post-transplant serum creatinine value and no dialysis requirement, and exclusion criteria including previous organ transplants, positive T or B cell crossmatch, and uncontrolled infections or medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer, testing the effectiveness of dasatinib and docetaxel drugs in combination, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with ovarian cancer, including epithelial ovarian cancer, fallopian tube carcinoma, and primary peritoneal carcinoma. The trial will test the effectiveness of lenalidomide, liposomal doxorubicin, and bevacizumab, as well as revlimid, doxil, and avastin, in treating platinum resistant/refractory EOC patients. The eligibility criteria include measurable disease, no prior anthracycline or lenalidomide use, and certain creatinine clearance levels.",
    "This sample is a phase 1 clinical trial testing the drug everolimus for the treatment of graft versus host disease in patients who have undergone allogeneic HSCT, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with various types of leukemia and myelodysplastic syndrome, testing the effectiveness of the drugs clofarabine and cyclophosphamide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug tesofensine on overweight to obese subjects with BMI 28-35 kg/m\u00b2, and the eligibility criteria include being otherwise healthy, male aged 18-50, and able to comply with study procedures.",
    "This sample is a phase 1/phase 2 trial for patients with chemotherapy-refractory metastatic castration-resistant prostate cancer (CRPC), testing the drug temsirolimus, and includes eligibility criteria such as confirmed adenocarcinoma of the prostate, evidence of disease progression, and specific medical parameters.",
    "This sample is a phase 1 trial testing the drugs lapatinib and docetaxel on patients with advanced solid tumors, specifically neoplasms of the breast, who are able to swallow oral medication.",
    "This sample is a phase 1 trial for patients with metastatic renal cell carcinoma or advanced refractory solid tumors, testing the association of bevacizumab (bvc) and pazopanib (pzp) as a potential treatment option. The eligibility criteria include age >18 years, specific disease progression criteria, ECOG performance status of 0 or 1, and adequate organ function. Exclusion criteria include prior treatment with pazopanib or bevacizumab, prior treatment with any tyrosine kinase inhibitor, and various other medical conditions.",
    "This sample is a phase 1/phase 2 trial for HIV-1 infection, testing the drug tbr-652 and its various dosages, with eligibility criteria including antiretroviral treatment-experienced patients, specific CD4 cell count and HIV RNA level requirements, and exclusion criteria such as presence of certain HIV strains, active CDC category C disease, and history of hepatitis B or C.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable or metastatic hepatocellular carcinoma, testing the drug rad001 (an mTor inhibitor) to evaluate its efficacy and safety, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with advanced, persistent or recurrent squamous cell carcinoma of the uterine cervix, testing the effectiveness of carboplatin and docetaxel as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial for patients with B-cell chronic lymphocytic leukemia, testing the drug forodesine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with locally recurrent breast cancer, testing the drug lyso-thermosensitive liposomal doxorubicin (thermodox), and includes eligibility criteria such as histologically confirmed adenocarcinoma of the breast, prior radiotherapy, and progression on hormonal therapy and chemotherapy.",
    "This sample is a phase 1/phase 2 trial for myeloma patients, testing the drugs trisenox, velcade, melphalan, and vitamin C, with eligibility criteria including primary refractory disease, age up to 75 years, Zubrod performance status of <2, and negative Beta hCG test in women with childbearing potential.",
    "This sample is a phase 1 clinical trial that includes patients with various hematologic malignancies, such as relapsed or refractory acute myelogenous leukemia (AML), relapsed or refractory pre-B-cell or T-cell acute lymphoblastic leukemia (ALL), and chronic myelogenous leukemia (CML) in accelerated or blastic phase. The study aims to evaluate the efficacy and safety of 7-hydroxystaurosporine and perifosine as potential treatments for these diseases. The eligibility criteria include specific disease types, prior treatment history, organ function, and exclusion of certain conditions.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of breast cancer and advanced malignant solid tumors using the drugs neratinib and vinorelbine, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial for patients with various types of malignant glioma, testing the drugs temozolomide and vorinostat, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for cancer patients with specific neoplasm diagnosis, no effective standard therapeutic options, and certain performance status, where vintafolide iv bolus and vintafolide iv infusion are the drugs being tested.",
    "This sample is a phase 1 clinical trial for the drug adalimumab in patients with ulcerative colitis, who have failed previous treatments, and have specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs \"ides\" and \"placebo\" on healthy individuals with specific inclusion and exclusion criteria, such as BMI 19-30 and no clinically significant disease, HIV, hepatitis B or C, drug abuse, smoking, or use of medication except paracetamol.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the drug bi 10773 at different doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients, testing the drugs docetaxel and epirubicin hydrochloride, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for patients with melanoma, testing the drugs buthionine sulfoximine and melphalan for regional therapy, with specific eligibility criteria including disease stage, previous treatment, and patient characteristics.",
    "This sample is a phase 1 trial for patients with chronic hepatitis B, testing the effectiveness of adefovir in reducing HBV DNA levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug fondaparinux for patients with morbid obesity, with specific inclusion and exclusion criteria, as well as various medical history and laboratory value requirements.",
    "This sample is a phase 1 trial for children with recurrent or refractory pediatric solid tumors, testing the effectiveness of carboplatin, cyclophosphamide, etoposide, thiotepa, and topotecan hydrochloride as treatment options. The eligibility criteria include age between 1 and 30, specific performance status, life expectancy of at least 2 months, and various health requirements such as adequate hematopoietic, hepatic, renal, cardiovascular, and neurologic functions. Prior concurrent therapies are also specified.",
    "This sample is a phase 1/phase 2 clinical trial for kidney transplantation, testing the drug aeb071, with inclusion criteria including adult recipients of a functioning kidney within 24 hours post transplant, and exclusion criteria including patients infected with Hepatitis B, C, or HIV, and patients with a history of cancer within the last 5 years.",
    "This sample is a phase 1/phase 2 trial for HIV-negative individuals, testing the effectiveness of dapivirine (tmc120) vaginal gel in preventing HIV infections, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for cancer patients, testing the drug aee788, with inclusion criteria including confirmed solid tumor, adequate organ function, age \u2265 18 years, Karnofsky performance status score \u2265 70%, and life expectancy \u2265 12 weeks, while exclusion criteria include active brain metastases, peripheral neuropathy > grade 2, diarrhea > grade 1, gastrointestinal dysfunction, compromised cardiac function, and concurrent severe and/or uncontrolled medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with small cell lung cancer, testing the effectiveness of vorinostat, carboplatin, and etoposide as chemotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer, testing the drug celecoxib, and includes eligibility criteria such as specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for patients with solid cancers that are not responsive to standard therapy or have no standard therapy available. The study will test the effectiveness of sunitinib, pemetrexed, cisplatin, and carboplatin as potential treatments. The inclusion criteria require patients to have a good performance status, while the exclusion criteria include prior treatment with pemetrexed or SU011248, coughing up blood within 4 weeks, and uncontrolled hypertension.",
    "This sample is a phase 1 clinical trial for patients with aggressive B-cell non-Hodgkin lymphoma, testing the effectiveness of velcade (bortezomib), rituximab, ifosfamide, carboplatin, and etoposide as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial investigating the effects of different oral contraceptives on follicle development in premenopausal women, with inclusion and exclusion criteria specified.",
    "This sample is a phase I/II clinical trial for patients with locally advanced or metastatic HER2-positive breast cancer, testing the efficacy of bez235 + trastuzumab and lapatinib + capecitabine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with active rheumatoid arthritis, testing the efficacy of a placebo drug in combination with methotrexate, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for sickle cell disease, testing the drugs eptifibatide and placebo, with inclusion criteria including age between 18 and 55 years, confirmed diagnosis of sickle cell anemia or sickle beta zero thalassemia, and normal baseline coagulation profile, and exclusion criteria including baseline hemoglobin < 6.0 gm/dl, history of major gastrointestinal bleeding or bleeding diathesis, and ongoing episode of acute chest syndrome.",
    "This sample is a phase 1/phase 2 trial for patients aged 0-18 with relapsed or residual juvenile myelomonocytic leukemia (JMML) after allogeneic HCT, testing the efficacy of drugs such as cyclosporine, cytarabine, and methotrexate, among others, with specific eligibility criteria including organ function and written informed consent.",
    "This sample is a phase 1 trial for sickle cell disease, testing the drug propranolol, and includes eligibility criteria such as age, weight, and hemoglobin levels.",
    "This sample is a phase 1/phase 2 clinical trial for multiple myeloma patients who have had one to three prior regimens and did not respond or relapsed. The study will test the drugs kw-2478 and bortezomib, and the eligibility criteria include confirmed diagnosis, signed informed consent, ECOG performance status \u2264 2, and adequate hematologic, liver, and renal function.",
    "This sample is a phase 1 clinical trial for patients with brain neoplasms, specifically supratentorial grade III or IV astrocytoma, who require a stereotactic biopsy for confirmation of tumor progression or differentiation. The study aims to evaluate the use of temsirolimus (torisel) as the next therapy for their tumor, with eligibility criteria including prior radiation therapy, adequate bone marrow, liver, and renal function, and negative pregnancy test for women of childbearing potential.",
    "This sample is a phase 1/phase 2 trial for the drug rp-1127 (glyburide for injection) in patients with acute ischemic stroke, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug ranibizumab for the treatment of rubeosis iridis and proliferative diabetic retinopathy in subjects with diabetes mellitus, who are willing to undergo cataract surgery and have an HgbA1c level below 12%.",
    "This sample is a phase 1 trial for the treatment of rheumatoid arthritis (RA) using methotrexate (metoject\u00ae prefilled pen), with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 1 clinical trial investigating the use of the drug i5np and placebo in patients undergoing major cardiac or vascular surgery requiring the use of a cardiopulmonary bypass machine (CBM) for the treatment of acute renal failure and acute kidney injury. The eligibility criteria include age between 21 and 85 years old, capability of giving consent, willingness to comply with study procedures, and specific risk factors for acute kidney injury.",
    "This sample is a phase 1 trial testing the drug sunitinib malate for the treatment of metastatic/unresectable adrenocortical carcinoma or melanoma, with specific eligibility criteria including performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug px-866, with specific eligibility criteria including age, performance status, life expectancy, prior treatments, and adequate organ function.",
    "This sample is a phase 1 trial testing the drug \"zyt1\" and placebo tablets on volunteers with obesity and lipid disorders, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) and leukemia, testing the drug clofarabine. The eligibility criteria include relapse or refractory to fludarabine-based regimen, specific blood counts, liver and renal function, and ECOG performance status. Exclusion criteria include heart disease, pregnancy or breastfeeding, recent chemotherapy, other malignancies, and significant medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, testing the efficacy of drugs such as picoplatin with 5-fu and leucovorin, folpi, and folfox, with specific eligibility criteria including histologically confirmed adenocarcinoma, metastatic disease, and no prior systemic therapy.",
    "This sample is a phase 1/phase 2 trial for primary erythromelalgia and inherited erythromelalgia, testing the drugs xpf-002 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic colorectal cancer, testing the effectiveness of capecitabine, gefitinib, and oxaliplatin as treatment options, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 1/phase 2 trial testing the drugs oxaliplatin, fludarabine, and cytarabine on patients with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of irritable bowel syndrome constipation predominant, using the drugs rose-010 and placebo, with eligibility criteria including a previous diagnosis of IBS, constipation predominant type IBS, and exclusion criteria such as pregnancy, breastfeeding, and certain medications.",
    "This sample is a phase 1 trial for non-small cell lung cancer patients, testing the drug rad001 in addition to standard radiation and chemotherapy, with specific eligibility criteria including disease stage, lung function, liver function, and renal function.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the effectiveness of chromium picolinate as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with metastatic breast cancer, testing the drug icaritin, with eligibility criteria including age, previous treatment, BMI, and absence of certain diseases, and exclusion criteria including hypersensitivity to flavonoid drugs and abnormal lab values.",
    "This sample is a phase 1 clinical trial for the drug ly2523355 in patients with acute leukemia, specifically acute myeloblastic leukemia (AML), who are either untreated or have relapsed/refractory disease. The study includes eligibility criteria such as age, performance status, and negative pregnancy test, as well as exclusion criteria such as recent treatment with unapproved drugs, CNS leukemia, and active malignancy.",
    "This sample is a phase 1 trial for patients with multiple myeloma and plasma cell neoplasm, testing the effectiveness of arsenic trioxide, bortezomib, and melphalan in combination with high-dose chemotherapy and autologous stem cell transplantation. The eligibility criteria include confirmed diagnosis of multiple myeloma, indication for therapy based on symptoms, stable disease or partial/complete remission, and candidate for high-dose chemotherapy with autologous stem cell transplantation. The patient characteristics include specific performance status, kidney and liver function, blood counts, cardiac function, and exclusion of certain medical conditions. The prior concurrent therapy includes previous radiation therapy and the possibility of continuing bisphosphonates after day +60.",
    "This sample is a phase 1 trial for patients with invasive breast cancer, testing the effectiveness of lapatinib, docetaxel, and trastuzumab as treatment options, with specific eligibility criteria including age, disease stage, and biomarker levels.",
    "This sample is a phase 1 trial for patients with refractory solid tumors and leukemia, testing the drugs bevacizumab, sorafenib, and cyclophosphamide, with specific eligibility criteria including age, organ function, prior therapy, and exclusion criteria such as bleeding diathesis and uncontrolled infection.",
    "This sample is a phase 1 clinical trial for Japanese individuals with type 1 diabetes mellitus, testing the effectiveness of insulin glargine hoe901 and a new formulation of insulin glargine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic triple negative breast cancer, testing the drugs azd2281 and paclitaxel, with specific inclusion and exclusion criteria.",
    "The sample is a phase 1 clinical trial for patients with metastatic melanoma and activating V600 BRAF mutation, testing the drugs ipilimumab and vemurafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for chronic pancreatitis, testing the drug human secretin, and includes eligibility criteria such as age, documented chronic pancreatitis, contraception requirements for females, negative pregnancy test, use of opioid analgesics, and exclusion criteria such as age, recent acute pancreatitis, severe cardiac or pulmonary disease, severe renal disease, previous adverse drug event to secretin, ongoing illicit drug or alcohol use, recent pancreatitis or pancreatic surgery, pregnancy or nursing, use of certain medications, and inability to give consent.",
    "This sample is a phase 1 clinical trial testing the drug tki258 (dovitinib) on patients with advanced solid tumors, excluding breast cancer, that have progressed despite standard therapy or have no standard therapy available. The eligibility criteria include specific laboratory values and a World Health Organization performance status of \u2264 2. Exclusion criteria include brain cancer, severe medical conditions, and not having recovered from previous anti-cancer therapies.",
    "This sample is a phase 1 clinical trial for stomach neoplasms, testing the drugs 5-fluorouracil, cisplatin, and sunitinib malate, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 trial for healthy males, testing the drugs bi 207127 na, bi 201335 na, midazolam, and tolbutamide, with inclusion and exclusion criteria related to medical conditions, allergies, drug use, and lifestyle factors.",
    "This sample is a clinical trial study that focuses on patients with recurrent or refractory malignant CNS tumors, including medulloblastoma, high grade glioma, and ependymoma, and it investigates the use of lapatinib ditosylate as a potential treatment option.",
    "This sample is a phase 1/phase 2 clinical trial for patients with proliferative diabetic retinopathy, testing the effectiveness of ranibizumab, an anti-VEGF injection, in treating diabetic neovascularization that has persisted for at least three months after previous laser treatment.",
    "This sample is a phase 1 clinical trial for Parkinson's disease, testing the drugs mk0657, placebo, levodopa, and carbidopa, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with melanoma, testing the drugs sunitinib and dacarbazine, with eligibility criteria including specific disease stage, organ function requirements, and exclusion criteria such as recent major surgery or radiation therapy.",
    "This sample is a phase 1 clinical trial for patients with platinum-resistant or refractory ovarian cancer, testing the combination of perifosine and docetaxel drugs, with eligibility criteria including tumor accessibility for biopsy and ECOG performance status of 0-2.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug darinaparsin. The eligibility criteria include having measurable lesions, adequate organ function, and no history of certain medical conditions.",
    "This sample is a phase 1/phase 2 trial testing the drugs pentostatin, tacrolimus, and methotrexate on patients with leukemia and lymphoma who are receiving allogeneic hematopoietic transplants. The eligibility criteria include specific disease types, certain health parameters, and restrictions on prior chemotherapy.",
    "This sample is a phase 1 trial for breast cancer patients who have undergone a unilateral segmental mastectomy, with the aim of studying the effects of melatonin and placebo on insomnia, with specific inclusion and exclusion criteria provided.",
    "This sample is a phase 1 clinical trial for cystic fibrosis patients, testing the effectiveness of sodium chloride (7%) in improving lung function and oxygen saturation levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic melanoma, testing the drug temozolomide, and includes eligibility criteria such as histologically confirmed melanoma, stage IV disease, measurable disease, prior systemic therapy, and exclusion criteria such as life expectancy less than 4 months, known HIV positivity, and concurrent use of certain medications.",
    "This sample is a phase 1 clinical trial testing the drug etelcalcetide and placebo in male subjects with secondary hyperparathyroidism, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with metastatic or unresectable cancer, testing the combination of decitabine and pegylated interferon-alfa 2b as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients with locally advanced, unresectable disease or resectable disease with surgery contra-indication. The study will test the effectiveness of carboplatin, rad001, and paclitaxel as treatment options. Eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for patients with Her-2 negative breast cancer, testing the drug paclitaxel, and includes eligibility criteria such as measurable disease, adequate organ function, and exclusion criteria such as bleeding disorders and concurrent hormone therapy.",
    "This sample is a phase 1 trial testing the drug vorinostat in patients with various high-risk lymphomas, including diffuse large B-cell lymphoma, follicular lymphoma, Hodgkin lymphoma, mantle cell lymphoma, and T-cell non-Hodgkin lymphoma, who have undergone autologous stem cell transplantation. The eligibility criteria include specific disease characteristics and patient characteristics, and exclude patients with certain medical conditions or concurrent therapies.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with glioblastoma or gliosarcoma, testing the effectiveness of sorafenib tosylate and temsirolimus as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with renal cell carcinoma, testing the combination of tivozanib (av-951) plus temsirolimus as a treatment option, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 1 clinical trial for patients with advanced, non-resectable and/or metastatic solid tumors who have failed conventional treatment, testing the drugs bibw 2992 and bibf 1120, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with metastatic cancer and brain metastases, testing the drug riluzole, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "This sample is a phase 1 trial for subjects with advanced or metastatic solid tumors, specifically targeting the disease of cancer, using the drug bms-690514, with eligibility criteria including adequate kidney, liver, and cardiac function.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients, testing the effectiveness of carboplatin, cisplatin, docetaxel, fluorouracil, and lapatinib ditosylate as treatment options, with specific eligibility criteria and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for the treatment of rheumatoid arthritis, where the drug being tested is ccx 354-c, and the eligibility criteria include stable RA based on ACR criteria, stable methotrexate dose, negative HIV and hepatitis screens, and the use of adequate contraception for subjects of childbearing potential.",
    "This sample is a phase 1/phase 2 trial for non-small cell lung cancer (NSCLC) patients who are deemed inoperable, and will be treated with curative intent using the drugs etoposide and cisplatin. The eligibility criteria include having measurable disease, no active malignancy within the past 5 years (except for non-melanoma skin cancers or carcinoma in situ of the cervix), being 18 years or older, having a life expectancy of greater than 6 months, and meeting certain organ and marrow function requirements. The exclusion criteria include having a primary tumor size greater than 6cm, a prior history of thoracic radiotherapy, and not receiving any other study agents.",
    "This sample is a phase 1/phase 2 clinical trial for multiple sclerosis, testing the effects of inhaled cannabis, oral THC, and placebos on spasticity in patients who meet specific inclusion criteria and do not have certain pre-existing conditions.",
    "This sample is a phase 1/phase 2 trial for metastatic pancreatic cancer, testing the efficacy of ipi-926 plus gemcitabine and placebo plus gemcitabine as treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for male patients with type 2 diabetes mellitus, testing the drugs azd1656 and placebo, with specific inclusion and exclusion criteria related to cardiovascular disease and blood pressure.",
    "This sample study is a phase 1 trial testing the drugs darapladib and diltiazem for the treatment of atherosclerosis, with specific eligibility criteria including age, BMI, and medical history, and exclusion criteria such as liver disease, alcohol consumption, and sensitivity to study medications.",
    "This sample is a phase 1 trial for patients with kidney cancer, testing the drug sorafenib. The eligibility criteria include having histologically confirmed clear cell renal cell carcinoma, measurable disease, and meeting certain health requirements.",
    "This sample is a phase 1/phase 2 trial for patients with inoperable stage III or IV malignant melanoma, testing the drugs imexon and dtic, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with leukemia or myelodysplastic syndromes, testing the drug cytarabine. The eligibility criteria include specific disease characteristics, patient characteristics, and restrictions on prior and concurrent therapy.",
    "This sample is a phase 1 trial for patients with HER2 overexpressing breast cancer and brain metastases, testing the effectiveness of lapatinib and herceptin in treating the disease.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic pancreatic cancer, testing the efficacy of gemcitabine and albumin-bound paclitaxel as the treatment. The eligibility criteria include having no prior therapy for metastatic disease, specific blood counts and chemistry levels, acceptable coagulation status, Karnofsky performance status greater or equal to 70, and measurable metastatic tumors. The exclusion criteria include known brain metastases, use of therapeutic coumadin, active infections, history of allergy to the study drug, serious medical risk factors, and enrollment in other clinical protocols or investigational trials.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drugs ocrelizumab and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with fallopian tube cancer, malignant tumor of peritoneum, and recurrent ovarian epithelial cancer. The drug being tested is docetaxel, and the eligibility criteria include having received prior platinum-based chemotherapy and meeting various medical requirements.",
    "This sample is a phase 1 trial for the treatment of chronic hepatitis B, testing the drugs dv-601 and entecavir, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable locally advanced or metastatic non-small-cell lung carcinoma (NSCLC). The drug being tested is patupilone, and the eligibility criteria include prior treatment with a platinum-containing regimen, age \u226518 years, performance status of 0-1, and specific hematologic and blood chemistry values. Patients with brain metastases are eligible if they meet certain criteria.",
    "This sample is a phase 1 trial for participants with type 2 diabetes mellitus, testing the effects of various drugs (placebo, insulin, glucose, glucagon) on eligibility criteria such as BMI, blood pressure, and glucose tolerance.",
    "This sample is a phase 1/phase 2 trial for individuals with pre-hypertension, testing the effectiveness of carvedilol phosphate, lisinopril, and a combination of both drugs, as well as a placebo, in reducing blood pressure and cardiovascular risk factors.",
    "This sample is a phase 1 clinical trial for the drug \"gsk1120212\" in patients with solid tumors, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for allergic asthma, testing the drugs qge031, omalizumab, and placebo, with inclusion criteria including positive skin prick test, airway hyperresponsiveness, and early asthmatic response, and exclusion criteria including pregnancy, smoking, and poorly controlled asthma.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with various types of brain tumors, testing the effectiveness of sorafenib tosylate, erlotinib hydrochloride, tipifarnib, and temsirolimus as treatment options, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1 trial that focuses on healthy subjects and non-dependent, recreational opioid users. The study aims to evaluate the effects of various drugs, including placebo and different formulations of alo-02 and oxycodone, on these subjects. The inclusion and exclusion criteria are also provided.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug lcl161. The inclusion criteria include having a solid tumor, a certain performance status, and meeting specific blood laboratory values, while the exclusion criteria include having brain tumors or brain metastases, unresolved nausea, vomiting, or diarrhea, and certain medical conditions that could compromise participation in the study.",
    "This sample is a phase 1/phase 2 trial for metastatic breast adenocarcinoma, testing the drugs docetaxel, epirubicin, and bevacizumab, with eligibility criteria including no previous therapy for metastatic breast cancer, age 18-75 years, and adequate liver, renal, and bone marrow function.",
    "This sample is a phase 1/phase 2 trial for patients with extensive stage or recurrent lung small cell carcinoma, testing the efficacy of carboplatin, cisplatin, etoposide, and sunitinib malate as treatment options, with specific eligibility criteria including histologically or cytologically documented small cell lung cancer, measurable disease, no prior chemotherapy for SCLC, completed radiation therapy, and specific performance status and cardiac health requirements.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC), testing the drugs rad001 and docetaxel. The eligibility criteria include having accessible biopsy, ECOG Performance Status of 0, 1, or 2, and adequate bone marrow, renal, and hepatic function. Exclusion criteria include chronic treatment with systemic steroids, uncontrolled brain or leptomeningeal metastases, and known hypersensitivity to everolimus or sirolimus.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung cancer, testing the combination of arq 197 and erlotinib as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the effectiveness of oxaliplatin, fludarabine, cytarabine, rituximab, and pegfilgrastim in treating patients with Richter's transformation, leukemia, or relapsed/refractory B-cell chronic lymphocytic leukemia. The eligibility criteria include age, performance status, renal and hepatic function, and platelet counts, while exclusion criteria include untreated infections, intolerance to certain drugs, pregnancy or lactation, recent chemotherapy or radiation therapy, and medical conditions that may interfere with the study.",
    "This sample is a phase 1 trial for the drug rosiglitazone maleate in patients with type 2 diabetes mellitus, with inclusion criteria including males and females aged 18-65 years, and exclusion criteria including clinically significant medical conditions and abnormalities in vital signs or laboratory parameters.",
    "This sample is a phase 1 trial testing the drugs \"gsk2849466\" and \"placebo\" on patients with the disease \"cachexia\", with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase I/II clinical trial testing the drug lenalidomide in patients with CD20+ B-cell non-Hodgkin lymphoma who have undergone autologous stem cell transplantation, and the eligibility criteria include specific disease types, previous treatment history, and various laboratory parameters.",
    "This sample is a phase 1 trial for healthy individuals, testing the safety and tolerability of dabigatran etexilate capsules, quinidine sulfate tablets, and fexofenadine tablets, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1/phase 2 clinical trial for esophagus cancer, testing the drugs oxaliplatin, docetaxel, and capecitabine, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory B- or T-cell non-Hodgkin's lymphoma, testing the effectiveness of bortezomib and gemcitabine hydrochloride as treatment options.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndromes or leukemia, who have failed or are ineligible for certain treatments, and are seeking a haploidentical related donor for bone marrow transplantation. The only drug mentioned is cyclophosphamide.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL) who have relapsed or refractory disease, and it will test the efficacy of bendamustine, rituximab, and lenalidomide as a treatment regimen. The eligibility criteria include specific age requirements, confirmed diagnosis of CLL, previous response to bendamustine, and various health parameters.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia, testing the combination therapy of decitabine and midostaurin, with specific inclusion and exclusion criteria, and various lab value requirements.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drug cc-5013, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer and carcinomatous meningitis, testing the effectiveness of gefitinib as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the drugs lapatinib and pemetrexed, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for pancreatic cancer patients, testing the drug pemetrexed disodium, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy requirements.",
    "This sample is a phase 1 clinical trial for the treatment of high-risk epithelial ovarian, primary peritoneal, and fallopian tube cancer using the drugs amg 386, paclitaxel, and carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of advanced stage ovarian cancer using the drug sb-485232 (interleukin 18) in combination with pegylated liposomal doxorubicin, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the drug otelixizumab in patients with rheumatoid arthritis, testing its efficacy in reducing disease activity in patients who have not responded to other treatments. The eligibility criteria include age, gender, BMI, ECG results, RA diagnosis, positive rheumatoid factor, active disease, previous treatment with at least one DMARD, and exclusion criteria include certain medical conditions, previous exposure to certain biologic therapies, recent surgeries, and pregnancy.",
    "This sample is a phase 1/phase 2 trial for patients with newly diagnosed stage I and II nasal Natural Killer (NK) cell lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin, vincristine, and prednisone as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial investigating the use of fondaparinux, an anticoagulant drug, in children aged 1-18 with venous or arterial thrombosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial that includes patients with advanced breast, gastric, head and neck, liver, and non-small cell lung cancer, and focuses on subjects with non-small cell lung cancer who have had a radiographic response to erlotinib treatment and have a documented mutation in EGFR exons 19 or 21. The study aims to evaluate the efficacy of the drug cudc-101 in these patients who have exhausted standard treatment options or have refused them.",
    "This sample is a phase 1/phase 2 trial for kidney diseases and kidney transplantation, testing the drugs daclizumab, mycophenolate mofetil (mmf), prednisone, tacrolimus, ganciclovir, valganciclovir, and trimethoprim and sulfamethoxazole, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small-cell lung carcinoma, testing the drugs chr-2797 (tosedostat) and erlotinib, with eligibility criteria including confirmed NSCLC, disease progression after platinum-based chemotherapy, and specific laboratory values within normal ranges.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for previously untreated multiple myeloma patients, testing the combination of ixazomib, lenalidomide, and dexamethasone as a systemic treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with hepatitis C who are nonresponders to standard treatment, testing the drugs imo-2125 and saline placebo. The inclusion criteria include being HCV-positive and a nonresponder to standard treatment, while the exclusion criteria include having HIV or hepatitis B, inadequate organ function, recent treatment with interferon-based therapies, significant medical diseases, and recent alcohol or drug abuse.",
    "This sample is a phase 1/phase 2 trial for the drug ro5024048 in patients with chronic hepatitis C virus infection, genotype-1, who are treatment-naive or have previously been treated with interferon. The eligibility criteria include specific disease diagnosis, HCV RNA measurement, liver biopsy, and various health parameters.",
    "This sample is a phase 1 trial for patients with Autistic Disorder, testing the drugs placebo and ro5028442, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with male breast cancer, stage IIIB, stage IIIC, or stage IV breast cancer, testing the drugs vorinostat and paclitaxel, with specific eligibility criteria including disease stage, performance status, blood counts, liver and kidney function, and exclusion criteria such as recent chemotherapy or radiotherapy, and allergies to study drugs or similar compounds.",
    "This sample is a phase 1/phase 2 trial for the treatment of Friedreich ataxia using resveratrol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with acute lymphoblastic leukemia, testing the drug native l asparaginase. The inclusion criteria include being between 1 and 55 years old, having relapsed after first remission, or being refractory to first-line chemotherapy for ALL.",
    "This sample is a phase 1/phase 2 clinical trial for untreated childhood brain stem glioma, testing the drug tipifarnib, with specific eligibility criteria including age, performance scale, prior therapy, blood counts, and other medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the drugs docetaxel and imatinib mesylate, with eligibility criteria including age, specific disease diagnosis, prior treatments, performance status, and organ function.",
    "This sample is a phase 1/phase 2 trial testing the effects of allopurinol and placebo on hypertension in renal transplant recipients, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with rectal cancer or colorectal cancer, testing the effectiveness of cetuximab, oxaliplatin, capecitabine, and diphenhydramine hydrochloride (HCL) as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for head and neck cancer patients, testing the effectiveness of cisplatin, doxorubicin hydrochloride, and fosbretabulin disodium drugs, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for rectal cancer patients, testing the drugs azd6244 and cediranib (azd2171), with eligibility criteria including confirmed rectal adenocarcinoma, specific tumor characteristics, and various health requirements.",
    "This sample is a phase 1/phase 2 trial for patients with breakthrough nausea and vomiting and unspecified adult solid tumors, testing the effectiveness of fosaprepitant dimeglumine and systemic chemotherapy in combination with 5-HT3 receptor antagonist antiemetics for chemotherapy-induced nausea and vomiting.",
    "This sample is a phase 1 clinical trial for patients with type 2 diabetes mellitus, testing the drugs mk-0941, placebo, and lantus insulin, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of chronic hepatitis C infection using the drugs ach-0143102 and ribavirin, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the combination of sunitinib and rapamycin as a potential treatment option, with eligibility criteria including histologically proven NSCLC, age \u226518 years, ECOG 0-2, and adequate bone marrow, liver, and renal function.",
    "This sample is a phase 1 trial for patients with metastatic renal cell carcinoma, testing the drugs cp-675,206 and su011248, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the drug pf-05161704 or placebo in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs darifenacin, tolterodine, and placebo on healthy individuals aged 50 years and above, with specific inclusion and exclusion criteria related to allergies, medical problems affecting heart rate, medication history, malignancy, pregnancy or nursing, and certain diseases.",
    "This phase 1 trial aims to evaluate the safety and efficacy of amifostine trihydrate and melphalan in patients with histologically confirmed amyloidosis, excluding secondary familial or localized amyloidosis, and with presence of monoclonal protein, while excluding primary amyloidosis manifested only by carpal tunnel syndrome or purpura. The study also includes specific eligibility criteria for age, performance status, hematopoietic, hepatic, renal, cardiovascular, and other factors, as well as prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with stage IV pancreatic cancer, testing the combination of erlotinib hydrochloride and gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease stage, performance status, blood counts, liver and kidney function, and exclusion of other medical conditions.",
    "This sample is a phase 1 trial testing the drug liraglutide versus placebo in patients with type 1 diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of pazopanib, erlotinib, and pemetrexed as potential treatments, with specific eligibility criteria including age, performance status, and organ function.",
    "This sample is a phase 1 clinical trial for Japanese subjects with type 2 diabetes mellitus, testing the effectiveness of insulin degludec in controlling blood sugar levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for ovarian cancer patients who have progressed following platinum and paclitaxel chemotherapy, and it involves the drugs cc-5013 and topotecan. The eligibility criteria include age >18, measurable metastatic disease, and ECOG performance status of 0 or 1.",
    "This sample is a phase 1/phase 2 trial for subjects with chronic plaque type psoriasis, testing the efficacy of various drugs including ciclosporin, betamethasone, and calcipotriol, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for adult patients with various types of brain tumors, including glioblastoma and meningioma, using erlotinib hydrochloride as the drug, with specific eligibility criteria and required medical tests.",
    "This sample is a phase 1 trial for the treatment of neuropathic pain, testing the efficacy of gabapentin at different doses, and includes eligibility criteria such as age, weight, medical history, and blood pressure.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed and/or relapsed/refractory multiple myeloma, testing the drugs cci-779 and bortezomib, with specific inclusion and exclusion criteria outlined in the protocol.",
    "This sample is a phase 1 clinical trial for patients with soft tissue sarcoma of the extremity, using chemotherapy as the treatment, with specific eligibility criteria related to the disease characteristics and patient characteristics.",
    "This sample is a phase 1 clinical trial for patients with an unspecified adult solid tumor, testing the drugs cyclophosphamide and imatinib. The eligibility criteria include having a diagnosis of advanced or metastatic solid tumor, being refractory to standard therapy or having no standard therapy available, and meeting various patient characteristics such as ECOG performance status, blood counts, liver and kidney function, and absence of certain medical conditions.",
    "This sample is a phase 1 trial that aims to evaluate the safety and efficacy of dacomitinib in healthy individuals and those with mild or moderate hepatic dysfunction, with specific inclusion and exclusion criteria outlined.",
    "In this phase 1 trial, the drug cetuximab is being tested on patients with non-small-cell lung carcinoma and neoplasm metastasis, and the eligibility criteria include having measurable disease tumor available for biopsies and a life expectancy of at least 3 months.",
    "This sample is a phase 1/phase 2 clinical trial for non-Hodgkin's lymphoma, testing the drugs bortezomib, chop, and rituximab, with specific eligibility criteria including histologically confirmed diagnosis, no prior anti-cancer therapy, CD20 antigen expression, measurable disease, and certain blood counts, while excluding CNS involvement, HIV disease, pregnancy or nursing, recent major surgery, and known peripheral neuropathy.",
    "This sample is a phase 1 clinical trial for patients with brain metastases, testing the effectiveness of lithium carbonate as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug kx2-391 on patients with advanced solid tumors or lymphoma, who have exhausted standard treatment options, and meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for type 1 diabetes, testing the drugs sar341402 and insulin aspart, with eligibility criteria including specific insulin dosage, C-peptide levels, and stable insulin regimen.",
    "This sample is a phase 1 clinical trial testing the drug fruquintinib on patients with solid malignant tumors who have failed standard treatment, and have specific eligibility criteria including age, performance status, and adequate organ function.",
    "This sample is a phase 1 clinical trial for patients with solid tumors, including breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. The trial is testing the drug ati-1123 (active drug = docetaxel) as a potential treatment option. The eligibility criteria include having a histologically confirmed solid tumor, progressive disease following standard chemotherapy, measurable tumors, acceptable organ function, and recovered from prior treatments. Exclusion criteria include certain cardiac diseases, active CNS metastasis, severe pulmonary disease, active infections, pregnancy or nursing, recent radiation or chemotherapy, and allergies to docetaxel or similar compounds.",
    "This sample is a phase 1 trial testing the drug gefitinib on patients with refractory solid tumors, and the eligibility criteria include confirmed histology, life expectancy of >12 weeks, and a WHO performance status of <2.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent melanoma, stage III melanoma, stage IV melanoma, or unspecified adult solid tumors, testing the drug imatinib mesylate. The eligibility criteria include specific disease diagnoses, measurable disease, certain laboratory values, and no history of certain medical conditions or concurrent medications.",
    "This sample is a phase 1/phase 2 clinical trial for cystic fibrosis patients with chronic P.aeruginosa infection, testing the efficacy of Arikayce\u2122 and placebo drugs in improving lung function (FEV1) and other eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with refractory multiple myeloma, evaluating the efficacy of obatoclax mesylate and bortezomib as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with Fanconi anemia or severe aplastic anemia, testing the drug fludarabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with non-small cell lung cancer, testing the combination of erlotinib and hydroxychloroquine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for kidney transplantation, testing the use of c1 esterase inhibitor and placebos as treatment options, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 1 clinical trial testing the combination of temsirolimus and capecitabine in patients with advanced solid tumors, who have no known curative therapy options, and meet specific eligibility criteria.",
    "This sample is a phase 1 trial for patients with pancreatic cancer who have undergone complete resection, and it aims to evaluate the efficacy of gemcitabine and bosutinib as adjuvant therapy. The eligibility criteria include specific histological criteria, performance status, age, and various laboratory values.",
    "This sample is a phase 1 trial testing the drugs romosozumab and placebo on postmenopausal individuals with osteopenia, with specific inclusion and exclusion criteria related to bone health and previous exposure to AMG 785.",
    "This sample is a phase 1/phase 2 trial for patients with melanoma, testing the combination of gleevec and temozolomide as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with b-cell chronic lymphocytic leukemia, small lymphocytic lymphoma, prolymphocytic leukemia, or Richter's transformation, testing the drugs pci-32765 and ofatumumab, with eligibility criteria including prior failed therapies, CD20 expression, ECOG performance status, and organ function requirements.",
    "This sample is a phase 1/phase 2 trial for patients with various hematological malignancies, who are scheduled for hematopoietic stem cell transplantation from unrelated donors and currently receiving a conditioning regimen. The study aims to evaluate the safety and efficacy of methotrexate, sirolimus, and tacrolimus as part of the treatment. The eligibility criteria include specific disease characteristics, donor compatibility requirements, and various patient characteristics such as age, performance status, and organ function.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drug he3286 in combination with methotrexate, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial for patients with progressive or recurrent malignant glioma, testing the drugs erlotinib hydrochloride and isotretinoin, with eligibility criteria including histological confirmation of the disease, Karnofsky performance status of >= 60%, and various laboratory requirements.",
    "This sample is a phase 1 clinical trial for the drug lbh589 in patients with multiple myeloma, who have received at least one prior line of therapy and meet specific eligibility criteria.",
    "This sample is a phase 1 trial for patients with metastatic non-small cell lung cancer or metastatic breast cancer, testing the drugs pazopanib and vinorelbine, with specific eligibility criteria including age, disease diagnosis, and prior treatment history.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors or lymphoma, testing the drug px-478, with specific eligibility criteria including age, performance status, predicted life expectancy, and adequate hematologic, hepatic, and renal function.",
    "This sample is a phase 1 trial for prostate cancer patients with rising PSA levels, testing the drugs bicalutamide and cp-675,206 (tremelimumab), and has specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial testing the drug deferasirox for the treatment of \u03b2-thalassemia and transfusional iron overload, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 clinical trial for patients with advanced, non-resectable and/or metastatic solid tumors, testing the drug bibw 2992 in patients with confirmed diagnosis of neoplasms, who have failed conventional treatment or for whom no therapy of proven efficacy exists, and who meet specific eligibility criteria.",
    "This sample is a phase 1 trial for patients with metastatic renal cell cancer, testing the effectiveness of IL-2, okt3, cyclophosphamide, fludarabine, and mesna as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the combination of bevacizumab, everolimus, and lbh589. The eligibility criteria include having a measurable site of disease, adequate bone marrow and liver function, and normal thyroid function. Women of childbearing potential must have a negative pregnancy test and use contraception. The exclusion criteria include receiving anticancer therapies within 4 weeks, major surgery within 4 weeks, and known hypersensitivity to the experimental drugs.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, using the drugs daclatasvir and placebo, with key inclusion criteria including being chronically infected with hepatitis C virus genotype 1 and having a BMI of 18 to 35 kg/m\u00b2.",
    "This sample is a phase 1/phase 2 trial for Crohn's disease, testing the efficacy of delayed release 6mp or calcitriol versus purinethol, with specific inclusion and exclusion criteria for eligible patients.",
    "This sample is a phase 1 trial for patients with breast cancer, testing the combination of paclitaxel and neratinib, with specific eligibility criteria including confirmation of metastatic breast cancer, hormone receptor and HER2 status, and certain blood count and liver function requirements.",
    "This sample is a phase 1/phase 2 trial for patients with HER2+ and ER+ metastatic breast cancer or resistant locally advanced breast cancer, testing the drug AUY922, with specific eligibility criteria including age, laboratory values, prior treatments, and measurable lesions.",
    "This sample is a phase 1 trial investigating the use of methadone hydrochloride for patients with chronic neuropathic pain syndrome related to cancer or its treatment, who require strong opioids to control pain.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis, testing the drugs ask8007 and placebo, with inclusion criteria including meeting the ARA 1987 revised criteria for RA classification and being treated with MTX, LEF, or SS2 for at least 4 months prior to baseline.",
    "This sample is a phase 1/phase 2 trial for patients with hematological malignancies who have undergone allogeneic stem cell transplantation, with eligibility criteria including specific donor requirements and disease characteristics, and the use of rituximab as a treatment option.",
    "This sample is a phase 1 clinical trial for patients with fallopian tube cancer, ovarian cancer, and primary peritoneal cavity cancer, testing the drugs docetaxel and idronoxil, with eligibility criteria including histologically confirmed diagnosis, recurrent advanced disease, and specific patient characteristics.",
    "This sample is a phase 1 trial for asthma patients, testing the drug gsk2269557 and its matching placebo, with inclusion criteria including being a healthy male between 18 and 55 years old, having a body weight greater than or equal to 55kg, and having an average QTcB less than 450 msec.",
    "This sample is a phase 1/phase 2 trial testing the drugs yspsl and placebo for patients undergoing primary cadaver renal transplants, with the disease being kidney diseases. The eligibility criteria include exclusion of patients receiving non-heart beating donor kidneys or kidneys from donors < 6 years of age, as well as patients receiving living donor kidneys or ABO-incompatible donor kidneys.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the efficacy of active and placebo comparators (drugs) on subjects who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung cancer, testing the drug gefitinib. The inclusion criteria include patients aged 18 or over with a histologically or cytologically confirmed diagnosis of non-small cell lung cancer, while the exclusion criteria include previous thoracic radiotherapy and known hypersensitivity to any component of the study medication.",
    "This sample is a phase 1 clinical trial for ulcerative colitis, testing the use of mesalamine as part of the normal treatment, with eligibility criteria including age, disease severity, and ability to swallow tablets.",
    "This sample is a phase 1/phase 2 clinical trial testing the drug CP-4055, both as a single agent and in combination with idarubicin, for the treatment of relapsed/refractory leukemias, specifically AML. The eligibility criteria include having no standard therapies available, being 18 years or older, having an ECOG performance status of 0-2, and meeting certain laboratory values. The exclusion criteria include allergies to similar compounds, positive HIV or hepatitis status, pregnancy or nursing, uncontrolled illness, and receiving other cytotoxic treatments.",
    "This sample is a phase 1 trial for the treatment of lymphoma, T-cell, cutaneous using a drug called shape (shp-141) at different concentrations, and the eligibility criteria include histopathologically confirmed CTCL, specific clinical stage, skin lesion involvement, and ECOG performance status.",
    "This sample is a phase 1 trial testing the drugs rituximab, cyclophosphamide, fludarabine, mesna, and sirolimus for the treatment of leukemia, lymphoma, and myeloma, with specific eligibility criteria including age, confirmed diagnosis, HLA matching, performance scale, and various medical parameters.",
    "This sample is a phase 1 trial for the drug GSK1322888 and placebo in patients with gastroparesis, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1/phase 2 trial for non-small-cell lung carcinoma patients who have progressed after prior chemotherapy or chemoradiotherapy, and it will test the efficacy of entinostat, sndx-275, and erlotinib as potential treatments.",
    "This sample is a phase I trial for patients with chronic hepatitis C genotype 1 who are non-responders or relapsers, and it will test the efficacy of betaine, peginterferon alpha 2a, and ribavirin as potential treatments.",
    "This sample is a phase 1/phase 2 trial for patients with localized breast cancer, testing the drugs bibf + paclitaxel and paclitaxel, with eligibility criteria including a primary tumor over 2 cm, HER2 negative status, and adequate hematologic, renal, and hepatic function.",
    "This sample is a phase 1/phase 2 trial for patients with type 2 diabetes, testing the drug aliskiren to treat incipient or overt diabetic nephropathy, with specific eligibility criteria including age, BMI, blood pressure, and medication history.",
    "This sample is a phase 1/phase 2 trial for patients with completely resected adenocarcinoma of the pancreas, testing the effectiveness of gemcitabine hydrochloride as a treatment option. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the combination of lapatinib and docetaxel drugs, with eligibility criteria including age over 18, confirmed HER positive breast cancer, and no prior systemic investigational agent within the past 30 days.",
    "This sample is a phase 1 trial for a malaria vaccine, testing the eligibility criteria for participants, including age, health status, travel history, and medical conditions, while excluding those with certain allergies, diseases, or medications.",
    "This sample is a phase 1/phase 2 clinical trial for peripheral T-cell lymphomas and non-Hodgkin lymphoma, testing the drug Velcade, with specific eligibility criteria including histological confirmation, performance status, age, measurable lesions, laboratory values, and exclusion criteria such as other malignancies and serious comorbid diseases.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, specifically colorectal cancer, who are refractory to established therapies. The drug being tested is osi-906, and the eligibility criteria include having a certain performance status, prior treatment history, and normal laboratory values.",
    "This sample is a phase 1 trial testing the drug aliskerin/valsartan and rampiril on African American men and women with hypertension and metabolic syndrome, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with relapsed malignant melanoma, testing the effectiveness of busulfan, cyclophosphamide, cyclosporine, and methotrexate as a treatment regimen, with specific eligibility criteria including age, performance status, and organ function.",
    "This sample is a phase 1/phase 2 trial for multiple myeloma, testing the drugs lenalidomide, bortezomib, dexamethasone, and doxil, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer (NSCLC) who have progressed after prior treatment. The study will test the drugs abt-751, pemetrexed, and placebo, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the drug dasatinib, and includes eligibility criteria such as specific disease stages, prior treatments, laboratory parameters, and concurrent medications.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer who have received prior chemotherapy regimens and are resistant to anthracycline and taxane. The study aims to evaluate the efficacy of hydroxychloroquine and ixabepilone as potential treatments.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory multiple myeloma or other plasma cell disorders, testing the drugs paricalcitol and zoledronic acid, with eligibility criteria including previous treatment for the disease, specific performance status and life expectancy requirements, and various medical exclusions.",
    "This sample is a phase 1 trial for patients with uveitis and glaucoma, testing the effectiveness of anecortave acetate in patients who have recently received a Retisert implant, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-Hodgkin's lymphoma, testing the effectiveness of rituximab, dhap, tec, and autologous stem cell transplantation as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IIIB or stage IV non-small cell lung cancer, testing the effectiveness of paclitaxel, carboplatin, and vorinostat as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drug JNJ-38877605 on patients with advanced or refractory solid tumors who are no longer eligible for approved therapies, and it includes specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial testing the drug nesiritide versus placebo in subjects with heart failure or asymptomatic systolic dysfunction, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced cancer, testing the drug RDEA119, with specific eligibility criteria and exclusion criteria, including patients with certain medical conditions and those who are pregnant or have HIV infection.",
    "This sample is a phase 1 trial for the drug txa127 in patients with myelodysplastic syndrome (MDS), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the drug sgx523 capsules, with eligibility criteria including failed standard therapy, specific laboratory values, and IHC evidence of phospho-MET expression on tumor material.",
    "This sample is a phase 1 trial for patients with non-small-cell lung carcinoma, testing the drugs cetuximab and bibw 2992 in patients with specific EGFR mutations, who have shown clinical benefit from previous EGFR TKI treatment, and have progressed on erlotinib or gefitinib within the last 30 days.",
    "This sample is a phase 1 clinical trial for patients with symptomatic Multiple Myeloma, who have previously been treated with at least one cycle of therapy and have shown progressive or refractory disease. The trial will test the effectiveness of bendamustine, lenalidomide, dexamethasone, aspirin, prophylaxis, and antibiotic drugs in treating the disease.",
    "This sample is a phase 1/phase 2 trial for amyotrophic lateral sclerosis (ALSO) patients, testing the efficacy of zinc and copper as a treatment, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with rectal cancer, testing the drug capecitabine. The eligibility criteria include having clinical stage T4 or recurrent adenocarcinoma of the rectum, confirmed histology, no distant metastatic disease, and certain health parameters within normal range. Exclusion criteria include prior pelvic radiotherapy, pregnancy or lactation, recent treatment for other carcinomas, uncontrolled intercurrent illness, and major surgery within 4 weeks.",
    "This sample is a phase 1/phase 2 trial testing the drugs amg 655 and doxorubicin for the treatment of locally advanced or metastatic, unresectable soft tissue sarcoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug semaglutide versus placebo in subjects with diabetes, diabetes mellitus type 2, or healthy individuals, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with acute lymphoblastic leukemia (ALL) who have received prior induction regimens and have relapsed or refractory disease. The study will test the drug clofarabine to evaluate its effectiveness in treating ALL patients.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug g-202, with specific eligibility criteria including acceptable liver and renal function, acceptable hematologic status, and exclusion criteria such as pre-existing cardiac conditions and active uncontrolled infection.",
    "This sample is a phase 1 clinical trial for patients with solid tumors who have progressed after receiving approved therapies, and it is testing the drug E7107. The eligibility criteria include having completed surgery and radiotherapy at least four weeks prior to study entry, being aged 18 or older, and having an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. The exclusion criteria include having symptomatic or progressive brain tumors, certain laboratory parameters outside of normal ranges, and a history of HIV, active hepatitis B or C, or severe/uncontrolled intercurrent illness or infection.",
    "This sample is a phase 1 clinical trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the effectiveness of the drug pur0200 and its placebo as well as an active comparator in improving lung function. The eligibility criteria include specific smoking history, lung function measurements, and exclusion of other diseases or conditions.",
    "This sample is a phase 1/phase 2 clinical trial for participants with metastatic colorectal cancer, testing the drugs tivantinib, placebo, cetuximab, and irinotecan, with eligibility criteria including prior chemotherapy, wild-type KRAS gene expression, measurable disease, and specific organ function requirements.",
    "This sample is a phase 1 clinical trial for multiple sclerosis patients who are currently on beta-interferon therapy, and it aims to evaluate the effectiveness of ACTH and methylprednisolone as treatment options. The eligibility criteria include having clinically definite multiple sclerosis, being between 18-65 years old, having experienced at least one MS relapse within the last year, and having an EDSS score of 3.0 - 6.5. The exclusion criteria include being pregnant or breastfeeding, having uncontrolled hypertension or diabetes, having a history of drug or alcohol abuse within the past year, and being on certain medications such as Tysabri or Novantrone.",
    "This sample is a phase 1 trial testing the drug nnc0215-0384 and placebo for the treatment of inflammation and rheumatoid arthritis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial testing the drug zgn-433 on obese, otherwise healthy females with specific inclusion and exclusion criteria, such as BMI range and history of weight loss agents or eating disorders.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the drugs gefitinib and gemcitabine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with advanced or metastatic hepatocellular carcinoma, testing the drugs ro5323441 and sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for healthy Caucasian individuals, testing the drugs Advagraf\u00ae and Prograf\u00ae. The eligibility criteria include no history of certain diseases, normal ECG, specific blood pressure range, non-smoker, and abstaining from alcohol during the study. Exclusion criteria include positive screen for illicit drugs or alcohol, certain infections, history of cancer, tuberculosis, head injuries, eating disorders, abnormal BMI, renal dysfunction, recent plasma or blood donation, drug or alcohol abuse, recent steroid injections, and recent live vaccine.",
    "This sample is a phase 1 clinical trial testing the drug batracylin on patients with metastatic or unresectable solid tumor malignancy or lymphoma, who have completed prior chemotherapy or biologic therapy, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for hormone refractory prostate cancer, testing the drugs picoplatin and docetaxel, with eligibility criteria including confirmed adenocarcinoma of the prostate, metastatic disease, and stable pain levels.",
    "This sample is a phase 1 trial testing the drug pazopanib (gw786034) on pediatric patients with relapsed or refractory solid tumors, including sarcoma, neuroblastoma, wilms tumor, osteosarcoma, and brain tumor, with specific eligibility criteria based on age, tumor type, and performance score.",
    "This sample is a phase 1/phase 2 trial for patients with systemic sclerosis, testing the effectiveness of imatinib in combination with eligibility criteria including fulfilling ACR criteria for SSc, having dyspnea on exertion, and showing evidence of alveolitis.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, testing the drugs idx719 and placebo, with inclusion criteria including documented GT1, GT2, or GT3 chronic HCV infection, and exclusion criteria including prior HCV treatment and co-infection with hepatitis B virus (HBV) and/or human immunodeficiency virus (HIV).",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small-cell lung carcinoma who have failed standard chemotherapy regimens, and it is testing the drug pt-523 for injection as a potential treatment option.",
    "This sample is a phase 1 clinical trial for patients with advanced stage malignancies, including breast cancer, ovarian cancer, prostate cancer, colon cancer, and renal cancer, who have failed previous chemotherapy treatments. The trial aims to evaluate the efficacy and safety of cyclophosphamide & zyc300 in combination with pre-dosing of cyclophosphamide. The eligibility criteria include measurable disease, age \u2265 18 years old, Eastern Cooperative Oncology Group Performance Status of 0 or 1, life expectancy > 6 months, and adequate hematological, renal, and hepatic function. Exclusion criteria include a history of brain metastases, recent treatments, and certain medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the combination of gleevec and chlorambucil drugs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with various types of cancer, including breast, colorectal, gastric, lung, ovarian, pancreatic, and unspecified adult solid tumors. The trial is testing the effectiveness of cyclophosphamide and fludarabine phosphate drugs in patients who meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with incurable metastatic lung or colorectal cancer, testing the efficacy of recombinant fowlpox-cea(6d)/tricom vaccine, recombinant vaccinia-cea(6d)-tricom vaccine, docetaxel, and sargramostim, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with central nervous system neoplasms and neoplasm metastasis, testing the drug temozolomide for eligibility criteria including age, cardiac function, pulmonary function, liver function, kidney function, performance status, and expected survival.",
    "This sample is a phase 1 clinical trial for patients with metastatic melanoma, testing the drug lbh589, with specific inclusion and exclusion criteria, and various disease codes associated with melanoma.",
    "This sample is a phase 1/phase 2 clinical trial for patients with high-risk myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), testing the drug mgcd0103, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, testing the effectiveness of bevacizumab, oxaliplatin, and capecitabine as chemotherapy drugs, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial for obesity, testing the drugs nnc 0070-0002-0453 and placebo, with inclusion criteria including a BMI between 27.0 to 39.0 kg/m2 for overweight/obese males and a BMI between 30.0 to 39.0 kg/m2 for obese male and female subjects, and exclusion criteria such as aggressive diet attempts, history of eating disorders, and tobacco use.",
    "This sample is a phase 1 clinical trial for patients with head and neck cancer, testing the drugs bortezomib and cisplatin, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 trial for patients with prostatic neoplasms, testing the effectiveness of samarium sm-153 lexidronam + docetaxel in treating castrate metastatic disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for psoriasis, testing the efficacy of various drugs including mapracorat and prednicarbate, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung carcinoma, lung neoplasms, lung cancer, and respiratory tract neoplasms, testing the drug gefitinib. The eligibility criteria include Asian ethnicity, specific performance status, and confirmation of the disease, among others.",
    "This sample is a phase 1 clinical trial for patients with type 1 diabetes, testing the effectiveness of pramlintide acetate in achieving glycemic goals while on insulin therapy.",
    "This sample is a phase 1/phase 2 trial for essential tremor, testing the drugs levetiracetam and placebo, with inclusion criteria including a history of tremor for 5 or more years and no other neurological problems, and exclusion criteria including prior stroke or other neurological disease, psychiatric problems, history of renal disease, and pregnancy.",
    "This sample is a phase 1 trial for hypertension, testing the efficacy of different drug combinations including amlodipine and losartan, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug brivanib for patients with progressive advanced or metastatic solid tumors, including colorectal, hepatocellular, or renal cancer, with specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with non-Hodgkin B-cell lymphoma, testing the drug aflibercept, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with colorectal cancer, specifically adenocarcinoma of the colon or rectum, and it focuses on the use of irinotecan hydrochloride as a treatment option. The eligibility criteria include having received prior chemotherapy, having measurable disease, and meeting certain medical and laboratory requirements.",
    "This sample is a phase 1/phase 2 trial for patients with rheumatoid arthritis, testing the combination of cdp 6038 sc and methotrexate as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs pf-03654764 and fexofenadine, along with a placebo, on healthy subjects. The inclusion criteria require no clinically relevant abnormalities, while the exclusion criteria include various diseases, positive urine drug screen, and recent treatment with an investigational drug.",
    "This sample is a phase 1/phase 2 trial for relapsing multiple sclerosis, testing the drug cdp323 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with type 2 diabetes mellitus, testing the drug ta-7284 and its placebo, with specific eligibility criteria including stable diabetes, BMI range, blood glucose levels, and blood pressure range.",
    "This sample is a phase 1 trial for individuals with essential hypertension who are not currently on antihypertensive therapy or are taking up to two antihypertensive agents and could be safely withdrawn. The study aims to evaluate the safety and efficacy of vasomera (pb1046) and 0.9% sodium chloride as potential treatments.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the drugs odm-201 tablet a, odm-201 tablet b, and odm-201 capsule formulation, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with solid tumor malignancy, testing the drug npi-2358, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with unspecified childhood solid tumors, testing the drugs temsirolimus, temozolomide, and irinotecan hydrochloride, with specific eligibility criteria including histologic verification of malignancy, no known curative therapy, and certain laboratory values within normal limits.",
    "This sample is a phase 1/phase 2 trial for patients with multiple myeloma, testing the drugs depsipeptide, bortezomib, and dexamethasone. The eligibility criteria include having previously been diagnosed with multiple myeloma, being between the ages of 18 and 75, having measurable disease, and meeting certain laboratory values.",
    "This sample is a phase 1 trial for patients with migraine, where the drug being tested is a placebo, and the eligibility criteria include a diagnosis of migraine, specific migraine frequency and medication usage, and the use of contraception for women of child-bearing potential.",
    "This sample is a phase 1 trial for pain management, testing the drugs ppc-5650 and placebo, with inclusion criteria including pain intensity and hypersensitivity, and exclusion criteria including gastrointestinal conditions and previous surgery.",
    "This sample is a phase 1 trial testing LY573636-sodium, a drug, for the treatment of relapsed or refractory acute myeloid leukemia and essential thrombocythemia, with specific eligibility criteria including age, hepatic and renal function, and previous therapies.",
    "This sample is a phase 1 trial testing the drug dabigatran etexilate in patients with chronic renal insufficiency, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with small cell carcinoma or lung cancer, testing the drugs topotecan and sorafenib, with specific eligibility criteria including prior chemotherapy, organ function requirements, and exclusion criteria such as pregnancy, active infections, and cardiac conditions.",
    "This sample is a phase 1 clinical trial for Parkinson's disease, testing the drugs bia 9-1067, levodopa/carbidopa, and levodopa/benserazide, with inclusion criteria including age between 18 and 45, negative tests for hepatitis B, C, and HIV, and exclusion criteria including significant infections, gastrointestinal symptoms, and history of drug abuse or alcoholism.",
    "The sample is a phase 1 trial for patients with ischemic stroke, testing the use of aspirin and warfarin as drugs, with specific inclusion and exclusion criteria related to the diagnosis and contraindications of the drugs.",
    "This sample is a phase 1 clinical trial for chemotherapy-naive patients with non-small cell lung cancer (NSCLC) and stage IIIB or stage IV disease. The study aims to evaluate the safety and efficacy of the drugs mk0683 and vorinostat in these patients. The inclusion criteria include being chemotherapy-naive and having normal organ and bone marrow function, while the exclusion criteria include having received radical thoracic radiation within 3 weeks, peripheral neuropathy above grade 2, ascites, pleural effusion or pericardiac effusion requiring treatment, uncontrolled concomitant illness, and being pregnant or breastfeeding.",
    "This sample is a phase 1 clinical trial for patients with type 2 diabetes mellitus, testing the drugs pf-04991532 and placebo, with eligibility criteria including stable metformin treatment, specific BMI and weight requirements, fasting C-peptide levels, and HbA1c levels. Exclusion criteria include various medical conditions and history of complications, surgeries, or cardiovascular diseases.",
    "This sample is a phase 1 trial testing the drug glpg0778 and placebo on healthy individuals with specific inclusion and exclusion criteria, such as age, BMI, platelet function, smoking, drug or alcohol abuse, and hypersensitivity to test substances.",
    "This sample is a phase 1 clinical trial testing the drug decitabine on patients with an unspecified adult solid tumor, who meet specific eligibility criteria.",
    "This sample is a phase 1 trial investigating the use of oral zinc and vitamin C supplements in children aged 3-8 years with autism spectrum disorder and a serum copper/zinc ratio greater than 2.0.",
    "This sample is a phase 1 trial for the treatment of hepatitis C, using the drugs mk-3281 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with CD20 and CD22-positive, B-cell NHL who have progressed after 1 or 2 prior therapies, and it involves the drugs inotuzumab ozogamicin and rituximab. The eligibility criteria include prior therapy with at least one dose of rituximab, ECOG performance status of 0/1, and no previous radioimmunotherapy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with advanced non-small cell lung cancer, testing the drug irinotecan. The eligibility criteria include prior chemotherapy treatment, high ISG15 levels, and adequate bone marrow, hepatic, and renal function. Patients with symptomatic brain metastases, pregnant or nursing women, and those with severe medical problems or previous hypersensitivity reactions to camptothecins are excluded from the study.",
    "This sample is a phase 1 clinical trial for patients with neoplasms, testing the drugs afatinib and vinorelbine for advanced malignancies with no standard therapies available, and includes specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for the drug pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma, with specific eligibility criteria and exclusion criteria listed.",
    "This sample is a phase 1 trial for pancreatic cancer patients, testing the combination of as703569/gemcitabine drugs, with specific eligibility criteria including prior treatment history and adequate organ functions.",
    "This sample is a phase 1 trial for HIV-1 infection, testing the drugs interleukin-2, gm-csf, and growth hormone, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase I trial investigating the use of normal saline control and vasopressin in patients with traumatic injuries and shock, with specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the drug raf265. The inclusion criteria include confirmed diagnosis of melanoma, measurable disease, ECOG performance status of 0 or 1, and no concurrent anticancer or investigational therapy for at least 4 weeks prior to enrollment. The exclusion criteria include significant cardiac disease or other significant medical/psychiatric disease, history of primary central nervous system tumor or brain metastases, history of melena, hematemesis, or hemoptysis within the last 3 months, and previous therapy with certain molecularly targeted agents.",
    "This sample is a phase 1/phase 2 trial for HIV infections, testing the drugs tenofovir df and tenofovir alafenamide, with inclusion criteria including specific HIV-1 RNA levels, CD4 count, and serum creatinine levels, and exclusion criteria including prior treatment with antiretroviral therapy and recent immunization.",
    "This sample is a phase 1 clinical trial testing the use of psilocybin, a drug, in treating anxiety in patients with advanced-stage cancer, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 1/phase 2 trial for patients with prostatic neoplasms, testing the drugs abiraterone acetate, abiraterone acetate mtd, and dexamethasone, with eligibility criteria including documented adenocarcinoma of the prostate, refractory or resistant to hormone therapy, and evidence of progressive prostate cancer.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the efficacy of gemcitabine, capecitabine, erlotinib, and bevacizumab in patients with locally advanced or metastatic disease who are not eligible for curative resection. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1/phase 2 clinical trial for small cell lung cancer (SCLC) patients who have progressed after one prior platinum-containing chemotherapy regimen, and it evaluates the efficacy of the drugs at-101 and topotecan. The eligibility criteria include confirmed SCLC, measurable disease, ECOG performance status 0-1, and adequate hematologic, liver, and renal function. Exclusion criteria include prior chemotherapy regimen with irinotecan, active secondary malignancy, unstable or progressive brain metastases, and uncontrolled concurrent illnesses.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory multiple myeloma, testing the effectiveness of perifosine, bortezomib, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug tki258. The inclusion criteria include written informed consent, agreement to remain hospitalized, ECOG performance status of 0 or 1, and specific hematological/blood chemistry values. The exclusion criteria include recent receipt of investigational compounds or other antineoplastic therapy, presence of CNS or leptomeningeal disease metastases, impaired cardiac function, and various other conditions.",
    "This phase 1 trial aims to evaluate the safety and efficacy of MN-221 in patients with chronic obstructive pulmonary disease (COPD), with specific inclusion and exclusion criteria, and the study will involve three different dose groups of the drug.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung cancer (NSCLC) who have failed prior treatment. The study will test the effectiveness of vorinostat and erlotinib drugs in treating NSCLC, and includes eligibility criteria such as confirmed disease, time since previous treatments, normal lab results, and exclusion criteria such as prior treatment with vorinostat or erlotinib, and certain medical conditions.",
    "This sample is a phase 1 trial testing the drug cep-18770 on patients with relapsed or refractory solid tumors or non-Hodgkin's lymphoma, who have not responded well to previous treatments, and meet various eligibility criteria.",
    "This sample is a phase 1 clinical trial for acute coronary syndrome, testing the drugs lc23-1306, placebo, and ticagrelor, with inclusion criteria including healthy male subjects between the ages of 20 and 50 years, specific BMI and weight ranges, informed consent, and acceptable medical history and laboratory results.",
    "This sample is a phase 1 clinical trial for patients with cystic fibrosis, testing the efficacy of tiotropium bromide low, medium, and high doses compared to a placebo, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for the treatment of choroidal neovascularization in patients with age-related macular degeneration, using the drug ranibizumab, and includes eligibility criteria such as visual acuity, age, and exclusion criteria such as allergies and previous participation in clinical trials involving anti-angiogenic drugs.",
    "This sample is a phase 1 trial that includes subjects with inflammation, rheumatoid arthritis, and healthy individuals. The trial involves the use of the drug nnc0114-0000-0005 and a placebo, and the eligibility criteria include specific age ranges, disease diagnoses, and the use of effective contraception.",
    "This sample is a phase 1 clinical trial for the drug vemurafenib in Chinese patients with metastatic melanoma, who have a positive BRAF V600 mutation result, and meet various eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with stage IV non-small cell lung cancer, testing the drug paclitaxel albumin-stabilized nanoparticle formulation, and includes eligibility criteria such as measurable disease, specific performance status, and normal organ function.",
    "This sample is a phase 1 clinical trial for asthma patients, testing the drugs gw805858 and placebo, with inclusion criteria including non-smokers aged 18-60, and exclusion criteria including allergies to inhaler ingredients and recent use of other medications.",
    "This sample is a phase 1 clinical trial for participants with advanced solid tumors, recurrent glioblastoma multiforme, or metastatic melanoma, testing the drugs mk-4827 and temozolomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of docetaxel and pemetrexed as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with malignant glioma, testing the drug sorafenib tosylate, with specific eligibility criteria including disease progression, recovery from prior therapy, and certain laboratory values within normal limits.",
    "This sample is a phase 1 trial for the drug asp1941 and placebo in subjects with type 2 diabetes mellitus, with specific inclusion and exclusion criteria based on disease duration, BMI, HbA1c levels, and previous medication use.",
    "This sample is a phase 1 clinical trial for knee osteoarthritis, testing the drugs sar113945 and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 1 trial is testing the drug th-302 on patients with various types of leukemia, myelodysplastic syndrome, myelofibrosis, and chronic lymphocytic leukemia, who have relapsed or are refractory to standard therapy, and are not eligible for higher priority protocols.",
    "This sample is a phase 1 trial for patients with unresectable hepatocellular carcinoma (HCC), testing the combination of lenalidomide and sorafenib as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with acute myeloid leukemia (AML) who have primary refractory AML or relapsed AML, and it involves the use of cytarabine and lovastatin as drugs. The eligibility criteria include having no prior remission, having a documented remission lasting >30 days, and not having received a high-dose cytarabine containing regimen within 3 months prior to registration.",
    "This sample is a phase 1 trial that aims to evaluate the safety and efficacy of dcvax-001 and poly-iclc compared to placebo in healthy adult males and females, with the inclusion criteria including being at low risk for HIV infection and using effective contraception, while the exclusion criteria include having HIV infection, any significant medical conditions, and a history of severe reactions to vaccination.",
    "This sample is a phase 1 clinical trial for patients with relapsed/refractory multiple myeloma, testing the combination of arsenic trioxide, ascorbic acid, and bortezomib as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for prostate cancer, testing the drugs bicalutamide, docetaxel, and gnrh analog, with specific eligibility criteria including no prior treatment for prostate cancer and acceptable lab values, and excluding individuals with a history of severe hypersensitivity reaction to docetaxel or other drugs formulated with Polysorbate 80.",
    "This sample is a phase 1 trial for the drug GSK1265744 in HIV-infected individuals, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for the drug abt-263 in patients with small cell lung cancer, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for major depressive disorder, testing the drugs alks 5461 and placebo, with inclusion criteria including a diagnosis of MDD and inadequate response to previous treatment, and exclusion criteria including certain psychiatric disorders and hypersensitivity to buprenorphine or opioid antagonists.",
    "This sample is a phase 1 clinical trial for patients with advanced HER2-positive breast cancer, testing the drugs cnf2024 and cnf2024 + trastuzumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of chronic hepatitis C, testing the drugs ALS-002158 and placebo, with specific inclusion and exclusion criteria for subjects with genotype 1 infection.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of campath, busulfan, fludarabine, and fk-506 in treating various hematologic diseases, including myelodysplastic and myeloproliferative disorders, acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, multiple myeloma, plasma cell dyscrasia, lymphoproliferative disorders, and other treatable non-malignant hematologic diseases. The study includes specific inclusion and exclusion criteria for eligible patients, such as age, performance status, cardiac and pulmonary function, and previous medical history. A healthy donor without contraindications for donation is also required.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the combination of osi-930 and erlotinib as a potential treatment option. The eligibility criteria include specific disease characteristics, age, performance status, blood counts, liver and kidney function, prior treatments, and contraceptive use. Exclusion criteria include certain cardiac, infectious, psychiatric, and ophthalmologic conditions, as well as pregnancy and breastfeeding.",
    "This sample is a phase I/II clinical trial for patients with colorectal cancer or unspecified adult solid tumors, testing the efficacy of capecitabine, irinotecan hydrochloride, and oxaliplatin in combination with bevacizumab, with specific eligibility criteria and prior concurrent therapy requirements.",
    "This sample is a phase 1 trial testing the drugs xl147 (sar245408) for solid tumors and lymphoma, with eligibility criteria including confirmed metastatic or unresectable tumors, previous treatment regimens, and adequate organ function.",
    "This sample is a phase 1 trial for patients with advanced, non-resectable and/or metastatic solid tumors who have failed conventional treatment, testing the drugs bi 6727 and bibf 1120, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for cystic fibrosis patients, testing the drugs oligog cf-5/20 and saline, with eligibility criteria including a confirmed diagnosis of cystic fibrosis, positive microbiological finding of Pseudomonas aeruginosa, and FEV1 between 35%-80% of predicted normal value.",
    "This sample is a phase 1 trial testing the drug varespladib methyl in individuals with renal impairment, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial that aims to evaluate the safety and tolerability of a drug called yh4808 in healthy male volunteers, with various dosage forms and a placebo, and includes specific inclusion and exclusion criteria for enrollment.",
    "This sample is a phase 1 clinical trial that includes patients with various childhood central nervous system tumors and extra-adrenal paraganglioma. The study aims to evaluate the safety and efficacy of vorinostat and temozolomide as potential treatments for these diseases. The eligibility criteria include specific disease diagnoses, measurable or evaluable disease, no known curative therapy, and certain laboratory values within normal ranges.",
    "This sample is a phase 1 trial for HIV infections, testing the drugs nevirapine, amprenavir, and abacavir, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 clinical trial for patients with prostatic neoplasms, testing the drug radium-223 dichloride (xofigo, bay88-8223), and includes eligibility criteria such as confirmed bone metastases and castrate level of testosterone.",
    "This sample is a phase 1/phase 2 clinical trial for patients with various types of acute myeloid leukemia, testing the effectiveness of clofarabine and cytarabine as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, with the drugs being tested being bilb 1941 zw and placebo. The eligibility criteria include having a confirmed HCV genotype 1, minimal to mild liver fibrosis, and a high HCV RNA load.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drug e2609 and placebo on healthy males and females aged 30 to 55 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the efficacy of intraventricular rituximab plus mtx in treating relapsed, refractory central nervous system lymphoma, intraocular lymphoma, and lymphomatous meningitis.",
    "This sample is a phase 1/phase 2 trial for small cell lung cancer (SCLC) using the drugs pemetrexed and cisplatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial for healthy adult males, testing the drugs trv130a and dextrose in water, with specific inclusion and exclusion criteria, and no specific diseases mentioned.",
    "This sample is a phase 1 trial for patients with unresectable hepatocellular carcinoma, liver metastases, or cholangiocarcinoma, testing the drug capecitabine (Xeloda) as a treatment option. The eligibility criteria include providing informed consent, being over 18 years old, having a Karnofsky performance status of over 60, and meeting specific laboratory values. The exclusion criteria include being pregnant or lactating, having a life expectancy of less than 3 months, having serious uncontrolled infections, and having prior fluoropyrimidine therapy.",
    "This sample is a phase 1 clinical trial testing the drug lde225 for the treatment of advanced solid tumor cancers, medulloblastoma, and basal cell carcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for non-small-cell lung carcinoma, testing the drugs cisplatinum and docetaxel, with eligibility criteria including confirmed NSCLC, specific laboratory and lung function requirements, and exclusion criteria such as prior chemotherapy or surgery for NSCLC.",
    "This sample is a phase 1 clinical trial for relapsed multiple myeloma patients, testing the effectiveness of carfilzomib, lenalidomide, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of hypertension, testing the drugs mk-7145 and hydrochlorothiazide (hctz) against placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial testing the drugs belinostat and azacitidine for the treatment of various types of leukemia and myelodysplastic syndrome, with specific eligibility criteria for patients to participate in the trial.",
    "This sample is a phase 1 clinical trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs mn-221 and placebo. The inclusion criteria include age, history of COPD, lung function measurements, negative pregnancy and drug tests, and ability to comply with the study procedures. The exclusion criteria include recent medication use, respiratory infections, abnormal laboratory results, and certain medical conditions.",
    "This sample is a phase 1 trial testing the drug \"gsk1322322\" and placebo for the treatment of bacterial infections, with specific eligibility criteria including age, gender, medical history, and laboratory parameters.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma, testing the effectiveness of lenalidomide, pioglitazone, dexamethasone, and treosulfan as treatment options, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with hepatocellular carcinoma (HCC) who are not eligible for curative therapy, testing the drug denspm for its effectiveness in treating HCC. The eligibility criteria include having histologically proven HCC or meeting specific criteria if biopsy is not possible, having measurable disease, and meeting certain laboratory values. The exclusion criteria include recent localized therapy or systemic therapy for HCC, receiving another investigational therapy, having unstable serious medical conditions, and having certain contraindications.",
    "This sample is a phase 1 clinical trial for patients with gastrointestinal stromal tumor, testing the effectiveness of imatinib mesylate and sunitinib malate drugs, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "This sample is a phase 1 clinical trial testing the drug ombrabulin (ave8062) in patients with advanced neoplastic disease, such as non-small cell lung cancer, epithelial ovary cancer, gastric cancer, transitional cell and bladder cancer, and head and neck cancer, who have an Eastern cooperative oncology group (ECOG) performance status of 0 to 1.",
    "This sample is a phase 1 trial investigating the use of extended-release bupropion hydrochloride in patients with depressive disorder, specifically those with a history of Major Depressive Disorder (MDD) with a seasonal pattern. The inclusion criteria include having a history of MDD with a seasonal pattern, while the exclusion criteria include a current or past history of seizure disorder or brain injury, a history or current diagnosis of anorexia nervosa or bulimia, and other psychiatric disorders.",
    "This sample is a phase 1 trial for patients with colorectal carcinoma, testing the combination therapy of irinotecan, levofolinate, and 5-fluorouracil (5-fu) for metastatic disease that is not amenable to potentially curative resection, with specific eligibility and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug Proellex on healthy adult females with conditions such as excessive menstrual bleeding, menstrual pain, uterine fibroids, and endometriosis, who meet certain eligibility criteria.",
    "This sample is a phase 1 trial testing the drug mln4924 on patients with relapsed and/or refractory lymphoma or multiple myeloma, with specific subtypes of lymphoma being evaluated. The eligibility criteria include having a confirmed diagnosis, evaluable tumor, suitable venous access, and adequate organ function, while exclusion criteria include recent systemic antineoplastic therapy, corticosteroid treatment, radiation therapy, and certain medication interactions.",
    "This sample is a phase 1/phase 2 trial for patients with vision-threatening autoimmune uveitis, testing the drug apremilast as a potential treatment option for those who have failed to respond to prednisone and other systemic immunosuppressive medications.",
    "This sample is a clinical trial study for prostate cancer patients in different phases, testing drugs such as arn-509 and abiraterone, with specific eligibility criteria for each phase.",
    "This sample is a phase 1/phase 2 clinical trial for patients with Malignant Pleural Mesothelioma (MPM), testing the effectiveness of carboplatin, bevacizumab, and pemetrexed as a treatment option. The eligibility criteria include specific disease diagnosis, measurable disease, performance status, renal and hepatic function, bone marrow function, and prior surgical procedures. Exclusion criteria include hypercalcemia, history of hemoptysis or thrombosis, ongoing unstable angina, congestive heart failure, recent surgical procedures, pregnancy or lactation, and inability to comply with study procedures. Adequate renal, hepatic, and bone marrow function are also required.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer, testing the drug erlotinib hcl, and includes eligibility criteria such as confirmed NSCLC, previous chemotherapy treatment, specific performance status, age, recovery from prior treatment effects, ability to comply with study procedures, and availability of tumor tissue for testing.",
    "This sample is a phase 1 clinical trial testing the drug ridaforolimus on patients with unresectable or metastatic cancer that is refractory to standard therapies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of hepatitis C, using the drug pf-00868554 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with prostate cancer, testing the drugs tak-700, docetaxel, and prednisone. The eligibility criteria include having a confirmed diagnosis of prostate adenocarcinoma, radiograph-documented metastatic disease, and prior surgical castration or concurrent use of an agent for medical castration.",
    "This sample is a phase 1/phase 2 trial for metastatic or relapsed locally advanced breast cancer patients who are HER2-positive, with eligibility criteria including no prior chemotherapy for metastatic disease, normal left ventricular ejection fraction, bidimensionally measurable disease, and oxygen saturation > 90% on room air. The drugs being tested are bevacizumab and herceptin.",
    "This sample is a phase 1 clinical trial for patients with locally advanced and surgically resectable esophageal or gastroesophageal junction cancer, testing the drug capecitabine (Xeloda) as a potential treatment option.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the effectiveness of dasatinib, trastuzumab, and paclitaxel as treatment options. The eligibility criteria include having confirmed breast cancer with documented metastasis, HER2 overexpression, and a performance status of 0 or 1. Various previous therapies are allowed, but certain medications and medical conditions are excluded.",
    "This sample is a phase 1/phase 2 clinical trial for patients with glioblastoma multiforme, testing the drug aee788, and includes eligibility criteria such as confirmed GBM, adequate organ function, age \u2265 18 years, Karnofsky performance status score \u2265 70%, and life expectancy \u2265 12 weeks.",
    "This sample is a phase 1 clinical trial for patients with non-resectable and/or metastatic cancer, focusing on squamous cell carcinomas of head and neck, esophagus, lung, or cervix. The study aims to evaluate the safety and efficacy of the drug bibw 2992 in combination with standard treatments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with symptomatic multiple myeloma, where the drug being tested is busulfan, and the eligibility criteria include age, renal function, pulmonary function, cardiac function, and myeloma markers.",
    "This sample is a phase 1/phase 2 trial for osteoarthritis, testing the use of normal saline as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the drug tmc278la in patients with HIV infections, with inclusion criteria including age between 18 to 50 years, absence of significant health problems, and willingness to undergo HIV testing, while exclusion criteria include positive blood screen for HIV antibodies, high-risk behavior for HIV infection, and history of severe drug allergy.",
    "This sample is a phase 1/phase 2 trial for patients with mantle cell lymphoma, testing the effectiveness of temsirolimus and bendamustine drugs in patients who are not eligible for high dose chemotherapy with auto-SCT or allo-SCT. The eligibility criteria include age 18 or older, specific disease classification, previous treatment history, adequate bone marrow function, and measurable disease. Exclusion criteria include prior treatment with any m-TOR inhibitor, unstable or severe uncontrolled medical conditions, abnormal liver and renal function, previous malignancy, concurrent treatment with certain medications, pregnancy or breastfeeding, recent surgery or therapy with investigational agents, and other specific conditions.",
    "This sample is a phase 1 trial for asthma patients, testing the drugs RNS60, normal saline, and budesonide, with inclusion criteria including non-smokers aged 18-65 with mild to moderate asthma and a currently prescribed inhaled corticosteroid medication, and exclusion criteria including chronic or acute diseases that might interfere with the evaluation of RNS60 and current or prior malignancies.",
    "This sample is a phase 1/phase 2 trial testing the drugs ino-8875 and placebo for the treatment of ocular hypertension and glaucoma, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for breast cancer patients, testing the drugs ixabepilone and capecitabine, with inclusion criteria of women over 20 years old with a confirmed diagnosis of adenocarcinoma originating in the breast, and exclusion criteria of having received three or more prior chemotherapy lines of treatment in the metastatic setting.",
    "This sample is a phase 1 trial testing the drug combination of axitinib plus everolimus in patients with malignant advanced solid tumors and carcinoma, renal cell, who have failed standard therapies and meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the effectiveness of pazopanib, gemcitabine, and cisplatin as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for brain tumors and central nervous system tumors, testing the drugs cyclosporine, etoposide, and vincristine sulfate, with specific eligibility criteria for patients including age, performance status, and prior therapy.",
    "This sample is a phase 1/phase 2 clinical trial for patients with anterior cruciate ligament injury and osteoarthritis, testing the effectiveness of hyaluronan as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the drug rotigotine in patients with Parkinson's disease, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1 trial for a malaria vaccine, where the drug being tested is a placebo, and the eligibility criteria include being between the ages of 18 and 45, practicing adequate contraception, and being in good health.",
    "This sample is a phase 1 trial testing the drugs mk-0736 and placebo for participants with peripheral vascular diseases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug brentuximab vedotin for patients with relapsed or refractory CD30-positive malignancy, and the eligibility criteria include having adequate organ function and an ECOG performance status of less than 2.",
    "This sample is a clinical trial for patients with leukemia, specifically those with chronic myelogenous leukemia (CML) who are resistant or intolerant to imatinib. The trial is divided into two phases (phase I and phase II) and the drug being tested is radotinib. The eligibility criteria include age, performance status, laboratory values, and previous treatments. Exclusion criteria include CNS infiltration, impaired cardiac function, severe GI disease, and other medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the drug Revlimid, with specific eligibility criteria including previous treatment regimens, disease stage, and performance status.",
    "This sample is a phase 1/phase 2 trial for the treatment of age-related macular degeneration and choroidal neovascularization using the drugs ibi-20089 and lucentis, with specific eligibility criteria for subjects aged 55 and older.",
    "This sample is a phase 1 clinical trial for cancer patients, testing the drugs ic83/ly2603618 and pemetrexed, with eligibility criteria including having at least one evaluable lesion, recovering from previous radiation therapy or surgery, having a life expectancy of at least 3 months, and not being pregnant or breastfeeding.",
    "This sample is a phase 1 trial for healthy non-smoking adult volunteers, testing the effects of dihydroergotamine mesylate (DHE) inhaler on migraine headaches, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for HIV infection, testing the drug panobinostat in patients who meet specific eligibility criteria, including having documented HIV-1 infection, receiving HAART, and having a CD4+ T-cell count >500/mm3.",
    "This sample is a phase 1 clinical trial for patients with neoplastic meningitis, testing the effectiveness of depocyt and temozolomide drugs in treating the disease, with specific eligibility criteria for patients to participate in the study.",
    "This sample is a phase 1/phase 2 clinical trial that aims to investigate the effectiveness of losartan, zileuton, n-acetylcysteine, pravastatin, and erythromycin in treating hermansky-pudlak syndrome (HPS), pulmonary fibrosis, oculocutaneous albinism, platelet storage pool deficiency, and metabolic disease, with specific eligibility criteria for participants.",
    "This sample is a phase 1 clinical trial testing the drug ixabepilone (oral formulation) on patients with advanced solid tumors, with specific inclusion and exclusion criteria.",
    "This sample is a phase I trial testing the effectiveness of haloperidol and placebo in treating nausea and vomiting, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for patients with atrial fibrillation, testing the effectiveness of mangosteen juice and placebo juice in cardioversion, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs capecitabine, epirubicin, amg 102, cisplatin, and placebo on patients with unresectable locally advanced or metastatic gastric or esophagogastric junction adenocarcinoma, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with cervical cancer or precancerous conditions, testing the drug zoledronate, with specific eligibility criteria including biopsy confirmation of cervical intraepithelial neoplasia (CIN) 2/3 or 3, visible lesion by colposcopy, and normal creatinine levels, among others.",
    "This sample is a phase 1/phase 2 trial for patients with prostate cancer, testing the effectiveness of docetaxel, prednisone, and vatalanib in combination, with specific eligibility criteria including disease progression despite castrate levels of testosterone and no pleural effusion or ascites causing respiratory compromise.",
    "This sample is a phase 1/phase 2 clinical trial for kidney transplantation, testing the drugs aeb071 and mycophenolic acid, with inclusion criteria including adult recipients of a functioning kidney transplant, and exclusion criteria including patients infected with hepatitis B or C, or with HIV, and patients with a history of cancer or severe systemic infections.",
    "This sample is a phase 1 trial for HIV uninfected individuals, testing the drug gm-csf, with inclusion criteria including good general health and specific MHC alleles, and exclusion criteria including autoimmune disease, mental illness, and pregnancy or breastfeeding.",
    "This sample is a phase 1 trial testing the efficacy of cisplatin and pazopanib in patients with metastatic solid tumors, specifically HER2-RH- breast cancer, who meet certain eligibility criteria such as having measurable or evaluable disease and a WHO performance status \u2264 1.",
    "This sample is a phase 1/phase 2 trial for metastatic colorectal cancer, colon cancer, and rectal cancer, testing the drugs placebo, amg 655, modified folfox6, and bevacizumab, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 clinical trial testing the drugs carfilzomib and dexamethasone in patients with hematologic malignancies including multiple myeloma, non-Hodgkin's lymphoma, Waldenstr\u00f6m's Macroglobulinemia, and Hodgkin's disease, who have relapsed or are refractory to prior therapies. The eligibility criteria include age \u226518, specific performance status, adequate organ function, and certain laboratory values. There are also exclusion criteria such as recent steroid therapy, recent radiation or chemotherapy, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial for patients with AML or high-risk MDS, testing the drugs idarubicin, sorafenib, and ara-c, with eligibility criteria including age, serum biochemical values, ability to take oral medication, and performance status.",
    "This sample is a phase 1 trial for advanced breast cancer patients, testing the effectiveness of cyclophosphamide, docetaxel, and doxorubicin hydrochloride as adjuvant therapy, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug osi-906, with eligibility criteria including refractory malignancy, ECOG performance status \u2264 2, predicted life expectancy \u2265 12 weeks, and various requirements for prior therapies, glucose levels, electrolyte levels, and organ function.",
    "This sample is a phase 1 trial for HIV infection, testing the effectiveness of the drug HAART in patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for locally advanced pancreatic ductal adenocarcinoma, testing the effectiveness of bevacizumab, 5-fluorouracil, oxaliplatin, and gemcitabine as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for the treatment of aplastic anemia using cyclophosphamide, cyclosporine, and mycophenolate mofetil, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced cancer, testing the drug sgx523 capsules, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug clofarabine for patients with hematologic malignancies, including AML, ALL, myelodysplasia, CML, and aggressive NHL, who have failed previous treatments and meet specific eligibility criteria.",
    "This sample is a phase 1 trial that focuses on patients with relapsed or refractory solid tumors, including lymphomas, and it involves the drugs vorinostat and velcade. The eligibility criteria include age restrictions, performance score requirements, and the absence of curative therapy options.",
    "This sample is a phase 1/phase 2 clinical trial for patients with advanced solid tumors refractory to standard therapy, testing the drug camptothecin (cpt) conjugated to a linear, cyclodextrin-based polymer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for pancreatic cancer, testing the drug vorinostat, and includes eligibility criteria such as ECOG performance status, tumor staging, and organ function requirements.",
    "This sample is a phase 1 clinical trial for cystic fibrosis, testing the efficacy of recombinant human igf-1 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory lymphoid malignancies, including B-cell, T-cell, or Hodgkin's disease, or untreated T-NHL or MCL, testing the efficacy of vorinostat, ifosfamide, carboplatin, and etoposide as chemotherapy drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with previously untreated urothelial carcinoma, testing the drug ipilimumab, and includes eligibility criteria such as requiring surgery for treatment, being ineligible for chemotherapy, and having adequate hematologic, kidney, and liver function.",
    "This sample is a phase 1/phase 2 trial for patients with non-small cell lung cancer (NSCLC), testing the drugs tlk286, carboplatin, and paclitaxel, with specific eligibility criteria including age, disease stage, ECOG status, and adequate organ function.",
    "This sample is a phase 1/phase 2 clinical trial for patients with liver carcinoma, testing the drugs ave1642, sorafenib, and erlotinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus and inadequate glycemic control, testing the effectiveness of canagliflozin compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for non-small cell lung cancer patients, testing the drug cetuximab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a clinical trial for phase 1/phase 2 participants with non-small cell lung cancer, malignant mesothelioma, or advanced/metastatic solid tumors, testing the combination of pemetrexed, cisplatin, and LY2603618 as a first-line palliative treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for the drug azd4877 in patients with advanced solid tumors, including lymphoma, and B-cell non-Hodgkin lymphoma that is not eligible for curative therapy or has relapsed. The eligibility criteria include relatively good overall health other than the cancer, while exclusion criteria include poor bone marrow function, serious heart conditions, and poor liver or kidney function.",
    "This sample is a phase 1 clinical trial testing the drug snx-5422 on patients with refractory solid tumor malignancies, specifically cancer, and the eligibility criteria include age over 18, confirmed histological diagnosis, and adequate organ function.",
    "This phase 1 trial is testing the drug MLN8054 in patients with metastatic and/or advanced solid tumors, including breast neoplasm, colon neoplasm, pancreatic neoplasm, and bladder neoplasm, who have exhausted standard treatment options and have a life expectancy of at least 3 months.",
    "This sample is a phase 1/phase 2 trial for metastatic colorectal cancer, testing the drugs pimasertib, placebo, and folfiri, with eligibility criteria including confirmed K-Ras mutated colon/rectum cancer and disease progression after first-line treatment with oxaliplatin and fluoropyrimidines based chemotherapy.",
    "This sample is a phase 1/phase 2 clinical trial for psoriasis, testing the effectiveness of hat1 topical solution and calcipotriol in patients with a psoriasis area and severity index (PASI) score between 3 and 12, who have not received systemic or topical immunosuppressive treatment within 4 weeks prior to enrollment.",
    "This sample is a phase 1 clinical trial testing the drug cudc-101 on subjects with advanced, refractory solid tumors, who have exhausted standard treatment options, and meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with non-hematologic malignancy, testing the drug bms-275183, with specific eligibility criteria including prior treatment history, blood counts, liver and kidney function, and age and contraception requirements.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent or stage III non-small cell lung cancer, testing the drugs bortezomib, paclitaxel, and carboplatin, with eligibility criteria including specific disease stage, performance status, blood counts, liver and kidney function, heart health, lung function, and exclusion of other severe diseases or infections.",
    "This sample is a phase 1 trial for rectal cancer patients, testing the combination of bevacizumab, capecitabine, and erlotinib, with specific eligibility criteria including performance status, age, tumor stage, and various medical conditions.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer, testing the drug AXL1717, and includes eligibility criteria such as age, diagnosis, organ function, and exclusion criteria such as ongoing infections, constipation, and other active malignancies.",
    "This sample is a phase 1 clinical trial testing the drugs mk-2206, paclitaxel, and trastuzumab in patients with advanced solid tumors, tumors, and cancer, who meet specific eligibility criteria including having HER2+ cancer and adequate organ function.",
    "This sample is a phase 1 trial for patients with mild to moderate persistent allergic asthma, testing the effectiveness of fluticasone compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for healthy subjects, testing the drugs bibr 796 bs and placebo, with inclusion criteria including age, BMI, and laboratory values within reference range, and exclusion criteria including medical abnormalities, disorders, allergies, drug use, and lifestyle factors.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), testing the drug dinaciclib. The inclusion criteria include having received prior therapy with fludarabine or equivalent nucleoside analogue, having an Eastern Cooperative Oncology Group (ECOG) performance status \u2264 2, and agreeing to use contraception. The exclusion criteria include having symptomatic brain metastases or primary central nervous system malignancy, recent chemotherapy or biologic therapy, serious or uncontrolled infection, HIV infection or HIV-related malignancy, and pregnancy or intent to become pregnant.",
    "This sample is a phase 1 trial for patients with lymphoma or unspecified adult solid tumors, testing the drug cdki at7519, with eligibility criteria including specific disease characteristics and patient characteristics such as ECOG performance status, blood counts, kidney function, and cardiac health.",
    "This sample is a phase 1 trial for patients with locally advanced pancreatic cancer, testing the drug gemcitabine hydrochloride, with specific eligibility criteria including performance status, blood counts, liver function, and exclusion of certain comorbidities.",
    "This sample is a phase 1 trial for patients with esophageal neoplasms, carcinoma, squamous cell, adenocarcinoma, and esophageal cancer, testing the drugs capecitabine (xeloda), [18-f] fluorodeoxyglucose (fdg), 5-fluorouracil (5-fu), and carboplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial testing the drugs entinostat and imatinib mesylate for the treatment of Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia and recurrent adult acute lymphoblastic leukemia, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 1 clinical trial testing the drugs cetuximab and lapatinib on patients with colorectal cancer, lung cancer, and head and neck cancer, who have progressed after standard therapy, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs rapamycin and methotrexate in patients with systemic sclerosis, who meet specific inclusion criteria such as satisfying the American College of Rheumatology classification criteria for systemic sclerosis and having skin thickening proximal to the elbows and/or knees.",
    "This sample is a phase 1/phase 2 trial for the treatment of malignant pleural mesothelioma and solid tumors, using drugs pemetrexed, cisplatin, and cbp501, with eligibility criteria including confirmed diagnosis, measurable disease, and adequate organ function.",
    "This sample is a phase 1 trial for patients with pancreatic cancer, testing the drugs gemcitabine and imatinib mesylate, with eligibility criteria including confirmed pancreatic cancer, measurable or evaluable disease, specific performance status, blood counts, liver and kidney function, and no other severe medical conditions or uncontrolled infections.",
    "This phase 1 trial is testing the combination of azacitidine and temozolomide in patients with soft tissue sarcoma or mesothelioma who have recurrent or progressive disease and are ineligible for other high priority studies, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with refractory solid tumors or lymphomas, testing the drugs tanespimycin and bortezomib, with eligibility criteria including performance status, blood counts, liver and kidney function, cardiac and pulmonary health, and exclusion of certain medical conditions.",
    "This sample is a phase 1 trial for patients with peripheral arterial disease, testing the drugs biwh 3 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer who have progressed despite prior therapy, and it involves the drugs rad001, cetuximab, and irinotecan. The eligibility criteria include age, confirmation of CRC diagnosis, measurable lesions, and performance status.",
    "This sample is a phase 1 clinical trial for patients with advanced cancer, testing the drug enmd-2076, with specific eligibility criteria including disease progression after treatment, certain laboratory values, and an Eastern Cooperative Oncology Group performance status of 0 or 1.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory acute lymphoblastic leukemia (ALL), testing the efficacy of a combination therapy including bortezomib, dexamethasone, peg-asparaginase, doxorubicin, cytarabine, methotrexate, vincristine, and triple it therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with head and neck cancer, testing the drugs placebo, palifermin, and cisplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial testing the drug \"bi 660848\" and a placebo on healthy males aged 21-50 with a BMI between 18.5 and <30 kg/m2, and includes inclusion and exclusion criteria for participation in the study.",
    "This sample is a phase 1/phase 2 trial for patients with bladder cancer, testing the drug paclitaxel, nanoparticle albumin-bound, in patients with recurrent bladder cancer refractory to standard intravesical therapy, who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable pancreatic cancer, testing the effectiveness of oxaliplatin, 5fu, and folfox 6 as chemotherapy drugs, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1 clinical trial for the drug losmapimod and moxifloxacin in patients with acute coronary syndrome, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for squamous cell cancer, testing the drugs cilengitide, cetuximab, 5-fluorouracil (5-fu), and cisplatin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with refractory/relapsed acute myeloid leukemia (AML) or myelodysplastic syndromes, testing the drugs vorinostat and decitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced or refractory solid tumors, testing the drug bay86-9766, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with locally advanced or metastatic colorectal cancer, testing the drugs zd6474, cetuximab, and irinotecan, with eligibility criteria including K-ras wildtype tumor, measurable disease, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the drug pd-0325901 in patients with metastatic or inoperable breast cancer, colon cancer, or melanoma, who meet specific eligibility criteria related to age, prior treatment, renal/liver/bone marrow function, reproductive potential, ECOG status, ability to swallow medication, and ability to follow protocol procedures.",
    "This phase 1 trial is investigating the use of sorafenib, a drug used to treat various cancers, in previously untreated or systemically treated poor prognosis non-small cell lung cancer patients who are eligible for palliative thoracic irradiation therapy.",
    "This sample is a phase 1 trial for patients with rheumatoid arthritis, testing the effectiveness of the drug CP-690,550 or placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer, testing the drugs carboplatin, paclitaxel, and medi-575, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial that aims to test the effectiveness of fludarabine, melphalan, and campath in treating various diseases such as preleukemia, myeloproliferative disorders, lymphoma, myeloma, and graft versus host disease, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for metastatic breast cancer, testing the drugs ct-p6, herceptin, and paclitaxel, with inclusion criteria including females with Her 2 over-expression and ECOG 0 or 1, and exclusion criteria including current CNS metastases, known infection, and pregnancy or nursing.",
    "This sample is a phase 1/phase 2 trial for patients with head and neck neoplasms and cancer of the head and neck, testing the drugs carboplatin, cetuximab, and rad001, with eligibility criteria including histologically proven squamous cell carcinoma of the head and neck, evaluable locoregional and/or metastatic disease, and adequate bone marrow, liver, and renal function.",
    "This sample is a phase 1 trial testing the drug glpg1205 and placebo in healthy males, with inclusion criteria of age 18-50 and BMI between 18-30 kg/m2, and exclusion criteria including any condition that might interfere with the study procedures, drug or alcohol abuse, and smoking.",
    "This sample is a phase 1/phase 2 trial for patients with locally advanced, inoperable or metastatic pancreatic adenocarcinoma, testing the combination of bay86-9766 and gemcitabine as a potential treatment option.",
    "This sample is a phase 1 trial for patients with lung cancer, pancreatic cancer, and esophageal cancer, testing the effectiveness of the drugs amg 706, gemcitabine, and cisplatin, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial testing the effectiveness of the drug anti-il-20 compared to a placebo in treating moderate to severe chronic plaque psoriasis, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for untreated or relapsed/refractory acute myeloid leukemia (AML) patients, testing the drug rad001 (everolimus). The eligibility criteria include age restrictions, previous treatment history, written consent, specific disease types, life expectancy, performance status, normal electrolyte levels, adequate hepatic and renal function, no active infections, and cessation of hydroxyurea prior to the study. Exclusion criteria include certain medical or psychiatric conditions, non-compliance to medication, CNS leukemia, uncontrolled viral infections, gastrointestinal diseases, and other severe or uncontrolled medical conditions. Male participants with female partners of childbearing potential must agree to use effective contraception.",
    "This sample is a phase 1/phase 2 trial for Friedreich's ataxia, testing the drugs placebo and deferiprone, with inclusion criteria including a confirmed mutation in the frataxin gene and GAA repeats \u2265 400, and exclusion criteria including iron deficiency and previous use of deferiprone.",
    "This sample is a phase 1 clinical trial for the treatment of dry eye, using the drugs ebi-005-1 and ebi-005-1 placebo, with eligibility criteria including healthy adults between 18 and 65 years old, non-tobacco users, and no history of certain diseases or eye abnormalities.",
    "This sample is a phase 1 clinical trial for patients with indolent B cell Non-Hodgkin's lymphoma, testing the effectiveness of bendamustine hydrochloride as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for lung cancer patients, testing the drug IPI-504, a known Hsp90 inhibitor, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia, testing the drug tki258, and includes inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 clinical trial for patients with HER-2-overexpressing breast cancer and metastatic disease, testing the efficacy of trastuzumab and rad001 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a clinical trial for patients with advanced metastatic gastric cancer or recurrent gastric cancer, testing the drug paclitaxel in phase 1/phase 2, with specific eligibility criteria including ECOG performance status \u2264 2 and proper bone marrow, kidney, and liver function.",
    "This sample is a phase 1 trial for patients with metastatic or unresectable clear cell renal cell carcinoma, testing the combination of rad001 and sorafenib as a treatment option. The eligibility criteria include specific disease characteristics, age, performance status, and adequate organ function.",
    "This sample is a phase 1 trial for breast cancer patients experiencing nausea and vomiting, testing the drugs aprepitant and cyclophosphamide, with specific eligibility criteria including ANC, platelet count, hemoglobin, serum creatinine, and AST/ALT levels.",
    "This sample is a phase 1/phase 2 trial for patients with cardiovascular diseases, specifically idiopathic cardiomyopathy, and heart failure. The study aims to evaluate the use of allopurinol and dobutamine as potential treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 clinical trial testing the drug tki258 on patients with advanced solid tumors that have progressed despite standard therapy, or for which no standard therapy exists. The trial has specific inclusion and exclusion criteria, and patients with brain cancer or concurrent severe medical conditions are excluded.",
    "This sample is a phase 1 clinical trial for patients with metastatic pancreatic cancer, testing the combination of cp-675,206 and gemcitabine as a chemotherapy treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of hypercholesterolemia using alirocumab, ezetimibe, ezetimibe placebo, and fenofibrate, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 1/phase 2 clinical trial for patients with hormone refractory prostate cancer, testing the effectiveness of docetaxel and gemcitabine drugs, with specific eligibility criteria including histologically verified adenocarcinoma of the prostate, stage IV disease, and satisfactory hepatic and renal function.",
    "This sample is a phase 1 trial testing the effectiveness of the drug anti-il-20 in treating inflammation and rheumatoid arthritis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for the drug sumatriptan in patients with migraine. The eligibility criteria include being between 18-55 years old, having a BMI of 18-32 kg/m2, and being in good health. The study also includes exclusion criteria such as having a history of migraines, allergies to sumatriptan or sulphonamides, and recent alcohol or drug abuse.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, testing the drugs arry-520 and filgrastim, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial for patients with metastatic or unresectable estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 negative breast cancer, testing the efficacy of dinaciclib and epirubicin hydrochloride as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug dapagliflozin, and the inclusion criteria include being on voglibose treatment for at least 8 weeks and being diagnosed with type 2 diabetes.",
    "This sample is a phase 1/phase 2 trial for the treatment of Sjogren's syndrome using rituximab (anti-cd20), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with locally advanced or metastatic cancer, testing the drug enzastaurin hydrochloride, and includes eligibility criteria such as specific disease characteristics and patient characteristics.",
    "This sample is a phase 1 clinical trial for patients with ovarian carcinoma, testing the drug fondaparinux, and includes eligibility criteria such as age, disease stage, performance status, and organ function.",
    "This sample is a phase 1 trial for patients with metastatic or unresectable solid tumors, specifically differentiated thyroid cancer and renal cell carcinoma, testing the efficacy of rosiglitazone and xl184 drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with non-Hodgkin lymphoma, testing the drugs sb-485232 and rituximab, with eligibility criteria including confirmed diagnosis, prior treatment with rituximab, and predicted life expectancy of at least 12 weeks.",
    "This sample is a phase 1 trial testing the drugs pazopanib and lapatinib on patients with advanced renal cell carcinoma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of fludarabine, obinutuzumab, bendamustine, and cyclophosphamide as treatment options, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with metastatic melanoma, testing the drugs disulfiram and arsenic trioxide, with eligibility criteria including measurable disease, prior systemic therapy, and a performance status of 0-2.",
    "This sample is a phase 1/phase 2 trial for patients with prostate cancer, testing the drugs sunitinib malate, docetaxel, and prednisone, with eligibility criteria including a histological diagnosis of adenocarcinoma of the prostate, metastatic prostate cancer unresponsive to hormone therapy, and adequate hepatic and renal function.",
    "This sample is a phase 1 clinical trial for patients with solid tumors or lymphoma who are resistant/refractory to approved therapies or for whom no appropriate therapies are available, and the drug being tested is lenvatinib. The eligibility criteria include completion of previous treatment, age greater than or equal to 18 years, Karnofsky performance status greater than or equal to 70%, and written informed consent. Exclusion criteria include brain tumors or metastases, certain laboratory parameters, uncontrolled infections, cardiac impairment, recent treatment with investigational drugs, pregnancy or lactation, and various medical conditions.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) who have relapsed after prior treatment, and it will test the effectiveness of rituximab and alemtuzumab as potential drugs for treatment.",
    "This sample is a phase 1/phase 2 trial for Crohn's disease, testing the drug chondroitin sulfate, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial testing the drugs belinostat and 5-fluorouracil (5-fu) on patients with advanced colorectal cancer or other adenocarcinomas, who have shown tumor progression after standard chemotherapy or where none is yet approved, and meet various eligibility criteria.",
    "This sample is a phase 1/phase 2 trial for non-small cell lung cancer patients, testing the drugs bevacizumab, erlotinib, and pemetrexed, with eligibility criteria including age, disease stage, performance status, renal and hepatic function, bone marrow function, and prior procedures, while excluding certain histologies, hypercalcemia, infections, and other conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia, testing the effectiveness of multiple drugs including busulfan, cyclophosphamide, and fludarabine phosphate, among others, in combination with stem cell transplant. The eligibility criteria include specific disease characteristics, availability of a donor, and various patient characteristics such as organ function and absence of certain infections.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer, testing the drug MDV3100, and includes eligibility criteria such as confirmed adenocarcinoma of the prostate, ongoing androgen deprivation therapy, and exclusion criteria such as brain metastases and history of another malignancy within the previous 5 years.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML), testing the combination of voreloxin injection and cytarabine as a treatment option. The eligibility criteria include specific disease subtypes, prior treatment history, and certain laboratory values.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of b-cell chronic lymphocytic leukemia and small lymphocytic lymphoma using the drug pci-32765. The eligibility criteria include age requirements, previous treatment history, ECOG performance status, and willingness to participate in evaluations and procedures. Exclusion criteria include prior malignancy, recent therapy, CNS involvement, major surgery, concomitant use of certain medications, significant ECG abnormalities, and lactating or pregnant status.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast neoplasms and metastases, neoplasm. The study aims to evaluate the efficacy of cyclophosphamide, doxorubicin hydrochloride, fludarabine phosphate, paclitaxel, and mesna in treating these diseases, with specific eligibility criteria for patient selection.",
    "This sample is a phase 1/phase 2 trial for women with Her-2 positive and ER-negative or ER-low breast cancer, testing the effectiveness of trastuzumab (herceptin\u00ae) in preventing metastasis, with specific eligibility criteria including no prior treatment with chemotherapy, hormonal therapy, or trastuzumab.",
    "This sample is a phase 1/phase 2 trial testing the use of g-csf and saline in patients preparing for in vitro fertilization and embryo transfer with endometrial growth of less than 7 mm, unresponsive to standard treatment, and excluding patients with sickle cell disease, renal insufficiency, upper respiratory infection or pneumonia, chronic neutropenia, and known past or present malignancy.",
    "This sample is a phase 1 trial for patients with breast cancer, testing the drugs lapatinib ditosylate and doxil, with eligibility criteria including confirmed adenocarcinoma of the breast, measurable disease, and specific patient characteristics and prior concurrent therapy requirements.",
    "This sample is a phase 1 trial for patients with unspecified adult solid tumors, testing the combination of pr-104, docetaxel, and gemcitabine hydrochloride, with specific eligibility criteria including confirmed tumor malignancy, certain blood counts, liver and kidney function, and exclusion of certain medical disorders or infections.",
    "This sample is a phase 1/phase 2 trial investigating the drugs ji-101 and everolimus for the treatment of refractory solid tumors, metastatic ovarian carcinoma, metastatic KRAS mutant colorectal cancer, and metastatic head and neck squamous cell cancer. The eligibility criteria include having measurable tumors, being in good organ and marrow function, and not having certain medical conditions or allergies.",
    "This sample is a phase 1/phase 2 trial for the treatment of chronic hepatitis C, testing the drugs bms-791325 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial that aims to evaluate the efficacy of amifostine trihydrate, busulfan, filgrastim, melphalan, and thiotepa in treating high-risk or relapsed solid tumors or brain tumors, including Ewing's sarcoma, rhabdomyosarcoma, Wilms' tumor, neuroblastoma, retinoblastoma, germ cell tumors, soft tissue sarcomas, ovarian sarcoma, primitive neuroectodermal tumors, chordomas, and hepatoblastoma, in patients aged 1 to 45 with specific eligibility criteria.",
    "This sample is a phase I clinical trial for patients with hepatocellular carcinoma (HCC) using the drug Nexavar, and it includes eligibility criteria such as age, diagnosis confirmation, performance status, and various health assessments.",
    "This sample is a phase I clinical trial for patients with asthma, testing the drug iloprost, and the eligibility criteria include age 18-60, controlled asthma, ability to give informed consent, ability to perform pulmonary function tests, ability to tolerate the initial Ventavis inhalation, and ability to comply with the study protocol.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer who have failed previous treatments, and it aims to evaluate the effectiveness of the drug he3235 in treating the disease. The eligibility criteria include having confirmed adenocarcinoma of the prostate, disease progression despite hormone therapy, and specific PSA levels or evidence of disease progression.",
    "This sample is a phase 1/phase 2 trial testing the combination of temsirolimus and sunitinib in patients with renal cell carcinoma, with specific inclusion and exclusion criteria for each phase of the trial.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors or lymphoma, testing the combination of gemcitabine hydrochloride and triapine as a potential treatment option. The eligibility criteria include specific requirements for performance status, blood counts, liver and kidney function, and exclusion of certain medical conditions.",
    "This sample is a phase 1 trial for asthma patients, testing the drugs gsk679586 and placebo, with inclusion criteria including age, body weight, non-smoking status, and ability to read and comprehend English, and exclusion criteria including medical unsuitability, allergies, previous exposure to antibody therapy, and history of chronic infections.",
    "This sample is a phase 1 clinical trial for HIV infections, testing the drug maraviroc in combination with other investigational antiretroviral compounds, with specific eligibility criteria based on genotype interpretation and resistance testing.",
    "This sample is a phase 1/phase 2 clinical trial for patients with glioblastoma or gliosarcoma, testing the drugs enzastaurin and temozolomide, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial for a drug called rv568 and a placebo, testing their effectiveness in treating respiratory syncytial virus infections. The eligibility criteria include being a healthy male aged 18-45, having low titres of RSV neutralising antibody, and not having certain medical conditions or recent medication use.",
    "This sample is a phase 1 clinical trial testing the drug regorafenib (stivarga, bay73-4506) on Chinese subjects with advanced solid tumors that are refractory to standard treatment or have no standard therapy available. The inclusion criteria include being over 18 years old, having an Eastern Cooperative Oncology Group performance status of 0-1, and having adequate bone marrow, liver, and renal function. The exclusion criteria include unstable/uncontrolled cardiac disease, history of arterial or venous thrombotic or embolic events, malabsorption condition, severe renal impairment, symptomatic metastatic brain or meningeal tumors, and clinically significant bleeding within 30 days before starting the study medication.",
    "This sample is a phase 1/phase 2 trial for non-Hodgkin's lymphoma, specifically diffuse large B-cell lymphoma and mantle cell lymphoma, using vincristine sulfate liposome injection plus rituximab as the drug combination, with specific eligibility criteria for patients to be included in the study.",
    "This sample is a phase 1/phase 2 trial for relapsed CD20-positive B-cell non-Hodgkin's lymphoma, testing the efficacy of drugs such as Zevalin, Rituxan, BCNU, VP-16, Ara-C, Melphalan, and G-CSF, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced cancer, solid tumors, and neoplasms, testing the drug rigosertib sodium, with specific eligibility criteria including previous treatment history, performance status, blood counts, liver and kidney function, and contraception requirements.",
    "This sample is a phase 1 trial testing the drug bavituximab in adults with HIV and chronic hepatitis C infection, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial that aims to evaluate the efficacy of temsirolimus and vinorelbine ditartrate in patients with metastatic or unresectable solid tumors, including lung, breast, ovary, cervix, prostate, uterus, renal, bladder, and neuroendocrine tumors, who have no standard curative treatment options available. The study has specific inclusion and exclusion criteria, and patients must meet certain health requirements to be eligible for participation.",
    "This sample is a phase 1 trial for patients with breast cancer, testing the drugs erlotinib and rad001, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 clinical trial testing the drug intravenous ezn-2968 (anti-hif-1\u03b1 lna as-odn) on patients with advanced and/or metastatic solid tumors or lymphoma who have failed standard therapy and have no known effective therapy available to them. The eligibility criteria include a confirmed diagnosis, measurable or evaluable disease, and age 18 years or older. Exclusion criteria include concurrent serious medical illness and prior chemotherapy or other cancer treatments within a specified timeframe.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of melanoma using Normothermic Isolated Limb Infusion (ILI) of melphalan, with inclusion criteria including signed informed consent, measurable disease, and availability for N-cadherin expression testing, and exclusion criteria including prior use of ADH-1, stage IV melanoma, and recent chemotherapy or major surgery.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the drug bi10773 and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with non-small cell lung cancer (NSCLC) who have undergone surgery, and it evaluates the use of cisplatin and vinorelbine as adjuvant chemotherapy treatments. The eligibility criteria include specific tumor characteristics, absence of distant metastasis, and various other medical requirements.",
    "This sample is a phase 1 trial for HIV patients who are currently receiving a stable antiretroviral regimen and are willing to switch therapy to test the effectiveness of rilpivirine, a drug used to treat HIV.",
    "This sample is a phase 1 trial for the drug dapagliflozin in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria related to diabetes diagnosis, glucose levels, and kidney function.",
    "This sample is a phase 1 trial testing the drug azd4877 for patients with lymphoma, and the eligibility criteria include certain types of cancer, failed previous treatments, and relatively good overall health.",
    "This sample is a phase 1 trial for patients with type 2 diabetes, testing the effectiveness of insulin degludec, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with chronic myelogenous leukemia and philadelphia chromosome positive acute lymphoblastic leukemia, testing the drug dasatinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for previously untreated aggressive non-Hodgkin's lymphoma, testing the effectiveness of cyclophosphamide, doxorubicin, vincristine, and prednisone as a treatment option. The eligibility criteria include measurable or evaluable disease, stage I-IV patients, age 18 or older, and no evidence of grade 3 or more neurosensory or neuromotor dysfunction. HIV positive patients, those with inadequate bone marrow and organ function, CNS involvement by lymphoma, uncontrolled intercurrent disease, active infection or fever, inadequate contraceptive precautions, pregnancy, or breastfeeding are excluded from the study.",
    "This phase 1 trial aims to evaluate the efficacy of decitabine and pegylated liposomal doxorubicin hydrochloride in treating patients with relapsed epithelial ovarian cancer, including fallopian tube and primary peritoneal cancer, who have received up to four previous lines of chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for Alzheimer's disease, testing the drug GSK933776 and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for healthy male volunteers, testing the drug hm10560a and placebo, with inclusion criteria including age range, BMI, medical health, and ability to abstain from alcohol and smoking, and exclusion criteria including infection history, hypersensitivity to recombinant human growth hormone, and various medical conditions and medication use.",
    "This sample is a phase 1/phase 2 trial for patients with breast cancer, testing the drugs ptk787 and trastuzumab, with specific eligibility criteria including HER2 gene amplification and restrictions on prior treatments and medical conditions.",
    "This sample is a phase 1 clinical trial for healthy adults, investigating the drugs sam-531 and donepezil, with inclusion criteria including age, body mass index, and overall good health, and exclusion criteria including various medical conditions and recent consumption of caffeine or alcohol.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or locally recurrent colorectal cancer, testing the drugs zd1839 and oxaliplatin in patients who have failed prior therapy with fluorouracil, leucovorin calcium, and irinotecan. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "This sample is a phase 1 trial for breast cancer patients, testing the drugs paclitaxel, docetaxel, and capecitabine, with eligibility criteria including histologic confirmation of invasive breast cancer, certain tumor sizes and lymph node involvement, and adequate organ function.",
    "This sample is a phase 1 trial for patients with melanoma, testing the drugs genasense\u00ae (oblimersen), abraxane\u00ae (paclitaxel protein-bound particles), and temodar\u00ae (temozolomide), with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for HCV infection, testing the drugs VCH 916 and placebo, with inclusion criteria including age, liver health, HCV genotype, and contraception use, and exclusion criteria including participation in other clinical trials, drug or alcohol use, liver cirrhosis, and certain medical conditions.",
    "This sample is a phase 1 trial for patients with recurrent platinum-sensitive or platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer, testing the efficacy of intravenous docetaxel with intraperitoneal oxaliplatin and intravenous oxaliplatin with intraperitoneal docetaxel as treatment options. The eligibility criteria include specific disease history, performance score, bone marrow and renal function, hepatic function, and prior treatments, while excluding patients with active infections, extra-abdominal metastases, active CNS metastases, and certain medical conditions.",
    "This sample is a phase 1/phase 2 trial investigating the use of bumetanide, a diuretic, in term babies with neonatal seizures who have received standard anticonvulsive therapy and meet specific inclusion criteria, excluding those with certain medical conditions or who have received diuretics or other anticonvulsive medications.",
    "This sample is a phase 1 clinical trial for patients with various types of cancer, testing the drugs gsk1120212 and gsk2110183, with specific eligibility criteria including age, disease type, prior treatment toxicities, and organ function.",
    "This sample is a phase 1 clinical trial for patients with type 1 diabetes mellitus, testing the effectiveness of insulin glargine and a new formulation of insulin glargine in Japanese patients, with specific inclusion and exclusion criteria.",
    "This sample is a phase I clinical trial for patients with breast cancer, testing the combination of lapatinib ditosylate and paclitaxel albumin-stabilized nanoparticle formulation as a treatment option. The eligibility criteria include histologically confirmed breast cancer, HER2/neu positive status, and specific patient characteristics such as normal organ function and absence of other malignancies. Prior concurrent therapy restrictions are also outlined.",
    "This sample is a phase 1 clinical trial for dementia, testing different drug combinations including placebo, donepezil, mk-3134, and scopolamine, with specific eligibility criteria for male participants between 18 and 40 years of age."
]
